Book Chapters
| Num | Title |
|---|---|
| 18 | Yilmaz Y, Younossi ZM. Obesity-associated nonalcoholic fatty liver disease. Clin Liver Dis. 2014 Feb;18(1):19-31. doi: 10.1016/j.cld.2013.09.018. Epub 2013 Oct 24. PMID: 24274862. |
| 17 | McGown C, Birerdinc A, Younossi ZM. Adipose tissue as an endocrine organ. Clin Liver Dis. 2014 Feb;18(1):41-58. doi: 10.1016/j.cld.2013.09.012. PMID:24274864. |
| 16 | Mehta R, Birerdinc A, Younossi ZM. Host genetic variants in obesity-related nonalcoholic fatty liver disease. Clin Liver Dis. 2014 Feb;18(1):249-67. doi:10.1016/j.cld.2013.09.017. Epub 2013 Oct 24. PMID: 24274878. |
| 15 | Younossi ZM. Obesity and liver disease. Clin Liver Dis. 2014 Feb;18(1):xiii-xiv. doi: 10.1016/j.cld.2013.09.020. Epub 2013 Oct 25. PMID: 24274879. |
| 14 | Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clin Liver Dis. 2016 May;20(2):205-14..doi:10.1016/j.cld.2015.10.001. Epub 2015 Dec 14. PMID: 27063264. |
| 13 | Younossi ZM (Guest Editor). Hepatitis C Infection: A Systemic Disease. Clin Liver Dis. 2017, Aug;21(3):449-453. doi: 10.1016/j.cld.2017.03.001. Epub 2017 Apr 20. PMID:28689584. |
| 12 | Sayiner M, Golabi P, Farhat F, Younossi ZM. Dermatologic Manifestations of Chronic Hepatitis C Infection. Clin Liver Dis. 2017 Aug;21(3):555-564. doi:10.1016/j.cld.2017.03.010. Epub 2017 Apr 25. PMID: 28689593. |
| 11 | Golabi P, Sayiner M, Bush H, Gerber LH, Younossi ZM. Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection. Clin Liver Dis. 2017 Aug;21(3):565-578. doi: 10.1016/j.cld.2017.03.011. Epub 2017 Apr 26.PMID: 28689594. |
| 10 | Stepanova M, Younossi ZM. Economic Burden of Hepatitis C Infection. Clin Liver Dis. 2017 Aug;21(3):579-594. doi: 10.1016/j.cld.2017.03.012. Epub 2017 Apr 22. PMID: 28689595. |
| 9 | Golabi P, Bush H, Younossi ZM. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clin Liver Dis. 2017 Nov;21(4):739-753. doi:10.1016/j.cld.2017.06.010. Epub 2017 Jul 29. PMID:28987260. |
| 8 | Younossi ZM, Henry L, Bush H, Mishra A. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clin Liver Dis. 2018 Feb;22(1):1-10. doi: 10.1016/j.cld.2017.08.001. Epub 2017 Oct 14. PMID: 29128049. |
| 7 | Golabi P, Isakov V, Younossi ZM. Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness. Clin Liver Dis. 2023 May;27(2):173-186. doi: 10.1016/j.cld.2023.01.001. Epub 2023 Feb 26. PMID: 37024201. |
| 6 | Henry L, Eberly KE, Shah D, Kumar A, Younossi ZM. Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2023 May;27(2):373-395. doi: 10.1016/j.cld.2023.01.022. Epub 2023 Mar 8. PMID: 37024214 |
| 5 | Stepanova M, Henry L, Younossi ZM. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2023 May;27(2):483-513. doi: 10.1016/j.cld.2023.01.007. Epub 2023 Mar 8. PMID:37024220. |
| 4 | Younossi ZM. (Guest Editor); An Update on Non-alcoholic Steatohepatitis Preface. Clin Liver Dis. 2023 May;27(2):xix. doi:10.1016/j.cld.2023.02.001. Epub 2023 Mar 9. PMID: 37024223. |
| 3 | Cheryl Pokalo, Felix Rivera Mercado. Magill's Medical Guide 9th Ed: Palliative Medicine, Salem Health. |
| 2 | Zobair M Younossi, Linda Henry. Quality of Life Issues for Patients with Cirrhosis, Publication house ‘Springer’. Chapter Complications of Cirrhosis pp 323-336 April 09 2015 |
| 1 | Lynn Gerber, Ali Weinstein, Lisa Pawloski. The Impact of Obesity and Nutrition on Chronic Liver Diseases: Role of Exercise in Optimizing the Functional Status of Patients with Nonalcoholic Fatty Liver Disease, Clinics In Liver Disease. Clin Liver Dis. 2014 Feb;18(1):113-27. doi: 10.1016/j.cld.2013.09.016 |
Publications
| Num | Title |
|---|---|
| 1 | Jillian Kallman Price, Leyla de Avila, Maria Stepanova, Ali Weinstein, Huong T. Pham, Wisna'odom Keo, Andrei Racila, Suzannah Gerber, Brian P. Lam, Lynn Gerber, Zobair M Younossi. Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women, International Journal of General Medicine. Int J Gen Med . 2023 Sep 27:16:4393-4404. doi: 10.2147/IJGM.S423910. eCollection 2023. |
| 2 | Maria Stepanova, Ameeta Kumar, Pamela Brandt, Nagashree Gundurao, Kenneth Cusi, Saleh Alqahtani, Zobair M Younossi. Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplantations in the U.S.: Data From a National Registry, Diabetes Care. Diabetes Care . 2023 Sep 25:dc231085. doi: 10.2337/dc23-1085. Online ahead of print. |
| 3 | Maria Buti. Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives, Journal of Hepatology. J Hepatol . 2023 Aug 25;S0168-8278(23)05041-9. doi: 10.1016/j.jhep.2023.07.029. Online ahead of print. |
| 4 | Zobair M Younossi, Linda Henry, Scott Isaacs, Kenneth Cusi. Identification of High Risk NAFLD Patients in Endocrinology Clinics, Endocrine Practice. Endocr Pract . 2023 Jul 3;S1530-891X(23)00469-X. doi: 10.1016/j.eprac.2023.06.012. Online ahead of print. |
| 5 | Maria Stepanova, Zobair M Younossi. Editorial: optimal combination of non-invasive tests to determine significant fibrosis in non-alcoholic fatty liver disease-authors' reply, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2023 Jun;57(12):1463-1464. doi: 10.1111/apt.17517. |
| 6 | Zobair M Younossi, Grace Lai-Hung Wong, Quentin Anstee, Linda Henry. The Global Burden of Liver Disease, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2023 Jul;21(8):1978-1991. doi: 10.1016/j.cgh.2023.04.015. Epub 2023 Apr 28. |
| 7 | James Minhui Paik, Elisabeth Eberly, Khaled W. Kabbara, Michael Harring, Youssef Younossi, Linda Henry, Manisha Verma, Zobair M Younossi. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.), Annals of Hepatology. Ann Hepatol . 2023 Jul-Aug;28(4):101108. doi: 10.1016/j.aohep.2023.101108. Epub 2023 Apr 23. |
| 8 | Jillian Kallman Price, Lynn Gerber, Maria Stepanova, Leyla de Avila, Ali Weinstein, Huong T. Pham, Fatema Nader, Mariam Afendy, Kathy Terra, Patrick Austin, Wisna'odom Keo, Andrei Racila, James M. Estep, Suzannah Gerber, Manisha Verma, Pegah Golabi, Brian P. Lam, Zobair M Younossi. Post-acute SARS-COV-2 symptoms are fewer, less intense over time in people treated with mono-clonal antibodies for acute infection, International Journal of General Medicine. Int J Gen Med . 2023 Apr 24:16:1479-1490. doi: 10.2147/IJGM.S406571. eCollection 2023. |
| 9 | Jeffrey V. Lazarus, CJ Kopka, Zobair M Younossi, Alina M. Allen. It's time to expand the fatty liver disease community of practice., Hepatology. Hepatology . 2023 Nov 1;78(5):1325-1328. doi: 10.1097/HEP.0000000000000411. Epub 2023 Jun 23. |
| 10 | Linda Henry, Zobair M Younossi. Reply: NAFLD/MAFLD: One size does not fit all, certainly not for children!, Hepatology. Hepatology . 2023 Jun 1;77(6):E191. doi: 10.1097/HEP.0000000000000397. Epub 2023 Apr 11. |
| 11 | Maria Stepanova, Linda Henry, Zobair M Younossi. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease., Clinics In Liver Disease. Clin Liver Dis . 2023 May;27(2):483-513. doi: 10.1016/j.cld.2023.01.007. Epub 2023 Mar 8. |
| 12 | Zobair M Younossi, Maria Stepanova, Sean C. Felix, Thomas Jeffers, Elena Younossi, Zachary Goodman, Andrei Racila, Brian P. Lam, Linda Henry. The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2023 Jun;57(12):1417-1422. doi: 10.1111/apt.17472. Epub 2023 Mar 26. |
| 13 | Linda Henry, Katherine Elizabeth Eberly, Dipam Shah, Ameeta Kumar, Zobair M Younossi. Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease., Clinics In Liver Disease. Clin Liver Dis . 2023 May;27(2):373-395. doi: 10.1016/j.cld.2023.01.022. Epub 2023 Mar 8. |
| 14 | Austin Henry, James Minhui Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, Lynn Gerber, Zobair M Younossi. Editorial: let's get physical-long-term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' reply., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2023 Mar;57(6):731-732. doi: 10.1111/apt.17349. |
| 15 | Michael Harring, Pegah Golabi, James Minhui Paik, Dipam Shah, Andrei Racila, Rebecca Cable, Manirath Srishord, Zobair M Younossi. Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis., Clin Gastroenterol Hepatol . 2023 Oct;21(11):2876-2888.e5. doi: 10.1016/j.cgh.2023.02.013. Epub 2023 Feb 26. |
| 16 | Pegah Golabi, Vasily Isakov, Zobair M Younossi. Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness, Clinics In Liver Disease. Clin Liver Dis . 2023 May;27(2):173-186. doi: 10.1016/j.cld.2023.01.001. Epub 2023 Feb 26. |
| 17 | Alina M. Allen, Jeffrey V. Lazarus, Zobair M Younossi. Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties., Journal of Hepatology. J Hepatol . 2023 Jul;79(1):209-217. doi: 10.1016/j.jhep.2023.01.026. Epub 2023 Feb 4. |
| 18 | Leyla de Avila, Jillian Kallman Price, Brian P. Lam, Ali Weinstein, Huong T. Pham, Patrick Austin, Wisna'odom Keo, Zaid Younossi, Pegah Golabi, Manisha Verma, Fatema Nader, Andrei Racila, Lynn Gerber, Zobair M Younossi. Regular Exercise is Associated with Low Fatigue Levels and Good Functional Outcomes Post- COVID-19: A Prospective Observational Study, American Journal of Physical Medicine and Rehabilitation. Am J Phys Med Rehabil . 2023 May 1;102(5):433-443. doi: 10.1097/PHM.0000000000002197. Epub 2023 Feb 1. |
| 19 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC., Hepatology Communications. Hepatol Commun . 2023 Feb 1;7(2):e0049. doi: 10.1097/HC9.0000000000000049. |
| 20 | Zobair M Younossi. Recent Research and Insights on the Disease Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, Gastroenterol Hepatol (NY). Gastroenterol Hepatol (N Y) . 2023 Feb;19(2):108-110. |
| 21 | Leyla de Avila, Linda Henry, James Minhui Paik, Naila Ijaz, Ali Weinstein, Zobair M Younossi. Nonalcoholic fatty liver disease (NAFLD) is independently associated with higher all-cause and cause-specific mortality, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2023 Sep;21(10):2588-2596.e3. doi: 10.1016/j.cgh.2023.01.006. Epub 2023 Jan 13. |
| 22 | Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khaled Alswat, Maria Buti, Marlen Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay Duseja, Stuart C. Gordon, Yuichiro Eguchi, Vasily Isakov, Stuart Roberts, Jian-Gao Fan, Ashwani K. Singal, Manuel Romero-Gomez, Aijaz Ahmed, Janus P. Ong, Brian P. Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani. Clinical and Patient-Reported Outcome Profile of Patients with Hepatitis B Viral Infection from the Global Liver Registryâ¢, Journal of Viral Hepatitis. J Viral Hepat . 2023 Apr;30(4):335-344. doi: 10.1111/jvh.13800. Epub 2023 Jan 11. |
| 23 | Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khaled Alswat, Maria Buti, Marlen Castellanos-Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay Duseja, Stuart C. Gordon, Yuichiro Eguchi, Vasily Isakov, Stuart Roberts, Jian-Gao Fan, Ashwani K. Singal, Manuel Romero-Gomez, Aijaz Ahmed, Janus P. Ong, Brian P. Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani. Clinical and patientâreported outcome profile of patients with hepatitis B viral infection from the Global Liver Registryâ¢, Journal of Viral Hepatitis. J Viral Hepat . 2023 Apr;30(4):335-344. doi: 10.1111/jvh.13800. Epub 2023 Jan 11. |
| 24 | Zobair M Younossi, Pegah Golabi, James Minhui Paik, Austin Henry, Dongen C Van, Linda Henry. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review., Hepatology. Hepatology . 2023 Apr 1;77(4):1335-1347. doi: 0.1097/HEP.0000000000000004. Epub 2023 Jan 3. |
| 25 | Zobair M Younossi, James Minhui Paik, Linda Henry, Joe Yang, Gail Fernandes, Maria Stepanova, Fatema Nader. The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States (U.S.), Journal of Clinical and Experimental Hepatology. J Clin Exp Hepatol . 2023 May-Jun;13(3):454-467. doi: 10.1016/j.jceh.2022.12.005. Epub 2022 Dec 22. |
| 26 | Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Rohit Loomba, Natarajan Ravendhran, Brian P. Lam, Fatema Nader, Andrei Racila, Linda Henry. A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2023 Feb;57(3):304-312. doi: 10.1111/apt.17346. Epub 2022 Dec 13. |
| 27 | Ali Weinstein, Dung Ngo, Leyla de Avila, Jillian Kallman Price, Pegah Golabi, Patrick Austin, Carey Escheik, Lynn Gerber, Zobair M Younossi. Association of physical activity an fine motor performance in individuals with type 2 diabetes mellitus and/or no-alcoholic fatty liver disease, Annals of Internal Medicine. Ann Med . 2023 Dec;55(1):1345-1353. doi: 10.1080/07853890.2023.2193422. |
| 28 | Austin Henry, James Minhui Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, Lynn Gerber, Zobair M Younossi. Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD), Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2022 Nov 15. doi: 10.1111/apt.17308. Online ahead of print. |
| 29 | Yusuf Yilmaz, Ahment Eren Toraman, Ceyda Alp, Zehra Dogan, Caglayan Keklikkiran, Maria Stepanova, Zobair M Younossi. Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2022 Nov 11. doi: 10.1111/apt.17301. Online ahead of print. |
| 30 | Zobair M Younossi, James Minhui Paik, Pegah Golabi, Youssef Younossi, Linda Henry, Fatema Nader. The Impact of Fatigue on Mortality of Patients with Non-alcoholic Fatty Liver Disease (NAFLD): Data from National Health and Nutrition Examination Survey (NHANES) 2005-2010 and 2017-2018, Liver International. Liver Int . 2022 Dec;42(12):2646-2661. doi: 10.1111/liv.15437. Epub 2022 Oct 6. |
| 31 | Maria Stepanova, Brian P. Lam, Elena Younossi, Sean C. Felix, Mariam Ziayee, Jillian Kallman Price, Huong T. Pham, Leyla de Avila, Kathy Terra, Patrick Austin, Thomas Jeffers, Carey Escheik, Pegah Golabi, Rebecca Cable, Manirath Srishord, Chapy Venkatesan, Linda Henry, Lynn Gerber, Zobair M Younossi. The Impact of Variants and Vaccination on the Mortality and Resource Utilization of Hospitalized Patients with COVID-19, BMC Infectious Diseases. BMC Infect Dis . 2022 Aug 22;22(1):702. doi: 10.1186/s12879-022-07657-z. |
| 32 | Catherine Van Dongen, James Minhui Paik, Michael Harring, Youssef Younossi, Jillian Kallman Price, Khaled W. Kabbara, Pegah Golabi, Zobair M Younossi. Sarcopenia, healthy living, and mortality in patients with chronic liver diseases, Hepatology Communications. Hepatol Commun . 2022 Aug 10. doi: 10.1002/hep4.2061. Online ahead of print. |
| 33 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova. The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry, Hepatology Communications. Hepatol Commun . 2022 Oct;6(10):2860-2866. doi: 10.1002/hep4.2048. Epub 2022 Jul 26. |
| 34 | Linda Henry, James Minhui Paik, Zobair M Younossi. Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2022 Sep;56(6):942-956. doi: 10.1111/apt.17158. Epub 2022 Jul 26. |
| 35 | Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveriro, Fatema Nader, Luisa Roade, Rafael Esteban, Zobair M Younossi. Corrigendum to 'Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B, JHEP Reports. JHEP Rep . 2022 Jul 20;4(9):100526. doi: 10.1016/j.jhepr.2022.100526. eCollection 2022 Sep. |
| 36 | Zobair M Younossi, P Aggarwal, I Shrestha, J Fernandes, P Johansen, M Augusto, S Nair. The burden of non-alcoholic steatohepatitis: A systematic review of health- related quality of life and patient-reported outcomes, JHEP Reports. JHEP Rep . 2022 Jun 15;4(9):100525. doi: 10.1016/j.jhepr.2022.100525. eCollection 2022 Sep. |
| 37 | Zobair M Younossi, Rohit Loomba. PATIENTS WITH RADIOGRAPHIC EVIDENCE FOR FATTY LIVER AND ABNORMAL LIVER ENZYMES SHOULD UNDERGO LIVER BIOPSY TO CONFIRM NASH, Digestive Disease Week. |
| 38 | Zobair M Younossi, Maria Stepanova, Robert P. Myers, Issah Younossi, Linda Henry. The Potential Role of Fatigue in Identifying Patients With NASH and Advanced Fibrosis Who Experience Disease Progression, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 May 6;S1542-3565(22)00448-7. doi: 10.1016/j.cgh.2022.04.023. Online ahead of print. |
| 39 | Zobair M Younossi, James Minhui Paik, Reem Al Shaheeb, Pegah Golabi, Issah Younossi, Linda Henry. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?, Hepatology. Hepatology . 2022 Nov;76(5):1423-1437. doi: 10.1002/hep.32499. Epub 2022 May 2. |
| 40 | Kenneth Cusi, Scott Isaacs, Diana Barb, Rita Basu, Sonia Caprio, W Timothy Garvey, Sangeeta Kashyap, Jeffrey I. Mechanick, Marialena Mouzaki, Karl Nadolsky, Mary E. Rinella, Mariam Vos, Zobair M Younossi. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD), Endocrine Practice. Endocr Pract . 2022 May;28(5):528-562. doi: 10.1016/j.eprac.2022.03.010. |
| 41 | Ali Weinstein, Leyla de Avila, Saisruthi Kannan, James Minhui Paik, Pegah Golabi, Lynn Gerber, Zobair M Younossi. Interrelationship between physical activity and depression in nonalcoholic fatty liver disease, World Journal of Hepatology. World J Hepatol . 2022 Mar 27;14(3):612-622. doi: 10.4254/wjh.v14.i3.612. |
| 42 | Maria Stepanova, Khaled W. Kabbara, Denise Mohess, Manisha Verma, Alva Roche-Green, Saleh Alqahtani, Janus P. Ong, Patrizia Burra, Zobair M Younossi. Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients, Hepatology. Hepatol Commun . 2022 Jul;6(7):1506-1515. doi: 10.1002/hep4.1915. Epub 2022 Feb 28. |
| 43 | Brian P. Lam, Maria Stepanova, Chapy Venkatesan, Ivan Garcia, Mary Jane Reyes, Mohammed Mannan, Soleyah C. Groves, Mehul Desai, Andrei Racila, Andrej Kolacevski, Linda Henry, Lynn Gerber, Zobair M Younossi. Outcomes of Hospitalized Patients with COVID-19 During the Course of the Pandemic in a Fully Integrated Health System, PLOS One. PLoS One . 2022 Feb 25;17(2):e0263417. doi: 10.1371/journal.pone.0263417. eCollection 2022. |
| 44 | Jeffrey V. Lazarus, Laurent Castera, Henry E. Mark, Alina M. Allen, LA Adams, Quentin Anstee, Marco Arrese, Saleh Alqahtani, Elisabetta Bugianesi, Massimo Colombo, Kenneth Cusi, Hannes Hagstrom, Rohit Loomba, Manuel Romero-Gomez, Jorn M. Schattenberg, M Thiele, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M Younossi, Sven Francques, Emmanuel A. Tsochatzis. Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice, JHEP Reports. JHEP Rep . 2022 Sep 22;5(1):100596. doi: 10.1016/j.jhepr.2022.100596. eCollection 2023 Jan. |
| 45 | Issah Younossi, Maria Stepanova, Mercedes Walters, Pegah Golabi, Manirath Srishord, Zobair M Younossi. Health-Related Quality of Life and Health Care Resource Utilization in Patients With Chronic Liver Disease and Primary Liver Cancer in the United States: Analysis of Medical Expenditure Panel Survey, Journal of Clinical and Experimental Hepatology. J Clin Exp Hepatol . 2022 Mar-Apr;12(2):272-277. doi: 10.1016/j.jceh.2021.12.012. Epub 2021 Dec 29. |
| 46 | Zobair M Younossi, Linda Henry. Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis, Endocrine Practice. Endocr Pract . 2022 Feb;28(2):204-213. doi: 10.1016/j.eprac.2021.12.010. Epub 2021 Dec 22. |
| 47 | James Minhui Paik, Khaled W. Kabbara, Katherine Elizabeth Eberly, Youssef Younossi, Linda Henry, Zobair M Younossi. Global burden of NAFLD and chronic liver disease among adolescents and young adults, Hepatology. Hepatology . 2022 May;75(5):1204-1217. doi: 10.1002/hep.32228. Epub 2021 Dec 21. |
| 48 | Pegah Golabi, James Minhui Paik, Elena Younossi, Khaled W. Kabbara, Zobair M Younossi. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 Dec;20(12):2838-2847.e7. doi: 10.1016/j.cgh.2021.12.015. Epub 2021 Dec 17. |
| 49 | Jeffrey V. Lazarus, Henry E. Mark, Marcela Villota-Rivas, Adam Palayew, Maria Patrizia Carrieri, Massimo Colombo, Mattias Ekstedt, Gamal Esmat, Jacob George, Giulio Marchesini, Marcelo Silva, C Wendy Spearman, Frank Tacke, Emmanuel A. Tsochatzis, Yusuf Yilmaz, Zobair M Younossi, Vincent Wai-Sun Wong, Shira Zelber-Sagi, Helena Cortez-Pinto, Quentin Anstee. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?, Journal of Hepatology. J Hepatol . 2022 Apr;76(4):771-780. doi: 10.1016/j.jhep.2021.10.025. Epub 2021 Dec 9. |
| 50 | Pegah Golabi, James Minhui Paik, Katherine Elizabeth Eberly, Leyla de Avila, Saleh Alqahtani, Zobair M Younossi. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C, Annals of Hepatology. Ann Hepatol . 2022 Jan-Feb;27(1):100556. doi: 10.1016/j.aohep.2021.100556. Epub 2021 Nov 18. |
| 51 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Fernandez, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, Georgios Papatheodoridis, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global NASH/NAFLD Registry, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 Oct;20(10):2296-2306.e6. doi: 10.1016/j.cgh.2021.11.004. Epub 2021 Nov 9. |
| 52 | Jeffrey V. Lazarus, Henry E. Mark, Quentin Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M Ashworth Dirac, Sven Francques, Jacob George, Hannes Hagstrom, Terry T-K Huang, Mona H. Ismail, Achim Kautz, Shiv Sarin, Rohit Loomba, Veronica Miller, Philip N Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary E. Rinella, Diana Romero, Manuel Romero-Gomez, Jorn M. Schattenberg, Emmanuel A. Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M Younossi, Shira Zelber-Sagi. Advancing the global public health agenda for NAFLD: a consensus statement, Nature Reviews Gastroenterology & Hepatology. Nat Rev Gastroenterol Hepatol . 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27. |
| 53 | Zobair M Younossi, Michael Harring, Youssef Younossi, Janus P. Ong, Saleh Alqahtani, Maria Stepanova. The Impact of NASH to Liver Transplantations With Hepatocellular Carcinoma in the United States, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2021 Oct 16;S1542-3565(21)01131-9. doi: 10.1016/j.cgh.2021.10.018. Online ahead of print. |
| 54 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Brian P. Lam, Fatema Nader, Henry A. Tran, Ingrid Schneider, Maria Stepanova. Serum Biomarkers are Associated with Atherosclerotic Cardiovascular Disease among Patients with Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 May;20(5):e1149-e1156. doi: 10.1016/j.cgh.2021.08.038. Epub 2021 Aug 28. |
| 55 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Rebecca Cable, Sean C. Felix, Thomas Jeffers, Elena Younossi, Huong T. Pham, Manirath Srishord, Patrick Austin, James M. Estep, Kathy Terra, Carey Escheik, Leyla de Avila, Pegah Golabi, Andrej Kolacevski, Andrei Racila, Linda Henry, Lynn Gerber. Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection, Hepatology Communications. Hepatol Commun . 2021 Jul 21;10.1002/hep4.1802. doi: 10.1002/hep4.1802. Online ahead of print. |
| 56 | Manisha Verma, James Minhui Paik, Issah Younossi, Daisong Tan, Hala Abdelaal, Zobair M Younossi. The impact of hepatocellular carcinoma diagnosis on patients' health-related quality of life, Cancer Medicine. Cancer Med . 2021 Sep;10(18):6273-6281. doi: 10.1002/cam4.4166. Epub 2021 Aug 18. |
| 57 | Saleh Alqahtani, Maria Stepanova, Khaled W. Kabbara, Issah Younossi, Alita Mishra, Zobair M Younossi. Liver Transplant Center Size and the Impact on Clinical Outcomes and Resource Utilization, Transplantation. Transplantation . 2022 May 1;106(5):988-996. doi: 10.1097/TP.0000000000003915. Epub 2021 Aug 5. |
| 58 | Saleh Alqahtani, Maria Stepanova, Khaled W. Kabbara, Issah Younossi, Alita Mishra, Zobair M Younossi. Liver Transplant Center Size and The Impact on the Clinical Outcomes and Resource Utilization, Transplantation. Transplantation . 2021 Aug 5. doi: 10.1097/TP.0000000000003915. Online ahead of print. |
| 59 | Khaled W. Kabbara, Pegah Golabi, Zobair M Younossi. Nonalcoholic steatohepatitis: global impact and clinical consequences, Endocrine Connections. Gastroenterology . 2021 Sep;161(3):1030-1042.e8. doi: 10.1053/j.gastro.2021.04.074. Epub 2021 Jul 26. |
| 60 | Zobair M Younossi, Maria Stepanova, Rebecca A Taub, Jordan Mark Barbone, Stephen A. Harrison. Hepatic Fat Reduction from Resmetirom in Patients with Nonalcoholic Steatohepatitis Association with Quality of Life Improvement, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 Jun;20(6):1354-1361.e7. doi: 10.1016/j.cgh.2021.07.039. Epub 2021 Jul 27. |
| 61 | Zobair M Younossi, Maria Stepanova, Rebecca A Taub, Jordan Mark Barbone, Stephen A. Harrison. Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 Jun;20(6):1354-1361.e7. doi: 10.1016/j.cgh.2021.07.039. Epub 2021 Jul 27. |
| 62 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Rohit Loomba, Quentin Anstee, Vlad Ratziu, Stephen A. Harrison, Arun J. Sanyal, Jorn M. Schattenberg, A Sidney Barritt, Mazen Noureddin, Martin Bonacci, Gail Cawkwell, Bruce Wong, Mary E. Rinella. Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis, Clinical Gastroenterology And Hepatology. lin Gastroenterol Hepatol . 2022 Sep;20(9):2050-2058.e12. doi: 10.1016/j.cgh.2021.07.020. Epub 2021 Jul 15. |
| 63 | Zobair M Younossi, Maria Stepanova, Mazen Noureddin, Kris V. Kowdley, Simone Strasser, Anita Kohli, Peter Ruane, Mitchell L. Shiffman, Aasim M. Sheikh, Nadege T Gunn, Caldwell. Stephen H. , Ryan S Huss, Robert P. Myers, Vincent Wai-Sun Wong, Naim Alkhouri, Zachary Goodman, Rohit Loomba. Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis, Hepatology Communications. Hepatol Commun . 2021 May 12;5(7):1201-1211. doi: 10.1002/hep4.1710. eCollection 2021 Jul. |
| 64 | James Minhui Paik, Seema Mir, Saleh Alqahtani, Youssef Younossi, Janus P. Ong, Zobair M Younossi. Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data, Hepatology Communications. Hepatol Commun . 2022 Jan;6(1):90-100. doi: 10.1002/hep4.1707. Epub 2021 Jul 8. |
| 65 | Zobair M Younossi, Janus P. Ong, Hirokazu Takahashi, Yusuf Yilmaz, Yuichiro Eguchi, Mohamed El Kassas, Maria Buti, Moises Diago, Ming-Hua Zheng, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Khaled Alswat, Wah Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay Duseja, Jacob George, Georgios Papatheodoridis, Saeed S Hamid, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Manuel Romero-Gomez, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 Jun;20(6):e1456-e1468. doi: 10.1016/j.cgh.2021.06.048. Epub 2021 Jul 3. |
| 66 | Zobair M Younossi, Janus P. Ong, Hirokazu Takahashi, Yusuf Yilmaz, Yuichiro, Eguchi, Mohamed El Kassas, Maria Buti, Moises Diago, Ming-Hua Zheng, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Khaled Alswat, Wah Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay Duseja, Jacob George, Georgios Papatheodoridis, Saeed S Hamid, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Manuel Romero-Gomez, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. A Global Survey of Physicians Knowledge About Non-alcoholic Fatty Liver Disease, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2021 Jul 3;S1542-3565(21)00719-9. doi: 10.1016/j.cgh.2021.06.048. Online ahead of print. |
| 67 | Tamoore Arshad, James Minhui Paik, Rakesh Biswas, Saleh Alqahtani, Linda Henry, Zobair M Younossi. Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016, Hepatology Communications. Hepatol Commun . 2021 Jul 1. doi: 10.1002/hep4.1760. Online ahead of print. |
| 68 | Saleh Alqahtani, James Minhui Paik, Rakesh Biswas, Tamoore Arshad, Linda Henry, Zobair M Younossi. Poor Awareness of Liver Disease Among Adults With NAFLD in the United States, Hepatology Communications. Hepatol Commun . 2021 Jul 1. doi: 10.1002/hep4.1765. Online ahead of print. |
| 69 | Jeffrey V. Lazarus, Quentin Anstee, Hannes Hagstrom, Kenneth Cusi, Helena Cortez-Pinto, Henry E. Mark, Michael Roden, Emmanuel A. Tsochatzis, Vincent Wai-Sun Wong, Zobair M Younossi, Shira Zelber-Sagi, Manuel Romero-Gomez, Jorn M. Schattenberg. Defining comprehensive models of care for NAFLD, Nature Reviews Gastroenterology & Hepatology. Nat Rev Gastroenterol Hepatol . 2021 Oct;18(10):717-729. doi: 10.1038/s41575-021-00477-7. Epub 2021 Jun 25. |
| 70 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Huong T. Pham, Arian Afendy, Rebecca Cable, Andrei Racila, Zahra Younoszai, Brian P. Lam, Pegah Golabi. Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease, Journal of American Medical Association Network Open. JAMA Netw Open . 2021 Sep 1;4(9):e2123923. doi: 10.1001/jamanetworkopen.2021.23923. |
| 71 | Pegah Golabi, James Minhui Paik, Saleh Alqahtani, Youssef Younossi, Gabriela Tuncer, Zobair M Younossi. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019, Journal of Hepatology. J Hepatol . 2021 May 31;S0168-8278(21)00358-5. doi: 10.1016/j.jhep.2021.05.022. Online ahead of print. |
| 72 | Zobair M Younossi, Linda Henry. Epidemiology of Non-alcoholic Fatty Liver Disease and Hepatocellular Carcinoma, JHEP Reports. JHEP Rep . 2021 May 11;3(4):100305. doi: 10.1016/j.jhepr.2021.100305. |
| 73 | James Minhui Paik, Pegah Golabi, Youssef Younossi, Nazaneen Saleh, Annan Nhyira, Zobair M Younossi. The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017, Hepatology Communications. Hepatol Commun . 2021 Jan 14;5(5):749-759. doi: 10.1002/hep4.1673. eCollection 2021 May. |
| 74 | Zobair M Younossi. TBD, American Journal of Managed Care. Ortiz, DK Rex, IS Grimm, MT Moyer, MK Hasan, D Pleskow, BJ Elmunzer, MA Khashab, O Sanaei, Firas H. Al-Kawas, SR Gordon, A Matthew, JM Levenick, HR Aslanian, F Antaki, D von Renteln, SD Crockett, A Rastogi, JA Gill, R Law, MB Wallace, PA Elias, TA MacKenzie, H Pohl, M Pellise. Factors associated with complete clip closure after endoscopic mucosal resection of large colorectal polyps, Endoscopy. Endoscopy . 2021 Nov;53(11):1150-1159. doi: 10.1055/a-1332-6727. Epub 2021 Apr 20. |
| 75 | Zobair M Younossi, Huong T. Pham, Sean C. Felix, Maria Stepanova, Thomas Jeffers, Elena Younossi, Hussain Allawi, Brian P. Lam, Rebecca Cable, Mariam Afendy, Zahra Younoszai, Arian Afendy, Nila Rafiq, Nahrain Alzubaidi, Yasser Ousman, Marc Bailey, Z Chris, Maria Castillo-Catoni, Pratima Fozdar, Maria Ramirez, Mehreen Husain, Evis Hudson, Ingrid Schneider, Pegah Golabi, Fatema Nader. Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease Using Noninvasive Tests From Primary Care and Endocrinology Real-World Practices, Clinical and Translational Gastroenterology. Clin Transl Gastroenterol. 2021 Apr 6;12(4):e00340. doi: 10.14309/ctg.0000000000000340. |
| 76 | Mehul Desai, Erik Osborn, Christopher S King, Oksana A Shlobin, Mitchell Pstotka, Liam Ryan, Saba Javid Akhtar, Ramesh Singh. Extracorporeal life support for cardiogenic shock during pregnancy and postpartum: a single center experience, Perfusion. Perfusion . 2022 Jul;37(5):493-498. doi: 10.1177/02676591211004369. Epub 2021 Mar 26. |
| 77 | Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveriro, Fatema Nader, Luisa Roade, Rafael Esteban, Zobair M Younossi. Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B, JHEP Reports. JHEP Rep . 2021 Mar 17;3(3):100280. doi: 10.1016/j.jhepr.2021.100280. eCollection 2021 Jun. |
| 78 | Manisha Verma, Zobair M Younossi. Integrating Patient-Reported Outcomes Within Routine Hepatology Care: A Prompt to Action, Hepatology. Hepatology . 2021 Apr;73(4):1570-1580. doi: 10.1002/hep.31550. Epub 2021 Mar 16. |
| 79 | Saleh Alqahtani, Pegah Golabi, James Minhui Paik, Brian P. Lam, Amir Moazzez, Hazem Elariny, Zachary Goodman, Zobair M Younossi. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease, Obesity Surgery. Obes Surg . 2021 May;31(5):2002-2010. doi: 10.1007/s11695-020-04996-1. Epub 2021 Feb 22. |
| 80 | Zobair M Younossi, Mary E. Rinella, Arun J. Sanyal, Stephen A. Harrison, Elizabeth Brunt, Zachary Goodman, David E. Cohen, Rohit Loomba. From NAFLD to MAFLD: Implications of a premature change in terminology, Hepatology. Hepatology . 2021 Mar;73(3):1194-1198. doi: 10.1002/hep.31420. Epub 2021 Feb 6. |
| 81 | Austin Henry, James Minhui Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, Lynn Gerber, Zobair M Younossi. Psychometric Characteristics and Validity of the PROMIS Cancer Function Brief 3D Profile, American Journal of Physical Medicine and Rehabilitation. Arch Phys Med Rehabil . 2022 May;103(5S):S146-S161. doi: 10.1016/j.apmr.2020.12.027. Epub 2021 Feb 4. |
| 82 | Victor de Avila, James Minhui Paik, Leyla de Avila, Linda Henry, Denise Mohess, Alva Roche-Green, Zobair M Younossi. Hospice care utilisation among elderly patients who died with hepatocellular carcinoma in the United States, JHEP Reports. JHEP Rep . 2021 Jan 27;3(2):100236. doi: 10.1016/j.jhepr.2021.100236. eCollection 2021 Apr. |
| 83 | Zobair M Younossi, Andrei Racila, Andrew J. Muir, Marc Bourliere, Alessandra Mangia, Stefan Zeuzem, Massimo Colombo, Michael Manns, Georgios Papatheodoridis, Maria Buti, Anuj Gaggar, Fatema Nader, Issah Younossi, Linda Henry, Maria Stepanova. Long-Term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 Feb;20(2):438-446. doi: 10.1016/j.cgh.2021.01.026. Epub 2021 Jan 22. |
| 84 | James Minhui Paik, Youssef Younossi, Linda Henry, Alita Mishra, Zobair M Younossi. Recent Trends in the Global Burden of Hepatitis B Virus: 2007-2017, Gastroenterology. Gastroenterology . 2021 Apr;160(5):1845-1846.e3. doi: 10.1053/j.gastro.2020.11.057. Epub 2021 Jan 6. |
| 85 | Zobair M Younossi, Kathleen E. Corey, Joseph K Lim. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review, Gastroenterology. Gastroenterology . 2021 Feb;160(3):912-918. doi: 10.1053/j.gastro.2020.11.051. Epub 2020 Dec 9. |
| 86 | Zobair M Younossi, Quentin Anstee, Vincent Wai-Sun Wong, Michael Trauner, Eric Lawitz, Stephen A. Harrison, Marianne Camargo, Kathryn Kersey, Mani Subramanian, Robert P. Myers, Maria Stepanova. The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis, Gastroenterology. Gastroenterology . 2021 Apr;160(5):1608-1619.e13. doi: 10.1053/j.gastro.2020.12.003. Epub 2020 Dec 8. |
| 87 | Zobair M Younossi, Mazen Noureddin, David Bernstein, Paul Y. Kwo, Mark Russo, Mitchell L. Shiffman, Ziad Younes, Manal F. Abdelmalek. Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations, American Journal of Gastroenterology. Am J Gastroenterol . 2021 Feb 1;116(2):254-262. doi: 10.14309/ajg.0000000000001054. |
| 88 | Zobair M Younossi, Linda Henry. Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening. Authors' reply, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2020 Dec;52(11-12):1761. doi: 10.1111/apt.16091. |
| 89 | Maria Stepanova, Zobair M Younossi. Reply, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2021 Jun;19(6):1299-1300. doi: 10.1016/j.cgh.2020.07.038. Epub 2020 Nov 26. |
| 90 | Zobair M Younossi, Vincent Wai-Sun Wong, Quentin Anstee, Manuel Romero-Gomez, Michael Trauner, Stephen A. Harrison, Eric Lawitz, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Robert P. Myers, Zachary Goodman, Maria Stepanova. Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes, Hepatology Communications. Hepatol Commun . 2020 Aug 28;4(11):1637-1650. doi: 10.1002/hep4.1581. eCollection 2020 Nov. |
| 91 | Susana Borges Gonzalez, Maria Stepanova, Mirtha Infante Velazquez, Caridad Ruenes Domech, Sila Gonzalez Suero, Zaily Dorta Guridi, Enrique Rogelio Arus Soler, Andrei Racila, Zobair M Younossi. Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience, Annals of Hepatology. Ann Hepatol . May-Jun 2021;22:100277. doi: 10.1016/j.aohep.2020.10.005. Epub 2020 Oct 29. |
| 92 | James Minhui Paik, Pegah Golabi, Youssef Younossi, Alita Mishra, Zobair M Younossi. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD, Hepatology. Hepatology . 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27. |
| 93 | Azza Karrar, Bijal Rajput, Siddharth Hariharan, Dinan Abdelatif, Mohamad Houry, Ali Moosvi, Irfan Ali, Daisong Tan, Sohailla Noor, Zahra Younoszai, Donna Esmaeili, Sean C. Felix, Lakshmi Alaparthi, Munkhzul Otgonsuren, Brian P. Lam, Zachary Goodman, Zobair M Younossi. Major Histocompatibility Complex Class I-Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease, Hepatology Communications. Hepatol Commun . 2020 Sep 30;5(1):63-73. doi: 10.1002/hep4.1610. eCollection 2021 Jan. |
| 94 | Jillian Kallman Price, Carey Escheik, Ali Weinstein, Patrice Winter, Lynn Gerber, Zobair M Younossi. Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease, The Journal of Clinical Hypertension. J Clin Hypertens (Greenwich) . 2020 Oct;22(10):1915-1923. doi: 10.1111/jch.13938. Epub 2020 Sep 17. |
| 95 | James Minhui Paik, Pegah Golabi, Youssef Younossi, Manirath Srishord, Alita Mishra, Zobair M Younossi. The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017, Hepatology Communications. Hepatol Commun . 2020 Sep 14;4(12):1769-1780. doi: 10.1002/hep4.1599. eCollection 2020 Dec. |
| 96 | Manisha Verma, Zobair M Younossi. Integrating Patient Reported Outcomes within Routine Hepatology Care: A Prompt to Action, Hepatology. Hepatology . 2020 Sep 12. doi: 10.1002/hep.31550. Online ahead of print. |
| 97 | Pegah Golabi, Lynn Gerber, James Minhui Paik, Rati Deshpande, Leyla de Avila, Zobair M Younossi. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease, JHEP Reports. JHEP Rep . 2020 Aug 15;2(6):100171. doi: 10.1016/j.jhepr.2020.100171. eCollection 2020 Dec. |
| 98 | Zobair M Younossi, Linda Henry. Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD-Authors' reply, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2020 Aug;52(4):712. doi: 10.1111/apt.15929. |
| 99 | Faisal M. Sanai, Faisal Abaalkhail, Fuad Hasan, Muhammad Hamed Farooqi, Nawal Al Nahdi, Zobair M Younossi. Management of nonalcoholic fatty liver disease in the Middle East, World Journal of Gastroenterology. World J Gastroenterol . 2020 Jul 7;26(25):3528-3541. doi: 10.3748/wjg.v26.i25.3528. |
| 100 | Zobair M Younossi, Kathleen E. Corey, Naim Alkhouri, Mazen Noureddin, Ira M. Jacobson, Brian P. Lam, Stephen C. Clement, Rita Basu, Stuart C. Gordon, Natarajan Ravendhran, Puneet Puri, Mary E. Rinella, Peter Scudera, Ashwani K. Singal, Linda Henry. Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2020 Aug;52(3):513-526. doi: 10.1111/apt.15830. Epub 2020 Jun 29. |
| 101 | Radhika Tampi, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Sally Shu, Henry Lik-Yuen Chan, James Fung, Maria Stepanova, Zobair M Younossi. Modelling the Economic and Clinical Burden of Non-Alcoholic Steatohepatitis in East Asia: Data from Hong Kong, Hepatology Research. Hepatol Res . 2020 Jun 14. doi: 10.1111/hepr.13535. Online ahead of print. |
| 102 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Gregory Trimble, Saleh Alqahtani, Issah Younossi, Aijaz Ahmed, Andrei Racila, Linda Henry. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2021 Mar;19(3):580-589.e5. doi: 10.1016/j.cgh.2020.05.064. Epub 2020 Jun 9. |
| 103 | James Minhui Paik, Pegah Golabi, Rakesh Biswas, Saleh Alqahtani, Chapy Venkatesan, Zobair M Younossi. Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States, Hepatology Communications. Hepatol Commun. 2020 Apr 4;4(6):890-903. doi: 10.1002/hep4.1510. eCollection 2020 Jun. |
| 104 | Pegah Golabi, James Minhui Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M Younossi. Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities, Hepatology Communications. Hepatol Commun . 2020 May 19;4(8):1136-1148. doi: 10.1002/hep4.1534. eCollection 2020 Aug. |
| 105 | Danubia Hester, Pegah Golabi, James Minhui Paik, Issah Younossi, Alita Mishra, Zobair M Younossi. Among Medicare Patients with Hepatocellular Carcinoma, Non-alcoholic Fatty Liver Disease Is the Most Common Etiology and Cause of Mortality, Journal of Clinical Gastroenterology. J Clin Gastroenterol . May/Jun 2020;54(5):459-467. doi: 10.1097/MCG.0000000000001172. |
| 106 | Mehmet Sayiner, Tamoore Arshad, Pegah Golabi, James Minhui Paik, F Farhat, Zobair M Younossi. Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population., Hepatology International. Hepatol Int . 2020 Jul;14(4):556-566. doi: 10.1007/s12072-020-10038-w. Epub 2020 Apr 16. |
| 107 | Maria Stepanova, Saleh Alqahtani, Alita Mishra, Issah Younossi, Chapy Venkatesan, Zobair M Younossi. Outcomes of liver transplantation by insurance types in the United States., American Journal of Managed Care. Am J Manag Care . 2020 Apr 1;26(4):e121-e126. doi: 10.37765/ajmc.2020.42839.. |
| 108 | Tamoore Arshad, Pegah Golabi, Linda Henry, Zobair M Younossi. Epidemiology of Non-alcoholic Fatty Liver Disease in North America, Current Pharmaceutical Design. Curr Pharm Des . 2020;26(10):993-997. doi: 10.2174/1381612826666200303114934. |
| 109 | Zobair M Younossi, Maria Stepanova, Ira M. Jacobson, Andrew J. Muir, Stanislas Pol, Stefan Zeuzem, Ziad Younes, Robert Herring, Eric Lawitz, Issah Younossi, Andrei Racila. Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes, Clinical Infectious Diseases. Clin Infect Dis. 2020 Feb 3;70(4):628-632. doi: 10.1093/cid/ciz243. |
| 110 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Arian Afendy, Eric Lawitz, Christian Schwabe, Peter Ruane, Jay Lalezari, K. Rajender Reddy, Ira M. Jacobson, Andrew J. Muir, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader. Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2020 Feb;18(2):468-476.e11. doi: 10.1016/j.cgh.2019.07.047. Epub 2019 Jul 31. |
| 111 | Vlad Ratziu, Arun J. Sanyal, Stephen A. Harrison, Vincent Wai-Sun Wong, Sven Francques, Zachary Goodman, Guruprasad P. Aithal, Kris V. Kowdley, Star Seyedkazemi, Laurent Fischer, Rohit Loomba, Manal F. Abdelmalek, Frank Tacke. Cenicriviroc Treatment for Adults with Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study., Hepatology. Hepatology. 2020 Jan 13. doi: 10.1002/hep.31108. [Epub ahead of print] |
| 112 | Zobair M Younossi, Linda Henry. Are Noninvasive Scoring Systems for Persons With Chronic Liver Disease Ready for Prime Time?, Gastroenterology. Gastroenterology. 2020 Jan;158(1):40-42. doi: 10.1053/j.gastro.2019.11.024. Epub 2019 Nov 16. |
| 113 | James Minhui Paik, Linda Henry, Pegah Golabi, Saleh Alqahtani, Gregory Trimble, Zobair M Younossi. Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006-2016, Open Journal Infectious Diseases. Open Forum Infect Dis . 2020 Jan 7;7(1):ofz509. doi: 10.1093/ofid/ofz509. eCollection 2020 Jan. |
| 114 | James Minhui Paik, Rati Deshpande, Pegah Golabi, Issah Younossi, Linda Henry, Zobair M Younossi. The Impact of Modifiable Risk Factors on the Long-term Outcomes of Non-alcoholic Fatty Liver Disease, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2020 Jan;51(2):291-304. doi: 10.1111/apt.15580. Epub 2019 Nov 29. |
| 115 | Zobair M Younossi, Radhika Tampi, Fatema Nader, Issah Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. Hypothetical Treatment of Patients with Nonalcoholic Steatohepatitis: Potential Impact on Important Clinical Outcomes, Liver International. Liver Int . 2020 Feb;40(2):308-318. doi: 10.1111/liv.14292. Epub 2019 Nov 25. |
| 116 | Zobair M Younossi, Radhika Tampi, Fatema Nader, Issah Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. Hypothetical treatment of patients with non-alcoholic steatohepatitis: Potential impact on important clinical outcomes., Liver International. Liver Int . 2020 Feb;40(2):308-318. doi: 10.1111/liv.14292. Epub 2019 Nov 25. |
| 117 | Zobair M Younossi, Radhika Tampi, Fatema Nader, Issah Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. Hypothetical Treatment of Patients with Advanced Non-Alcoholic Steatohepatitis: Impact on Important Clinical Outcomes, Liver International. Liver Int. 2019 Nov 9. doi: 10.1111/liv.14292. [Epub ahead of print] |
| 118 | Pegah Golabi, Logan Rhea, Linda Henry, Zobair M Younossi. Hepatocellular carcinoma and non-alcoholic fatty liver disease., Hepatology International. Hepatol Int. 2019 Nov;13(6):688-694. doi: 10.1007/s12072-019-09995-8. Epub 2019 Nov 7. |
| 119 | Zobair M Younossi, Maria Stepanova, Quentin Anstee, Eric Lawitz, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Kathryn Kersey, Georgia Li, Mani Subramanian, Robert P. Myers, Stephen Djedjos, Takeshi Okanoue, Michael Trauner, Zachary Goodman, Stephen A. Harrison. Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2019 Nov;17(12):2552-2560.e10. doi: 10.1016/j.cgh.2019.02.024. Epub 2019 Feb 16. |
| 120 | Zobair M Younossi, Radhika Tampi, Andrei Racila, Ying Qiu, Leah Burns, Issah Younossi, Fatema Nader. Economic and Clinical Burden of Non-alcoholic Steatohepatitis (NASH) in Patients with Type 2 Diabetes Mellitus (T2DM) in the United States, Journal of Hepatology. J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4. |
| 121 | Zobair M Younossi, Linda Henry. The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease, American Journal of Gastroenterology. Am J Gastroenterol. 2019 Nov;114(11):1714-1715. doi: 10.14309/ajg.0000000000000433. |
| 122 | Ali Weinstein, James M. Estep, Leyla de Avila, Michael P. Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Jillian Kallman Price, Lynn Gerber, Zobair M Younossi. Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study, Journal of Neuroimmunology. Send to J Neuroimmunol. 2019 Oct 15;335:577022. doi: 10.1016/j.jneuroim.2019.577022. Epub 2019 Aug 14. |
| 123 | Ali Weinstein, James M. Estep, Leyla de Avila, Michael P. Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Jillian Kallman Price, Lynn Gerber, Zobair M Younossi. Relationship Among Neurotransmitters, Cytokines and Cognitive Performance for Individuals with Hepatitis C Achieving Sustained Virologic Response: A Pilot Study, Journal of Neuroimmunology. J Neuroimmunol. 2019 Oct 15;335:577022. doi: 10.1016/j.jneuroim.2019.577022. Epub 2019 Aug 14. |
| 124 | Leyla de Avila, Ali Weinstein, James M. Estep, Michael P. Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C., Liver International. Liver Int. 2019 Sep;39(9):1631-1640. doi: 10.1111/liv.14115. Epub 2019 May 3. |
| 125 | Zobair M Younossi, Maria Stepanova, Pegah Golabi, Robert S. Epstein, Marcie Strauss, Fatema Nader, Andrei Racila. Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database, Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 Oct;53(9):693-698. doi: 10.1097/MCG.0000000000001120. |
| 126 | Lynn Gerber, Haley Bush, Radha Holavanahalli, Peter Esselman, Jeffrey Schneider, Allen Heinemann, Steven Garfinkel, Cindy Cai. A scoping review of burn rehabilitation publications incorporating functional outcomes., Burns. Burns. 2019 Aug;45(5):1005-1013. doi: 10.1016/j.burns.2018.09.029. Epub 2018 Oct 26. |
| 127 | Zobair M Younossi, Pegah Golabi, Leyla de Avila, James Minhui Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis, Journal of Hepatology. J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4. |
| 128 | Min Kim, James Minhui Paik, Pegah Golabi, Thomas Jeffers, Alita Mishra, Zobair M Younossi. Resource Utilization and Outcomes of Medicare Recipients With Chronic Hepatitis B in the United States., Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 Sep;53(8):e341-e347. doi: 10.1097/MCG.0000000000001110. |
| 129 | Zobair M Younossi, Radhika Tampi, Andrei Racila, Ying Qiu, Leah Burns, Issah Younossi, Fatema Nader. Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S, Diabetes Care. Diabetes Care . 2020 Feb;43(2):283-289. doi: 10.2337/dc19-1113. Epub 2019 Oct 28. |
| 130 | Mehmet Sayiner, Maria Stepanova, Leyla de Avila, Pegah Golabi, Andrei Racila, Zobair M Younossi. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients, Digestive Diseases And Sciences. Dig Dis Sci. 2020 Feb;65(2):416-422. doi: 10.1007/s10620-019-05786-1. Epub 2019 Aug 27. |
| 131 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, K. Rajender Reddy, Robert John Wong, Alessandra Mangia, Andrew J. Muir, Ira M. Jacobson, CS Djedjos, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader, Andrei Racila. Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life, American Journal of Gastroenterology. Am J Gastroenterol . 2019 Oct;114(10):1636-1641. doi: 10.14309/ajg.0000000000000375. |
| 132 | James Minhui Paik, Linda Henry, Leyla de Avila, Elena Younossi, Andrei Racila, Zobair M Younossi. Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States, Hepatology Communications. Hepatol Commun. 2019 Aug 14;3(11):1459-1471. doi: 10.1002/hep4.1419. eCollection 2019 Nov. |
| 133 | Lynn Gerber, Haley Bush, Cindy Cai, L Morse, L Worobey, Steven Garfinkel. Scoping review of peer reviewed publications addressing rehabilitation for people sustaining traumatic spinal cord injury, The Journal of Spinal Cord Medicine. J Spinal Cord Med. 2019 Aug 12:1-7. doi: 10.1080/10790268.2019.1645415. [Epub ahead of print] |
| 134 | Azza Karrar, Siddharth Hariharan, Yousef Fazel, Ali Moosvi, Mohamad Houry, Zahra Younoszai, Thomas Jeffers, Li Zheng, Munkhzul Otgonsuren, Sharon Hunt, Fanny Monge, Zachary Goodman, Zobair M Younossi. Analysis of Human Leukocyte Antigen (HLA) Allele Polymorphism in Patients with Non Alcoholic Fatty Liver Disease, Medicine. Medicine (Baltimore). 2019 Aug;98(32):e16704. doi: 10.1097/MD.0000000000016704. |
| 135 | Patrick Austin, Lynn Gerber, James Minhui Paik, Jillian Kallman Price, Carey Escheik, Zobair M Younossi. Aerobic Capacity and Exercise Performance in Nonalcoholic Fatty Liver Disease, The Journal of Sports Medicine and Physical Fitness. J Sports Med Phys Fitness. 2019 Aug;59(8):1376-1388. doi: 10.23736/S0022-4707.19.09231-4. Epub 2019 Feb 12. |
| 136 | Patrick Austin, Lynn Gerber, James Minhui Paik, Jillian Kallman Price, Carey Escheik, Zobair M Younossi. Exercise Responsiveness in Non-alcoholic Fatty Liver Disease (NAFLD), The Journal of Sports Medicine and Physical Fitness. J Sports Med Phys Fitness. 2019 Aug;59(8):1376-1388. doi: 10.23736/S0022-4707.19.09231-4. Epub 2019 Feb 12. |
| 137 | Tamoore Arshad, Linda Henry, Zobair M Younossi. Validation of the chronic liver disease questionnaire for non-alcoholic steatohepatitis in patients: impact for the clinic, Expert Review of Gastroenterology Hepatology. Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):709-710. doi: 10.1080/17474124.2019.1636646. Epub 2019 Jun 28. |
| 138 | Zobair M Younossi, Maria Stepanova, Youssef Younossi, Pegah Golabi, Alita Mishra, Nila Rafiq, Linda Henry. Epidemiology of chronic liver diseases in the USA in the past three decades., GUT. Gut . 2020 Mar;69(3):564-568. doi: 10.1136/gutjnl-2019-318813. Epub 2019 Jul 31. |
| 139 | Lynn Gerber, Ali Weinstein, Rohini Mehta, Zobair M Younossi. Importance of fatigue and its measurement in chronic liver disease, World Journal of Gastroenterology. World J Gastroenterol. 2019 Jul 28;25(28):3669-3683. doi: 10.3748/wjg.v25.i28.3669. |
| 140 | Rati Deshpande, Maria Stepanova, Pegah Golabi, Kimberly Brown, Zobair M Younossi. Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units., Journal of Viral Hepatitis. J Viral Hepat. 2019 Nov;26(11):1293-1300. doi: 10.1111/jvh.13173. Epub 2019 Aug 2. |
| 141 | Azza Karrar, Siddharth Hariharan, Yousef Fazel, Ali Moosvi, Mohamad Houry, Zahra Younoszai, Thomas Jeffers, Li Zheng, Munkhzul Otgonsuren, Sharon Hunt, Fanny Monge, Zachary Goodman, Zobair M Younossi. Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease, Medicine. Medicine (Baltimore) . 2019 Aug;98(32):e16704. doi: 10.1097/MD.0000000000016704. |
| 142 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Yusuf Yilmaz, Ajay Duseja, Yuichiro Eguchi, Mohamed El Kassas, Marlen Castellanos-Fernandez, Jacob George, Ira M. Jacobson, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Marco Arrese, Victor de Ledinghen, Manuel Romero-Gomez, Nahum Mendez-Sanchez, Aijaz Ahmed, Robert John Wong, Georgios Papatheodoridis, Lawrence Serfaty, Issah Younossi, Mariam Ziayee, H. Afendy. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2019 Jul;17(8):1625-1633.e1. doi: 10.1016/j.cgh.2018.11.033. Epub 2018 Nov 23. |
| 143 | Pegah Golabi, Natsu Fukui, Munkhzul Otgonsuren, Mehmet Sayiner, Alita Mishra, Zobair M Younossi. Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients with Nonalcoholic Fatty Liver Disease, Hepatology Communications. Hepatol Commun. 2019 Jun 6;3(8):1050-1060. doi: 10.1002/hep4.1387. eCollection 2019 Aug. |
| 144 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Georgios Papatheodoridis, Harry Janssen, Kosh Agarwal, Mindie H. Nguyen, Edward J. Gane, Naoky Tsai, Fatema Nader. Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication., Liver International. Liver Int. 2019 Oct;39(10):1837-1844. doi: 10.1111/liv.14171. Epub 2019 Jul 2. |
| 145 | Zobair M Younossi, Frank Tacke, Marco Arrese, Barjesh Chander Sharma, Ibrahim Mostafa, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Yusuf Yilmaz, Jacob George, Jian-Gao Fan, Mariam Vos. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, Hepatology. Hepatology . 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251. |
| 146 | Zobair M Younossi. Emerging Research on MGL-3196 for the Treatment of Nonalcoholic Steatohepatitis., Journal of Gastroenterology and Hepatology. Gastroenterol Hepatol (N Y). 2019 Jun;15(6):317-319. |
| 147 | Zobair M Younossi, Pegah Golabi, Linda Henry. A Comprehensive Review of Patient-reported Outcomes in Patients With Chronic Liver Diseases., Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 May/Jun;53(5):331-341. doi: 10.1097/MCG.0000000000001179. |
| 148 | Lynn Gerber, Haley Bush, Cindy Cai, Steven Garfinkel, Leighton Chan, Bridget Cotner, Amy Wagner. Scoping review of clinical rehabilitation research pertaining to traumatic brain injury: 1990-2016, NeuroRehabilitation. NeuroRehabilitation. 2019;44(2):207-215. doi: 10.3233/NRE-182599 |
| 149 | Pegah Golabi, James Minhui Paik, Rashmi Reddy, Elisabetta Bugianesi, Gregory Trimble, Zobair M Younossi. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States., BMC Gastroenterology. BMC Gastroenterol. 2019 Apr 16;19(1):56. doi: 10.1186/s12876-019-0972-6. |
| 150 | Leyla de Avila, Ali Weinstein, James M. Estep, Michael P. Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Cytokine Balance is Restored as Patient Reported Outcomes (PROs) Improve in Patients Recovering from Chronic Hepatitis C (CHC), Liver International. Liver Int. 2019 Sep;39(9):1631-1640. doi: 10.1111/liv.14115. Epub 2019 May 3. |
| 151 | Pegah Golabi, James Minhui Paik, Jessica P. Hwang, Su H. Wang, Hannah Lee, Zobair M Younossi. Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States, Liver International. Liver Int. 2019 Apr;39(4):748-757. doi: 10.1111/liv.14038. Epub 2019 Feb 13. |
| 152 | Mehmet Sayiner, Pegah Golabi, Zobair M Younossi. Disease Burden of Hepatocellular Carcinoma: A Global Perspective, Digestive Diseases And Sciences. Dig Dis Sci . 2019 Apr;64(4):910-917. doi: 10.1007/s10620-019-05537-2. |
| 153 | Haley Bush, Nila Rafiq, Zobair M Younossi. Implementation of Value-based Medicine (VBM) to Patients with Chronic Hepatitis C (HCV) Infection, Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 Apr;53(4):262-268. doi: 10.1097/MCG.0000000000001174. |
| 154 | Zobair M Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro, Eguchi, Masashi Mizokami, Young-Suk Lim, Yock-Young Lim, Ming-Lung Yu, Maria Stepanova. Systematic Review with Meta-Analysis: The Extrahepatic Manifestations in Chronic Hepatitis C Virus-Infected Patients in East Asia, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2019 Mar;49(6):644-653. doi: 10.1111/apt.15131. Epub 2019 Feb 13. |
| 155 | Zobair M Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro, Eguchi, Masashi Mizokami, Young-Suk Lim, Yock Young Dan, Ming-Lung Yu, Maria Stepanova. Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2019 Mar;49(6):644-653. doi: 10.1111/apt.15131. Epub 2019 Feb 13. |
| 156 | James M. Estep, Rohini Mehta, Gary Bratthauer, Lakshmi Alaparthi, Fanny Monge, Irfan Ali, Dinan Abdelatif, Zahra Younoszai, Maria Stepanova, Zachary Goodman, Zobair M Younossi. Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis., BMC Gastroenterology. BMC Gastroenterol. 2019 Feb 11;19(1):27. doi: 10.1186/s12876-019-0951-y. |
| 157 | Haley Bush, James Minhui Paik, Pegah Golabi, Leyla de Avila, Carey Escheik, Zobair M Younossi. Impact of hepatitis C virus and insurance coverage on mortality., American Journal of Managed Care. Am J Manag Care. 2019 Feb;25(2):61-67. |
| 158 | Zobair M Younossi, Radhika Tampi, Masoom Priyadarshini, Fatema Nader, Issah Younossi, Andrei Racila. Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States, Hepatology. Hepatology. 2019 Feb;69(2):564-572. doi: 10.1002/hep.30254. Epub 2019 Jan 8. |
| 159 | Omer Shahab, Mehmet Sayiner, James Minhui Paik, Sean C. Felix, Pegah Golabi, Zobair M Younossi. Burden of Primary Biliary Cholangitis among Inpatient Population in the United States, Hepatology Communications. Hepatol Commun. 2019 Jan 28;3(3):356-364. doi: 10.1002/hep4.1314. eCollection 2019 Mar. |
| 160 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2019 Sep;17(10):2093-2100.e3. doi: 10.1016/j.cgh.2019.01.001. Epub 2019 Jan 11. |
| 161 | Haley Bush, Pegah Golabi, Munkhzul Otgonsuren, Nila Rafiq, Chapy Venkatesan, Zobair M Younossi. Nonalcoholic Fatty Liver is Contributing to the Increase in Cases of Liver Disease in US Emergency Departments, Journal of Clinical Gastroenterology. J Clin Gastroenterol . 2019 Jan;53(1):58-64. doi: 10.1097/MCG.0000000000001026. |
| 162 | Mehmet Sayiner, Zobair M Younossi. Nonalcoholic Steatohepatitis Is Becoming a Top Indication for Liver Transplantation Worldwide, Liver Transplantation. Liver Transpl. 2019 Jan;25(1):10-11. doi: 10.1002/lt.25387. |
| 163 | Pegah Golabi, James Minhui Paik, Natsu Fukui, Cameron T. Locklear, Leyla de Avila, Zobair M Younossi. Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality., Clinical Diabetes. Clin Diabetes. 2019 Jan;37(1):65-72. doi: 10.2337/cd18-0026. |
| 164 | Zobair M Younossi, Maria Stepanova, K. Rajender Reddy, Michael Manns, Marc Bourliere, Stuart C. Gordon, Eugene R. Schiff, Tram T. Tran, Issah Younossi, Andrei Racila. Viral Eradication is Required for Sustained Improvement of Patient-Reported Outcomes in Patients with Hepatitis C, Liver International. Liver Int. 2019 Jan;39(1):54-59. doi: 10.1111/liv.13900. Epub 2018 Jul 15 |
| 165 | Haley Bush, Pegah Golabi, Munkhzul Otgonsuren, Nila Rafiq, Chapy Venkatesan, Zobair M Younossi. Non-alcoholic Fatty Liver Is Contributing to the Increase in Cases of Liver Disease in U.S. Emergency Departments, Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 Jan;53(1):58-64. doi: 10.1097/MCG.0000000000001026. |
| 166 | Zobair M Younossi, Giulio Marchesini, Helena Cortez-Pinto, Salvatore Petta. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation., Transplantation. Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484. |
| 167 | Pegah Golabi, James Minhui Paik, Jessica P. Hwang, Su H. Wang, Hannah Lee, Zobair M Younossi. Prevalence and outcomes of nonâalcoholic fatty liver disease (NAFLD) among Asian American adults in the United States, Liver International. Liver Int . 2019 Apr;39(4):748-757. doi: 10.1111/liv.14038. Epub 2019 Feb 13. |
| 168 | Tamoore Arshad, Pegah Golabi, James Minhui Paik, Alita Mishra, Zobair M Younossi. Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population., Hepatology Communications. Hepatol Commun. 2018 Nov 27;3(1):74-83. doi: 10.1002/hep4.1285. eCollection 2019 Jan. |
| 169 | Mehmet Sayiner, Brian P. Lam, Pegah Golabi, Zobair M Younossi. Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis., Therapeutic Advances in Gastroenterology. Therap Adv Gastroenterol. 2018 Nov 15;11:1756284818811508. doi: 10.1177/1756284818811508. eCollection 2018. |
| 170 | Haley Bush, Lynn Gerber, Maria Stepanova, Carey Escheik, Zobair M Younossi. Impact of Healthcare Reform on the Payer Mix Among Young Adult Emergency Department Utilizers Across the United States (2005-2015), Medicine. Medicine (Baltimore) . 2018 Dec;97(49):e13556. doi: 10.1097/MD.0000000000013556. |
| 171 | Zobair M Younossi. Non-alcoholic fatty liver disease - A global public health perspective, Journal of Hepatology. J Hepatol . 2019 Mar;70(3):531-544. doi: 10.1016/j.jhep.2018.10.033. Epub 2018 Nov 9. |
| 172 | Zobair M Younossi, Georgios Papatheodoridis, Patrice Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis. The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease., Journal of Viral Hepatitis. J Viral Hepat . 2018 Nov:25 Suppl 3:6-14. doi: 10.1111/jvh.13005. |
| 173 | Ali Weinstein, Leyla de Avila, James Minhui Paik, Pegah Golabi, Carey Escheik, Lynn Gerber, Zobair M Younossi. Cognitive Performance in Individuals With Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus., Psychosomatics. Psychosomatics . 2018 Nov;59(6):567-574. doi: 10.1016/j.psym.2018.06.001. Epub 2018 Jun 10. |
| 174 | James Minhui Paik, Pegah Golabi, Zahra Younoszai, Alita Mishra, Gregory Trimble, Zobair M Younossi. Chronic Kidney Disease is Independently Associated with Increased Mortality in Patients with Non-alcoholic Fatty Liver Disease, Liver International. Liver Int. 2018 Oct 22. doi: 10.1111/liv.13992. [Epub ahead of print] |
| 175 | James Minhui Paik, Pegah Golabi, Zahra Younoszai, Alita Mishra, Gregory Trimble, Zobair M Younossi. Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease, Liver International. Liver Int. 2019 Feb;39(2):342-352. doi: 10.1111/liv.13992. Epub 2018 Dec 4. |
| 176 | Brian P. Lam, Kyle Kurzke, Zobair M Younossi. The Clinical and Economic Burden of Nonalcoholic Steatohepatitis, Current Hepatology Reports. Current Hepatology Reports (2018) 17:345â349 https://doi.org/10.1007/s11901-018-0423-9 |
| 177 | Pegah Golabi, Yousef Fazel, Munkhzul Otgonsuren, Carey Escheik, Mehmet Sayiner, Zobair M Younossi. Association of Parity in Patients with Chronic Liver Disease., Annals of Hepatology. Ann Hepatol. 2018 Oct 16;17(6):1035-1041. doi: 10.5604/01.3001.0012.7204. |
| 178 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, Michael R. Charlton, Rohit Loomba, Robert P. Myers, Mani Subramanian, John McHutchison, Zachary Goodman. Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib., Liver International. Liver Int. 2018 Oct;38(10):1849-1859. doi: 10.1111/liv.13706. Epub 2018 Feb 22. |
| 179 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2019 Sep;17(10):2093-2100.e3. doi: 10.1016/j.cgh.2019.01.001. Epub 2019 Jan 11. |
| 180 | Cameron T. Locklear, Pegah Golabi, Lynn Gerber, Zobair M Younossi. Exercise as an intervention for patients with end-stage liver disease: Systematic review., Medicine. Medicine (Baltimore). 2018 Oct;97(42):e12774. doi: 10.1097/MD.0000000000012774. |
| 181 | Zobair M Younossi, Maria Stepanova, William Balistreri, Kathleen B. Schwarz, Karen Murray, Philip Rosenthal, Sanjay Bansal, Sharon Hunt. Health-Related Quality of Life in Adolescent Patients with Hepatitis C Genotype 1 Treated with Sofosbuvir and Ledipasvir, Journal of Pediatric Gastroenterology And Nutrition. J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):112-116. doi: 10.1097/MPG.0000000000001754. |
| 182 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Calvin Q. Pan, Harry Janssen, Georgios Papatheodoridis, Fatema Nader. Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2019 Jul;17(8):1641-1642.e1. doi: 10.1016/j.cgh.2018.09.041. Epub 2018 Sep 27. |
| 183 | Omer Shahab, Rakesh Biswas, James Minhui Paik, Haley Bush, Pegah Golabi, Zobair M Younossi. Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality., Hepatology Communications. Hepatol Commun. 2018 Sep 24;2(10):1227-1234. doi: 10.1002/hep4.1241. eCollection 2018 Oct. |
| 184 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Aybike Birerdinc, Maria Stepanova, Dinan Abdelatif, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Jeiran Kianoush, Alex Hodge, Weidong Zhou, Fanny Monge, Lakshmi Alaparthi, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease., BMC Medical Genomics. BMC Med. 2018 Sep 12;16(1):170. doi: 10.1186/s12916-018-1136-1. |
| 185 | Zobair M Younossi, Maria Stepanova, Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, Caldwell. Stephen H. , Mitchell L. Shiffman, Raul Aguilar Schall, Bryan McColgan, GM Subramanian, Robert P. Myers, A Miur, Nezam H. Afdhal, Jaime Bosch, Zachary Goodman. The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options., Journal of Hepatology. J Hepatol. 2018 Dec;69(6):1365-1370. doi: 10.1016/j.jhep.2018.08.013. Epub 2018 Aug 23. |
| 186 | Andrew A. Li, Donghee Kim, W.R. Kim, Pratima Dibba, Katherine Wong, George Cholankeril, Ira M. Jacobson, Zobair M Younossi, Aijaz Ahmed. Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016., Journal of Viral Hepatitis. J Viral Hepat . 2018 Dec;25(12):1608-1616. doi: 10.1111/jvh.12981. Epub 2018 Sep 11. |
| 187 | Pegah Golabi, Haley Bush, Maria Stepanova, Cameron T. Locklear, Ira M. Jacobson, Alita Mishra, Gregory Trimble, Madeline Erario, Chapy Venkatesan, Issah Younossi, Zachary Goodman, Zobair M Younossi. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016., Medicine. Medicine (Baltimore). 2018 Aug;97(31):e11518. doi: 10.1097/MD.0000000000011518. |
| 188 | Zobair M Younossi. Patient-Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition., Hepatology. Hepatology. 2018 Dec;68(6):2405-2412. doi: 10.1002/hep.30125. |
| 189 | Daisong Tan, Zachary Goodman. Liver Biopsy in Primary Biliary Cholangitis: Indications and Interpretation, Clinics In Liver Disease. Clin Liver Dis. 2018 Aug;22(3):579-588. doi: 10.1016/j.cld.2018.03.008. |
| 190 | Zobair M Younossi. Disparities in Access to Direct Acting Antiviral Regimens for Hepatitis C Virus (HCV): The Impact of Race and Insurance Status., American Journal of Gastroenterology. Send to Am J Gastroenterol. 2018 Sep;113(9):1285-1286. doi: 10.1038/s41395-018-0200-y. Epub 2018 Jul 18. |
| 191 | Mehmet Sayiner, Pegah Golabi, Maria Stepanova, Fatema Nader, Issah Younossi, Andrei Racila, Zobair M Younossi. Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Utilization, Hepatology. Hepatology. 2018 Jul 17. doi: 10.1002/hep.30174. [Epub ahead of print] |
| 192 | Zobair M Younossi, Rohit Loomba, Quentin Anstee, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander-Tetri, Lawrence Serfaty, Francesco Negro, Caldwell. Stephen H. , Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel Lavine, Philippe Mathurin, Michael R. Charlton, Zachary Goodman, Naga Chalasani, Kris V. Kowdley, Jacob George, Keith Lindor. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis., Hepatology. Hepatology. 2018 Jul;68(1):349-360. doi: 10.1002/hep.29721. |
| 193 | Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching-Lung Lai, Henry Lik-Yuen Chan, Lai Wei. Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection., Journal of Viral Hepatitis. J Viral Hepat . 2018 Dec;25(12):1429-1437. doi: 10.1111/jvh.12965. Epub 2018 Aug 22. |
| 194 | Zobair M Younossi, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim. Sofosbuvir and Ledipasvir is Associated with High Sustained Virologic Response and Improvement of Health-Related Quality of Life in East Asian Patients with Hepatitis C Virus Infection, Journal of Viral Hepatitis. J Viral Hepat. 2018 Jul 4. doi: 10.1111/jvh.12965. [Epub ahead of print] |
| 195 | Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching-Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei MD Lai. The Effect of Interferon-Free Regimens on Health-Related Quality of Life in East Asian Patients with Chronic Hepatitis C., Liver International. Liver Int. 2018 Jul;38(7):1179-1187. doi: 10.1111/liv.13650. Epub 2018 Jan 25. |
| 196 | Zobair M Younossi, Arian Afendy, Maria Stepanova, Andrei Racila, Fatema Nader, Rachel Gomel, Ricky Safer, William Lenderling, Anne Skalicky, Robert P. Myers, Mani Subramanian, John McHutchison, Cynthia Levy, Christopher L. Bowlus, Kris V. Kowdley, Andrew J. Muir. Development and Validation of a Primary Sclerosing Cholangitis-Specific Patient-Reported Outcomes Instrument: The PSC PRO, Hepatology. Hepatology. 2018 Jul;68(1):155-165. doi: 10.1002/hep.29664. Epub 2018 May 10. |
| 197 | Linda Henry, Zobair M Younossi. Response to the letter: Hepatitis C screening in opioid epidemics in the United States and societal perspectives., Liver International. Liver Int. 2018 Jul;38(7):1331. doi: 10.1111/liv.13891. |
| 198 | Rohini Mehta, Gladys Shaw, Peter Masschelin, Sean C. Felix, Munkhzul Otgonsuren, Ancha Baranova, Zachary Goodman, Zobair M Younossi. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH)., PLOS One. 2018 Jun 21;13(6):e0199294. doi: 10.1371/journal.pone.0199294. eCollection 2018. |
| 199 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Ira M. Jacobson, Elisabetta Bugianesi, Ajay Duseja, Yuichiro Eguchi, Vincent Wai-Sun Wong, Francesco Negro, Yusuf Yilmaz, Manuel Romero-Gomez, Jacob George, Aijaz Ahmed, Robert John Wong, Issah Younossi, Mariam Ziayee, Arian Afendy. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3. doi: 10.1016/j.cgh.2018.05.057. Epub 2018 Jun 14. |
| 200 | Zobair M Younossi, Rohit Loomba, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander-Tetri, Lawrence Serfaty, Francesco Negro, Caldwell. Stephen H. , Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel Lavine, Philippe Mathurin, Michael R. Charlton, Naga Chalasani, Quentin Anstee, Kris V. Kowdley, Jacob George, Zachary Goodman, Keith Lindor. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis., Hepatology. Hepatology. 2018 Jul;68(1):361-371. doi: 10.1002/hep.29724. |
| 201 | Zobair M Younossi, Maria Stepanova, Tarik Asselah, Graham R. Foster, Keyur Patel, Norbert Brau, Mark G. Swain, Tram T. Tran, Rafael Esteban, Massimo Colombo, Stephen Pianko, Linda Henry, Marc Bourliere. Hepatitis C in Patients with Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes, Clinical Infectious Diseases. Clin Infect Dis. 2018 May 17;66(11):1742-1750. doi: 10.1093/cid/cix1106. |
| 202 | Maria Stepanova, Issah Younossi, Andrei Racila, Zobair M Younossi. Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)., Value in Health. Value Health. 2018 May;21(5):612-621. doi: 10.1016/j.jval.2017.10.005. Epub 2017 Dec 6. |
| 203 | Zobair M Younossi. The epidemiology of nonalcoholic steatohepatitis, Clinical Liver Disease. Clin Liver Dis (Hoboken). 2018 Apr; 11(4): 92â94. Published online 2018 Apr 20. doi: 10.1002/cld.710 |
| 204 | Zobair M Younossi. Patient-Reported Outcomes for Patients With Chronic Liver Disease., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2018 Jun;16(6):793-799. doi: 10.1016/j.cgh.2017.12.028. Epub 2018 Apr 19. |
| 205 | Aybike Birerdinc, Sasha Stoddard, Zobair M Younossi. The Stomach as an Endocrine Organ: Expression of Key Modulatory Genes and Their Contribution to Obesity and Non-alcoholic Fatty Liver Disease (NAFLD)., Current Gastroenterology Report. Curr Gastroenterol Rep. 2018 Apr 19;20(6):24. doi: 10.1007/s11894-018-0629-6. |
| 206 | Zobair M Younossi, Maria Stepanova, Kathleen B. Schwarz, Wirth Stefan , Philip Rosenthal, Regino Gonzalez-Peralta, Karen Murray, Linda Henry, Sharon Hunt. Quality of Life in Adolescents with Hepatitis C Treated with Sofosbuvir and Ribavirin., Journal of Viral Hepatitis. J Viral Hepat. 2018 Apr;25(4):354-362. doi: 10.1111/jvh.12830. Epub 2017 Dec 26. |
| 207 | Zobair M Younossi, Maria Stepanova, Stuart C. Gordon, Stefan Zeuzem, Michael Mann, Ira M. Jacobson, Marc Bourliere, Curtis L. Cooper, Steven L. Flamm, K. Rajender Reddy, Kris V. Kowdley, Issah Younossi, Sharon Hunt. Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2018 Apr;16(4):567-574.e6. doi: 10.1016/j.cgh.2017.11.023. Epub 2017 Nov 16. |
| 208 | Zobair M Younossi. Reply., Hepatology. Hepatology. 2018 Jul;68(1):390. doi: 10.1002/hep.29896. |
| 209 | Pegah Golabi, Maria Stepanova, Huong T. Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll, Zobair M Younossi. Non-alcoholic Steatofibrosis Can Independently Predict Mortality in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2018 Mar 20;5(1):e000198. doi: 10.1136/bmjgast-2018-000198. eCollection 2018. |
| 210 | Maria Stepanova, Alexander Thompson, J Doyle, Issah Younossi, Leyla de Avila, Zobair M Younossi. Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens., Journal of Infectious Diseases. J Infect Dis. 2018 Mar 13;217(7):1033-1043. doi: 10.1093/infdis/jix681. |
| 211 | Pegah Golabi, Maria Stepanova, Huong T. Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll, Zobair M Younossi. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD), BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2018 Mar 20;5(1):e000198. doi: 10.1136/bmjgast-2018-000198. eCollection 2018. |
| 212 | Zobair M Younossi, Maria Stepanova, Harry Janssen, Kaushik Agarwal, Mindie H. Nguyen, Edward J. Gane, Naoky Tsai, Issah Younossi, Andrei Racila. Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported Outcomes., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2018 Oct;16(10):1641-1649.e6. doi: 10.1016/j.cgh.2018.02.037. Epub 2018 Mar 2. |
| 213 | Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Mehmet Sayiner, Nila Rafiq, Zobair M Younossi. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)., Medicine. Medicine (Baltimore). 2018 Mar;97(13):e0214. doi: 10.1097/MD.0000000000010214. |
| 214 | Zobair M Younossi. The efficacy of new antiviral regimens for hepatitis C infection: Evidence from a systematic review., Hepatology. Hepatology. 2018 Mar;67(3):1160-1162. doi: 10.1002/hep.29580. Epub 2018 Jan 26. |
| 215 | Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Mehmet Sayiner, Nila Rafiq, Zobair M Younossi. Components of Metabolic Syndrome Increase the Risk of Mortality in Non-alcoholic Fatty Liver Disease (NAFLD), Medicine. Medicine (Baltimore). 2018 Mar;97(13):e0214. doi: 10.1097/MD.0000000000010214. |
| 216 | Zobair M Younossi, Henry Lik-Yuen Chan, Yock Young Dan, Mei Hsuan Lee, Young-Suk Lim, Eliza Kruger, Seng Tan. Impact of Ledipasvir/Sofosbuvir on the Work Productivity of Genotype 1 Chronic Hepatitis C Patients in Asia., Journal of Viral Hepatitis. J Viral Hepat. 2018 Mar;25(3):228-235. doi: 10.1111/jvh.12808. Epub 2017 Nov 29. |
| 217 | Zobair M Younossi, Atsushi Tanaka, Yuichiro, Eguchi, Linda Henry, Rachel Beckerman, Masashi Mizokami. Treatment of Hepatitis C Virus Leads to Economic Gains Related to Reduction in Cases of Hepatocellular Carcinoma and Decompensated Cirrhosis in Japan., Journal of Viral Hepatitis. J Viral Hepat. 2018 Feb 25. doi: 10.1111/jvh.12886. [Epub ahead of print] |
| 218 | Maria Stepanova, Fatema Nader, Christophe Bureau, Danielle Adebayo, Laure Elkrief, Dominique Valla, Markus Peck-Radosavljevic, Anne McCune, Victor Vargas, Macarena Simon-Talero, Juan Cordoba, Paolo Angeli, Silvia Rossi. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study., Quality of Life Research. Qual Life Res. 2018 Jun;27(6):1513-1520. doi: 10.1007/s11136-018-1813-8. Epub 2018 Feb 19. |
| 219 | Zobair M Younossi, Linda Henry, Haley Bush, P Mishra. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis., Clinical Liver Disease. Clin Liver Dis. 2018 Feb;22(1):1-10. doi: 10.1016/j.cld.2017.08.001. Epub 2017 Oct 14. |
| 220 | Zobair M Younossi. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation., Liver Transplantation. Liver Transpl . 2018 Feb;24(2):166-170. doi: 10.1002/lt.25003. |
| 221 | Zobair M Younossi, Deidre Blissett, Rob Blissett, Linda Henry, Youssef Younossi, Rachel Beckerman, Sharon Hunt. In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered., Liver International. Liver Int. 2018 Feb;38(2):258-265. doi: 10.1111/liv.13519. Epub 2017 Aug 24. |
| 222 | Zobair M Younossi. Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection-Author's reply., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2018 Feb;47(4):537-538. doi: 10.1111/apt.14481. |
| 223 | Lynn Gerber, Dinesh Kumbhare. Physiatry Reviews for Evidence in Practice Second-Order Peer Review: Does Massage Therapy Have Value in the Treatment for Tension Type Headache?, American Journal of Physical Medicine and Rehabilitation. Am J Phys Med Rehabil. 2018 Feb;97(2):141-142. doi: 10.1097/PHM.0000000000000833. |
| 224 | Omer Shahab, Pegah Golabi, Zobair M Younossi. Chronic kidney disease in patients with chronic hepatitis C virus infection., Minerva Gastroenterologica e Dietologica. Minerva Gastroenterol Dietol . 2018 Dec;64(4):376-382. doi: 10.23736/S1121-421X.18.02466-2. Epub 2018 Jan 10. |
| 225 | Natsu Fukui, Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Haley Bush, Zobair M Younossi. Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2018 Mar;47(5):680-688. doi: 10.1111/apt.14484. Epub 2018 Jan 3. |
| 226 | Zobair M Younossi, Maria Stepanova, Ira M. Jacobson, Tarik Asselah, Edward J. Gane, Eric Lawitz, Graham R. Foster, Stuart Roberts, Alexander Thompson, Bernard Willems, Tania M. Welzel, Brian Pearlman, Issah Younossi, Andrei Racila, Linda Henry. Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3., Alimentary Pharmacology & Therapeutics. Send to Aliment Pharmacol Ther. 2018 Jan;47(2):259-267. doi: 10.1111/apt.14423. Epub 2017 Nov 27. |
| 227 | Zobair M Younossi, Quentin Anstee, M Marietti, T Hardy, Linda Henry, M Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention., Nature Reviews Gastroenterology & Hepatology. Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20. |
| 228 | Maria Stepanova, Alexander Thompson, J Doyle, Leyla de Avila, Zobair M Younossi. Hepatitis C Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment with Interferon-Free Regimens., Journal of Infectious Diseases. J Infect Dis. 2017 Dec 26. doi: 10.1093/infdis/jix681. [Epub ahead of print] |
| 229 | Zobair M Younossi. Nonalcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: Implications for Liver Transplantation., Liver Transplantation. Liver Transpl . 2018 Feb;24(2):166-170. doi: 10.1002/lt.25003. |
| 230 | Aybike Birerdinc, Zobair M Younossi. Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis, Annals of Hepatology. Ann Hepatol. 2018 January-February;17(1):11-13. doi: 10.5604/01.3001.0010.7530. |
| 231 | Natsu Fukui, Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Haley Bush, Zobair M Younossi. Hospice Care in Medicare Patients with Primary Liver Cancer: The Impact on Resource Utilization and Mortality, Alimentary Pharmacology & Therapeutics. 2018 Mar;47(5):680-688. doi: 10.1111/apt.14484. Epub 2018 Jan 3. |
| 232 | Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching-Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei MD Lai. The effect of interferonâfree regimens on healthârelated quality of life in East Asian patients with chronic hepatitis C, Liver International. Liver Int. 2018 Jul;38(7):1179-1187. doi: 10.1111/liv.13650. Epub 2018 Jan 25. |
| 233 | Natsu Fukui, Pegah Golabi, Munkhzul Otgonsuren, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. Demographics, Resource Utilization and Outcomes of Patients with Chronic Liver Disease Receiving Hospice Care in the United States , American Journal of Gastroenterology. Am J Gastroenterol. 2017 Nov;112(11):1700-1708. doi: 10.1038/ajg.2017.290. Epub 2017 Oct 10. |
| 234 | Natsu Fukui, Pegah Golabi, Munkhzul Otgonsuren, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States., American Journal of Gastroenterology. Am J Gastroenterol. 2017 Nov;112(11):1700-1708. doi: 10.1038/ajg.2017.290. Epub 2017 Oct 10. |
| 235 | Zobair M Younossi. The Efficacy of New Anti-Viral Regimens for Hepatitis C Infection: Evidence from A Systematic Review., Hepatology. Hepatology. 2017 Oct 10. doi: 10.1002/hep.29580. [Epub ahead of print] |
| 236 | Lynn Gerber, Bonnie Hodsdon, Leora Ellen Comis, Leighton Chan, John I. Gallin, Charles L. McGarvey. A Brief Historical Perspective of Cancer Rehabilitation and Contributions From the National Institutes of Health, American Academy of Physical Medicine and Rehabilitation. PM R. 2017 Sep;9(9S2):S297-S304. doi: 10.1016/j.pmrj.2017.07.005. |
| 237 | Mehmet Sayiner, Pegah Golabi, F Farhat, Zobair M Younossi. Dermatologic Manifestations of Chronic Hepatitis C Infection., Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):555-564. doi: 10.1016/j.cld.2017.03.010. Epub 2017 Apr 25. |
| 238 | Zobair M Younossi. Preface., Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):xiii. doi: 10.1016/j.cld.2017.05.001. |
| 239 | Pegah Golabi, Haley Bush, Zobair M Younossi. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, Clinics In Liver Disease. Clin Liver Dis. 2017 Nov;21(4):739-753. doi: 10.1016/j.cld.2017.06.010. Epub 2017 Jul 29. |
| 240 | Zobair M Younossi, Katrin Kochems, Marc De Ridder, Desmond Curran, Eveline Bunge, Laurence de Moerlooze. The impact of diabetes mellitus on the progression of chronic hepatitis B: a systematic review, Human Vaccines and Immunotherapeutics. Hum Vaccin Immunother. 2017 Nov 2;13(11):2695-2706. doi: 10.1080/21645515.2017.1353850. Epub 2017 Jul 25. |
| 241 | Zobair M Younossi, Katrin Kochems, Marc De Ridder, Desmond Curran, Eveline Bunge, Laurence de Moerlooze. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease., Human Vaccines and Immunotherapeutics. Hum Vaccin Immunother. 2017 Nov 2;13(11):2695-2706. doi: 10.1080/21645515.2017.1353850. Epub 2017 Jul 25. |
| 242 | Haley Bush, Pegah Golabi, Zobair M Younossi. Pediatric Non-Alcoholic Fatty Liver Disease, Children. Children (Basel). 2017 Jun 9;4(6). pii: E48. doi: 10.3390/children4060048. |
| 243 | Zobair M Younossi, Maria Stepanova, Nila Rafiq, Linda Henry, Rohit Loomba, Hala Makhlouf, Zachary Goodman. Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease, Hepatology Communications. Hepatol Commun. 2017 Jun 6;1(5):421-428. doi: 10.1002/hep4.1054. eCollection 2017 Jul. |
| 244 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, David Wyles, Shyam Kottilil, Sharon Hunt. Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study., Liver International. Liver Int. 2017 Dec;37(12):1796-1804. doi: 10.1111/liv.13462. Epub 2017 May 25. |
| 245 | Zobair M Younossi. Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2017 Aug;15(8):1144-1147. doi: 10.1016/j.cgh.2017.05.029. Epub 2017 May 23. |
| 246 | Maria Stepanova, Leyla de Avila, Mariam Afendy, Issah Younossi, Huong T. Pham, Rebecca Cable, Zobair M Younossi. Direct and Indirect Economic Burden of Chronic Liver Disease in the United States, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2017 May;15(5):759-766.e5. doi: 10.1016/j.cgh.2016.07.020. Epub 2016 Jul 25. |
| 247 | Zobair M Younossi, Haesuk Park, Douglas T. Dieterich, Sammy Saab, Aijaz Ahmed, Stuart C. Gordon. The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society , Liver International. Liver Int. 2017 May;37(5):662-668. doi: 10.1111/liv.13298. Epub 2016 Nov 29. |
| 248 | Pegah Golabi, Mehmet Sayiner, Haley Bush, Lynn Gerber, Zobair M Younossi. Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection., Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):565-578. doi: 10.1016/j.cld.2017.03.011. Epub 2017 Apr 26. |
| 249 | Maria Stepanova, Zobair M Younossi. Economic Burden of Hepatitis C Infection., Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):579-594. doi: 10.1016/j.cld.2017.03.012. Epub 2017 Apr 22. |
| 250 | Zobair M Younossi. Hepatitis C Infection: A Systemic Disease, Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):449-453. doi: 10.1016/j.cld.2017.03.001. Epub 2017 Apr 20. |
| 251 | Pegah Golabi, Munkhzul Otgonsuren, Mehmet Sayiner, Aimal Arsalla, Trevor Gogoll, Zobair M Younossi. The Prevalence of Parkinson Disease among Patients with Hepatitis C Infection., Annals of Hepatology. 2017 May - Jun;16(3):342-348. doi: 10.5604/16652681.1235476. |
| 252 | Maria Stepanova, Stephen C. Clement, Robert John Wong, Sammy Saab, Aijaz Ahmed, Zobair M Younossi. Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States., Clinical Diabetes. Clin Diabetes. 2017 Apr;35(2):79-83. doi: 10.2337/cd16-0018. |
| 253 | Pegah Golabi, Sofie Fazel, Munkhzul Otgonsuren, Mehmet Sayiner, Cameron T. Locklear, Zobair M Younossi. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities., Medicine. Medicine (Baltimore). 2017 Mar;96(9):e5904. doi: 10.1097/MD.0000000000005904. |
| 254 | Mehmet Sayiner, Munkhzul Otgonsuren, Rebecca Cable, Issah Younossi, Mariam Afendy, Pegah Golabi, Linda Henry, Zobair M Younossi. Variables associated with inpatient and outpatient resource utilization among medicare beneficiaries with NAFLD with or without cirrhosis, Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2017 Mar;51(3):254-260. doi: 10.1097/MCG.0000000000000567. |
| 255 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Mark S. Sulkowski, Graham R. Foster, Alessandra Mangia, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Fatema Nader, Linda Henry. Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2017 Mar;15(3):421-430.e6. doi: 10.1016/j.cgh.2016.10.037. Epub 2016 Nov 12. |
| 256 | Zobair M Younossi, Stuart C. Gordon, Aijaz Ahmed, Douglas T. Dieterich, Sammy Saab, Rachel Beckerman. Treating Medicaid Patients with Hepatitis C: Clinical and Economic Impact, American Journal of Managed Care. Am J Manag Care. 2017 Feb;23(2):107-112. |
| 257 | Ali Weinstein, G Diao, Heibatollah Baghi, Carey Escheik, Lynn Gerber, Zobair M Younossi. Demonstration of Two Types of Fatigue in Subjects with Chronic Liver Disease using Factor Analysis, Quality of Life Research. Qual Life Res. 2017 Feb 21. doi: 10.1007/s11136-017-1516-6. [Epub ahead of print] |
| 258 | Zobair M Younossi, Maria Stepanova, Linda Henry, Andrei Racila, Brian P. Lam, Huong T. Pham, Sharon Hunt. A Disease-Specific Quality of Life Instrument for Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: CLDQ-NAFLD, Liver International. Liver Int. 2017 Feb 17. doi: 10.1111/liv.13391. [Epub ahead of print] |
| 259 | Zobair M Younossi, Maria Stepanova, Rafael Esteban, Ira M. Jacobson, Stefan Zeuzem, Mark S. Sulkowski, Linda Henry, Fatema Nader, Rebecca Cable, Mariam Afendy, Sharon Hunt. Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity, Medicine. Medicine (Baltimore). 2017 Feb;96(7):e5914. doi: 10.1097/MD.0000000000005914. |
| 260 | Lynn Gerber. Cancer-Related Fatigue: Persistent, Pervasive, and Problematic, Physical Medicine and Rehabilitation Clinics of North America. Phys Med Rehabil Clin N Am. 2017 Feb;28(1):65-88. doi: 10.1016/j.pmr.2016.08.004. |
| 261 | Lynn Gerber, Siddhartha Sikdar, Jacqueline V. Aredo, Katee Armstrong, William Rosenberg, Hui Shao, Jay Shah. Beneficial Effects of Dry Needling for Treatment of Chronic Myofascial Pain Persist for 6 Weeks After Treatment Completion, American Academy of Physical Medicine and Rehabilitation. PM R. 2017 Feb;9(2):105-112. doi: 10.1016/j.pmrj.2016.06.006. Epub 2016 Jun 11. |
| 262 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Mercedes Walters, Sharon Hunt. Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials., Health and Quality of Life Outcomes. Health Qual Life Outcomes. 2017 Jan 31;15(1):25. doi: 10.1186/s12955-017-0598-8. |
| 263 | Pegah Golabi, Thomas Jeffers, Zahra Younoszai, Munkhzul Otgonsuren, Mehmet Sayiner, Alita Mishra, Chapy Venkatesan, Madeline Erario, Zobair M Younossi. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma., Annals of Hepatology. 2017 Jul-Aug;16(4):555-564. doi: 10.5604/01.3001.0010.0290. |
| 264 | Maria Stepanova, Cameron T. Locklear, Nila Rafiq, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry., Clinical Transplantation. Clin Transplant. 2016 Dec;30(12):1570-1577. doi: 10.1111/ctr.12859. Epub 2016 Nov 8. |
| 265 | Maria Stepanova, Mehmet Sayiner, Leyla de Avila, Zahra Younoszai, Andrei Racila, Zobair M Younossi. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor., BMC Gastroenterology. BMC Gastroenterol. 2016 Nov 15;16(1):137. |
| 266 | Pegah Golabi, Elzafir Elsheikh Abdelrahman, Azza Karrar, James M. Estep, Issah Younossi, Maria Stepanova, Lynn Gerber, Zobair M Younossi. The Levels of Monoamine Neurotransmitters and Measures of Mental and Emotional Health in HCV Patients Treated with Ledipasvir (LDV) and Sofosbuvir (SOF) with or without Ribavirin (RBV) , Medicine. Medicine (Baltimore). 2016 Nov;95(46):e5066. |
| 267 | Zobair M Younossi. Sofosbuvir (SOF) and Ledipasvir (LDV) Improves Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) (manuscript), Journal of Viral Hepatitis. Volume 23, Issue 11,November 2016 ,Pages 857â865 |
| 268 | Zobair M Younossi, Atsushi Tanaka, Yuichiro Eguchi, Young-Suk Lim, Ming-Lung Yu, Norifumi Kawada, Yock Young Dan, C Brooks-Rooney, Francesco Negro, Mario Mondelli. The impact of hepatitis C virus outside the liver: evidence from Asia , Liver International. Liver Int. 2017 Feb;37(2):159-172. doi: 10.1111/liv.13272. Epub 2016 Nov 10. |
| 269 | Linda Henry, Zobair M Younossi. Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C. , Expert Review of Pharmacoeconomics and Outcomes Research. Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):659-665. Epub 2016 Oct 12. |
| 270 | Maria Stepanova, Zobair M Younossi. Letter: effects of hepatitis C infection on the post-lung transplant mortality - authors' reply., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2016 Oct;44(7):768-9. doi: 10.1111/apt.13759 |
| 271 | Zobair M Younossi, Aybike Birerdinc, Linda Henry. Hepatitis C Infection: A Multi-Faceted Systemic Disease with Clinical, Patient Reported and Economic Consequences, Journal of Hepatology. 2016 Oct;65(1 Suppl):S109-19. doi: 10.1016/j.jhep.2016.07.005 |
| 272 | Zobair M Younossi, Haesuk Park, Douglas T. Dieterich, Sammy Saab, Aijaz Ahmed, Stuart C. Gordon. Assessment of Cost of Innovation versus the Value of Health Gains Associated with Treatment of Chronic Hepatitis C in the United States: The Quality-Adjusted Cost of Care, Medicine. Medicine (Baltimore) . 2016 Oct;95(41):e5048. doi: 10.1097/MD.0000000000005048. |
| 273 | Zobair M Younossi, Deidre Blissett, Rob Blissett, Linda Henry, Maria Stepanova, Youssef Younossi, Andrei Racila, Sharon Hunt, Rachel Beckerman. The Economic and Clinical Burden of Nonalcoholic Fatty Liver Disease (NAFLD) in the United States and Europe, Hepatology. Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26. |
| 274 | Ali Weinstein, Patrice Winter, Ancha Baranova, Aybike Birerdinc, Katherine Doyle, Lynn Gerber. Poster 16 Effect of Cancer-Related Fatigue on Cytokine Reactivity to Challenge Tasks in Breast Cancer Survivors., Physical Medicine and Rehabilitation Clinics of North America. PM R. 2016 Sep;8(9S):S166. doi: 10.1016/j.pmrj.2016.07.059. Epub 2016 Sep 24. |
| 275 | Rohini Mehta, Jeiran Kianoush, Aaron B. Koenig, Munkhzul Otgonsuren, Zachary Goodman, Ancha Baranova, Zobair M Younossi. The Role of Mitochondrial Genomics in Patients with Non-Alcoholic Steatohepatitis (NASH) , Biomed Central Medical Genetics. BMC Med Genet. 2016 Sep 5;17(1):63. doi: 10.1186/s12881-016-0324-0 |
| 276 | Zobair M Younossi, Maria Stepanova, Linda Henry, Issah Younossi, Ali Weinstein, Fatema Nader, Sharon Hunt. Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus, Journal of Viral Hepatitis. 2016 Aug;23(8):623-30. doi: 10.1111/jvh.12528. Epub 2016 Mar 14 |
| 277 | Elliot B. Tapper, Bruce R. Bacon, Michael P. Curry, Douglas T. Dieterich, Steven L. Flamm, Lauren Guest, Kris V. Kowdley, Yoori Lee, Naoky Tsai, Zobair M Younossi, Nezam H. Afdhal. Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study., Hepatology. Hepatology. 2016 Aug 17. doi: 10.1002/hep.28782. [Epub ahead of print] |
| 278 | Mehmet Sayiner, Maria Stepanova, Huong T. Pham, Bashir Noor, Mercedes Walters, Zobair M Younossi. Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease, BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2016 Aug 16;3(1):e000106. doi: 10.1136/bmjgast-2016-000106. eCollection 2016. |
| 279 | Zobair M Younossi, Maria Stepanova, Michael R. Charlton, Michael P. Curry, Robert S. Brown, Sharon Hunt. Patient-Reported Outcomes in Decompensated Cirrhotics with Hepatitis C Treated with Sofosbuvir and Velpatasvir with or without Ribavirin: Results from a Phase 3 Randomised Controlled Trial, The Lancet Gastroenterology and Hepatology. Lancet Gastroenterol Hepatol. 2016 Oct;1(2):122-132. doi: 10.1016/S2468-1253(16)30009-7. Epub 2016 Aug 3. |
| 280 | Aaron B. Koenig, Maria Stepanova, Sean C. Felix, Shirley Kalwaney, Stephen C. Clement. Hepatitis A and B Vaccinations Rates in Patients with Chronic Liver Disease (CLD) and Type 2 Diabetes (DM), Liver International. 2016 Aug;36(8):1096-100. doi: 10.1111/liv.1316 |
| 281 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Mercedes Walters, Sharon Hunt. Quality of Life of Japanese Patients with Chronic Hepatitis C Treated with Ledipasvir and Sofosbuvir, Medicine. Medicine (Baltimore). 2016 Aug;95(33):e4243. doi: 10.1097/MD.0000000000004243 |
| 282 | Elzafir Elsheikh Abdelrahman, Thomas Jeffers, Zahra Younoszai, Sharon Hunt, Brian P. Lam, Munkhzul Otgonsuren, Maria C. Albano, Ingrid Schneider, Brian Marsiglia, Bryan Raybuck, Zobair M Younossi. Non-Hematopoietic Circulating Progenitor Cells and Presence of Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease, Journal of Cytology & Histology. Elsheikh et al., J Cytol Histol 2016, 7:3 DOI: 10.4172/2157-7099.1000423 |
| 283 | Rohini Mehta, Munkhzul Otgonsuren, Zahra Younoszai, Hussain Allawi, Bryan Raybuck, Zobair M Younossi. Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease, BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2016 Jul 26;3(1):e000096. doi: 10.1136/bmjgast-2016-000096. eCollection 2016 |
| 284 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Graham R. Foster, Nancy Reau, Alessandra Mangia, Keyur Patel, Norbert Brau, Stuart Roberts, Nezam H. Afdhal, Fatema Nader, Linda Henry. RIBAVIRIN-FREE REGIMEN WITH SOFOSBUVIR AND VELPATASVIR IS ASSOCIATED WITH HIGH EFFICACY AND IMPROVEMENT OF PATIENT-REPORTED OUTCOMES IN PATIENTS WITH GENOTYPES 2 AND 3 CHRONIC HEPATITIS C: RESULTS FROM ASTRAL-2 AND 3 CLINICAL TRIALS, Clinical Infectious Diseases. Clin Infect Dis. 2016 Oct 15;63(8):1042-8. doi: 10.1093/cid/ciw496. Epub 2016 Jul 20. |
| 285 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Susanna Naggie, Linda Henry, Sharon Hunt. Sofosbuvir and Ledipasvir Improve Patient-Reported Outcomes in Patients Co-infected with Hepatitis C and Human Immunodeficiency Virus, Journal of Viral Hepatitis. 2016 Jun 13. doi: 10.1111/jvh.12554 |
| 286 | Aaron B. Koenig, Maria Stepanova, Sammy Saab, Aijaz Ahmed, Robert John Wong, Zobair M Younossi. Long-term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the U.S. transplant registry. , Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2016 Aug;44(3):271-8. doi: 10.1111/apt.13693. Epub 2016 Jun 9 |
| 287 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Youssef Younossi, Sharon Hunt. ADHERENCE TO TREATMENT OF CHRONIC HEPATITIS C: FROM INTERFERON CONTAINING REGIMENS TO INTERFERON AND RIBAVIRIN FREE REGIMENS, Medicine. 2016 Jul;95(28):e4151. doi: 10.1097/MD.0000000000004151. PubMed PMID: 27428205; PubMed Central PMCID |
| 288 | Aaron B. Koenig, Maria Stepanova, Sean C. Felix, Shirley Kalwaney, Stephen C. Clement, Zobair M Younossi. Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?, Liver International. Liver Int. 2016 Aug;36(8):1096-100. doi: 10.1111/liv.13164. Epub 2016 Jun 2 |
| 289 | Zobair M Younossi, Haesuk Park, Stuart C. Gordon, John R. Ferguson, Aijaz Ahmed, Douglas T. Dieterich, Sammy Saab. Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naïve Patients With Hepatitis C, American Journal of Managed Care. Am J Manag Care. 2016 May;22(6 Spec No.):SP205-11 |
| 290 | Zobair M Younossi, Maria Stepanova, Linda Henry. Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C, Value in Health. Value Health. 2016 Jul-Aug;19(5):544-51. doi: 10.1016/j.jval.2016.02.005. Epub 2016 Apr 26 |
| 291 | Pegah Golabi, Cameron T. Locklear, Patrick Austin, Sophie K. Afdhal, Melinda Byrns, Lynn Gerber, Zobair M Younossi. Effectiveness of exercise in hepatic fat mobilization in nonalcoholic fatty liver disease: Systematic review, World Journal of Gastroenterology. 2016 July 21; 22(27): 6318-6327. DOI: 10.3748/wjg.v22.i27.6318 |
| 292 | Mehmet Sayiner, Maria Stepanova, Huong T. Pham, Bashir Noor, Mercedes Walters, Zobair M Younossi. Assessment of Health Utilities and Patientsâ Quality of Life in Patients with Non-Alcoholic Fatty Liver Disease, BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2016 Aug 16;3(1):e000106. doi: 10.1136/bmjgast-2016-000106. eCollection 2016. |
| 293 | Zobair M Younossi, Louis L. LaLuna, John J. Santoro, Flavia Mendes, Victor Araya, Natarajan Ravendhran, Lisa Pedicone, Idania Lio, Fatema Nader, Sharon Hunt, Andrei Racila, Maria Stepanova. Implementation of Baby Boomer Hepatitis C Screening and Linking to Care in Gastroenterology Practices: A Multi-Center Pilot Study, BMC Gastroenterology. BMC Gastroenterol. 2016 Apr 4;16(1):45. doi: 10.1186/s12876-016-0438-z |
| 294 | Zobair M Younossi, Douglas T. Dieterich, Bruce R. Bacon, Michael P. Curry, Steven L. Flamm, Kris V. Kowdley, Yoori Lee, Naoky Tsai, Nezam H. Afdhal. Access to Therapy in the Era of All Direct Acting Antiviral Regimens: Real World Experience From the TRIO Network, Gastroenterology. APRIL 2016 Vol 5 Issue 4 Supplement 4 _ S1-S1271 |
| 295 | Zobair M Younossi, Puneetinder Mann, Mark Wymer. Reply to the letter to the editor: Global Epidemiology of Non-alcoholic Fatty Liver Disease (NAFLD), Hepatology. 2016 Mar 31. doi: 10.1002/hep.28587. [Epub ahead of print] |
| 296 | Mehmet Sayiner, Zobair M Younossi. Identifying Patients at Risk from Non-alcoholic Fatty Liver-Related Hepatocellular Carcinomas, Hepatic Oncology. (2016) 3(2), 101â103, ePub March 23, 2016 |
| 297 | Zobair M Younossi, Linda Henry. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality, Gastroenterology. 2016 Jun;150(8):1778-85. doi: 10.1053/j.gastro.2016.03.005. Epub 2016 Mar 12 |
| 298 | Zobair M Younossi, Maria Stepanova, Henry Lik-Yuen Chan, Mei Hsuan Lee, Ming-Lung Yu, Yock Young Dan, Moon Seok Choi, Linda Henry. Patient-Reported Outcomes in Asian Patients with Chronic Hepatitis C Treated with Ledipasvir and Sofosbuvir, Medicine. 2016 Mar;95(9):e2702. doi: 10.1097/MD.0000000000002702 |
| 299 | Mehmet Sayiner, Mark Wymer, Pegah Golabi, Joel Ford, Indie Srishord, Zobair M Younossi. Presence of Hepatitis C (HCV) Infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation , Alimentary Pharmacology & Therapeutics. 15 MAR 2016 DOI: 10.1111/apt.13592 |
| 300 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens, American Journal of Gastroenterology. 2016 Mar 29. doi: 10.1038/ajg.2016.99. [Epub ahead of print] |
| 301 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Ira M. Jacobson, Kosh Agarwal, Christophe Hezode, Fatema Nader, Linda Henry, Sharon Hunt. Sofosbuvir/Velpatasvir Improves Patient-Reported Outcomes in HCV Patients: Results from ASTRAL-1 Placebo-Controlled Trial, Journal of Hepatology. J Hepatol. 2016 Jul;65(1):33-9. doi: 10.1016/j.jhep.2016.02.042. Epub 2016 Mar 5 |
| 302 | Maria Stepanova, Zobair M Younossi. Letter: new treatments for hepatitis C have implications for quality of life in people who inject drug â authors' reply, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2016 Apr;43(7):841-2. doi: 10.1111/apt.13545 |
| 303 | Zobair M Younossi, Linda Henry, Haesuk Park, Ayoade Adeyemi, Maria Stepanova. The Extra-Hepatic Manifestations of Hepatitis C - A Meta-Analysis of Prevalence Rates, Effects on Patient-Reported Outcomes and Economic Burden, Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00230-4. doi: 10.1053/j.gastro.2016.02.039. [Epub ahead of print] |
| 304 | Zobair M Younossi, Aaron B. Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology. Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22 |
| 305 | Pegah Golabi, Munkhzul Otgonsuren, Rebecca Cable, Sean C. Felix, Aaron B. Koenig, Mehmet Sayiner, Zobair M Younossi. Non-alcoholic Fatty Liver Disease (NAFLD) Is Associated with Impairment of Health Related Quality of Life (HRQOL), Health and Quality of Life Outcomes. 2016 Feb 9;14(1):18. doi: 10.1186/s12955-016-0420-z |
| 306 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Linda Henry. Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens, Journal of the American Geriatrics Society. 2016 Feb;64(2):386-93. doi: 10.1111/jgs.13928. Epub 2016 Jan 30 |
| 307 | Yousef Fazel, Aaron B. Koenig, Mehmet Sayiner, Zachary Goodman, Zobair M Younossi. Epidemiology and natural history of non-alcoholic fatty liver disease, Metabolism: Clinical & Experimental. Metabolism. 2016 Aug;65(8):1017-25. doi: 10.1016/j.metabol.2016.01.012. Epub 2016 Jan 29 |
| 308 | Chapy Venkatesan, Alita Mishra, Amanda Morgan, Maria Stepanova, Linda Henry, Zobair M Younossi. Outcomes Trends for Acute Myocardial Infarction, Congestive Heart Failure, and Pneumonia, 2005-2009, American Journal of Managed Care. 2016 Jan 1;22(1):e9-17 |
| 309 | Ali Weinstein, Carey Escheik, Bibiana Oe, Jillian Kallman Price, Lynn Gerber, Zobair M Younossi. Perception of Effort During Activity in Patients With Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease, Physical Medicine and Rehabilitation Clinics of North America. 2016 Jan;8(1):28-34. doi: 10.1016/j.pmrj.2015.06.001. Epub 2015 Jun 11 |
| 310 | Lynn Gerber, James M. Estep, Maria Stepanova, Carey Escheik, Ali Weinstein, Zobair M Younossi. Effects of Viral Eradication with Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients with Chronic HCV Infection, Clinical Gastroenterology And Hepatology. 2016 Jan;14(1):156-164.e3. doi: 10.1016/j.cgh.2015.07.035. Epub 2015 Aug 1 |
| 311 | Issah Younossi, Ali Weinstein, Maria Stepanova, Sharon Hunt, Zobair M Younossi. Mental and Emotional Impairment in Patients With Hepatitis C is Related to Lower Work Productivity, Psychosomatics. 2016 Jan-Feb;57(1):82-8. doi: 10.1016/j.psym.2015.10.005. Epub 2015 Oct 23 |
| 312 | Ali Weinstein, Carey Escheik, Bibiana Oe, Jillian Kallman Price, Lynn Gerber, Zobair M Younossi. Perception of Effort During Activity in Patients with Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease, PM&R. 2016 Jan;8(1):28-34. doi: 10.1016/j.pmrj.2015.06.001. Epub 2015 Jun 11 |
| 313 | Pegah Golabi, Mehmet Sayiner, Yousef Fazel, Aaron B. Koenig, Linda Henry, Zobair M Younossi. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis, Expert Review of Gastroenterology Hepatology. 2016 Jan;10(1):63-71. doi: 10.1586/17474124.2016.1099433. Epub 2015 Oct 15 |
| 314 | Pegah Golabi, Munkhzul Otgonsuren, Winnie Suen, Aaron B. Koenig, Bashir Noor, Zobair M Younossi. Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients with Chronic Hepatitis C (CH-C) in the United States, Medicine. 2016 Jan;95(3):e2482. doi: 10.1097/MD.0000000000002482 |
| 315 | Zobair M Younossi, Maria Stepanova, James M. Estep, Francesco Negro, Paul Clark, Sharon Hunt, Qinghua Song, Matthew Paulson, Luisa Stamm, Diana Brainard, Mani Subramanian, John McHutchison, Keyur Patel. Dysregulation of Distal Cholesterol Biosynthesis in Association with Relapse and Advanced Disease in CHC Genotype 2 and 3 Treated with Sofosbuvir and Ribavirin , Journal of Hepatology. 2016 Jan;64(1):29-36. doi: 10.1016/j.jhep.2015.08.027. Epub 2015 Sep 1 |
| 316 | Zobair M Younossi, Maria Stepanova, Stanislas Pol, Jean-Pierre Bronowicki, Maria Patrizia Carrieri, Marc Bourliere. The Impact of Ledipasvir/Sofosbuvir on Patient-Reported Outcomes in Cirrhotic Patients with Chronic Hepatitis C: The SIRIUS Study., Liver International. 2016 Jan;36(1):42-8. doi: 10.1111/liv.12886. Epub 2015 Jun 24 |
| 317 | Zobair M Younossi, Aaron B. Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Global Epidemiology of Non-Alcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence and Outcomes, Hepatology. 2015 Dec 28. doi: 10.1002/hep.28431. [Epub ahead of print] |
| 318 | Maria Stepanova, Linda Henry, Rishi Garg, Shirley Kalwaney, Sammy Saab, Zobair M Younossi. Risk of Post-Transplant Type 2 Diabetes in Patients Undergoing Liver Transplant for Non-Alcoholic Steatohepatitis , BMC Gastroenterology. BMC Gastroenterol. 2015 Dec 15;15:175. doi: 10.1186/s12876-015-0407-y. |
| 319 | Maria Stepanova, Linda Henry, Rishi Garg, Shirley Kalwaney, Sammy Saab, Zobair M Younossi. Risk of De Novo Post-Transplant Type 2 Diabetes in Patients Undergoing Liver Transplant for Non-Alcoholic Steatohepatitis, BMC Gastroenterology. 2015 Dec 15;15:175. doi: 10.1186/s12876-015-0407-y |
| 320 | Mehmet Sayiner, Aaron B. Koenig, Linda Henry, Zobair M Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World, Clinics In Liver Disease. May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14 |
| 321 | Zobair M Younossi. Ethics of Prescribing New Direct Acting Antiviral Agents, Clinical Liver Disease. Volume 6, Issue 5, Version of Record online: 9 DEC 2015 |
| 322 | Zobair M Younossi, Linda Henry. Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease, PharmacoEconomics. 2015 Dec;33(12):1245-53. doi: 10.1007/s40273-015-0316-5 |
| 323 | Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario, Sharon Hunt. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009., Hepatology. 2015 Dec;62(6):1723-30. doi: 10.1002/hep.28123. Epub 2015 Oct 24 |
| 324 | Haesuk Park, Ayoade Adeyemi, Linda Henry, Maria Stepanova, Zobair M Younossi. A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection, Journal of Viral Hepatitis. 2015 Nov;22(11):897-905. doi: 10.1111/jvh.12413. Epub 2015 Apr 22 |
| 325 | Zobair M Younossi. The price of shortening antiâhepatitis C virus therapy: Is this truly cost saving?, Clinical Liver Disease. November 2015 Volume 6, Issue 5 Pages 126â128 DOI: 10.1002/cld.514 |
| 326 | Maria Stepanova, Zobair M Younossi. Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage, Digestive Diseases And Sciences. 2015 Nov;60(11):3248-51. doi: 10.1007/s10620-015-3709-6. Epub 2015 May 19 |
| 327 | Zobair M Younossi. What is the ethical responsibility of a provider when prescribing the new direct-acting antiviral agents to patients with hepatitis C infection?, Clinical Liver Disease. November 2015 Volume 6, Issue 5 Pages 117â1119 DOI: 10.1002/cld.509 |
| 328 | Zobair M Younossi, Ashley S. Brown, Maria Buti, Stefano Fagiuoli, Stefan Mauss, William Rosenberg, Lawrence Serfaty, Ankur Srivastava, Nathaniel Smith, Maria Stepanova, Rachel Beckerman. Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries, Journal of Viral Hepatitis. 20 OCT 2015 DOI: 10.1111/jvh.12483 |
| 329 | Lynn Gerber, Zobair M Younossi. Reply to Debilitating fatigue as a treatment indication in chronic hepatitis C, Journal of Hepatology. J Hepatol . 2015 Dec;63(6):1534-5. doi: 10.1016/j.jhep.2015.08.035. Epub 2015 Sep 12. |
| 330 | Brian P. Lam, Thomas Jeffers, Zahra Younoszai, Yousef Fazel, Zobair M Younossi. The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment, Therapeutic Advances in Gastroenterology. 2015 Sep;8(5):298-312. doi: 10.1177/1756283X15587481 |
| 331 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Susanna Naggie, Massimo Puoti, Chloe Orkin, Sharon Hunt. Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes., Journal of Infectious Diseases. 2015 Aug 1;212(3):367-77. doi: 10.1093/infdis/jiv005. Epub 2015 Jan 12 |
| 332 | Maria Stepanova, Homan Wai, Sammy Saab, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. The outcomes of adult liver transplants in the United States from 1987 to 2013, Liver International. 2015 Aug;35(8):2036-41. doi: 10.1111/liv.12779. Epub 2015 Jan 21 |
| 333 | Zobair M Younossi, Maria Stepanova, Nid Afdhal, Kris V. Kowdley, Stefan Zeuzem, Linda Henry, Sharon Hunt, Patrick Marcellin. Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir., Journal of Hepatology. 2015 Aug;63(2):337-45. doi: 10.1016/j.jhep.2015.03.014. Epub 2015 Mar 17 |
| 334 | Yousef Fazel, Brian P. Lam, Pegah Golabi, Zobair M Younossi. Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C, Expert Opinion on Drug Safety. 2015 Aug;14(8):1317-26. doi: 10.1517/14740338.2015.1053868. Epub 2015 Jun 4 |
| 335 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Fatema Nader, Sharon Hunt. The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life, Alimentary Pharmacology & Therapeutics. 2015 Aug;42(3):286-95. doi: 10.1111/apt.13269. Epub 2015 Jun 9 |
| 336 | Zobair M Younossi, Linda Henry. Overall Health-Related Quality of Life in Patients With End-Stage Liver Disease, Clinical Liver Disease. 28 JUL 2015; 6(1). DOI:10.1002/cld.480 |
| 337 | Zobair M Younossi, Elzafir Elsheikh Abdelrahman, Maria Stepanova, Lynn Gerber, Fatema Nader, Luisa Stamm, Diana Brainard, John McHutchison. Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels, Journal of Viral Hepatitis. 2015 July 1; doi:10.1111/jvh.12448 |
| 338 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Aijaz Ahmed, Brian P. Lam, Manirath Srishord, Chapy Venkatesan, Homan Wai, Linda Henry. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes, Journal of Viral Hepatitis. doi: 10.1111/jvh.12449. Epub 2015 Aug 20 |
| 339 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Kris V. Kowdley, Stefan Zeuzem, Sharon Hunt. Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials, Hepatology. 2015 Jun;61(6):1798-808. doi: 10.1002/hep.27724. Epub 2015 Mar 18 |
| 340 | Azza Karrar, Maria Stepanova, Lakshmi Alaparthi, Sneha Lingam, Zahra Younoszai, Li Zheng, Khatera Salem Malik, Elena Younossi, Fanny Monge, Sharon Hunt, Zachary Goodman, Zobair M Younossi. Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease, Journal of Gastroenterology and Hepatology. J Gastroenterol Hepatol. 2015 May;30(5):900-8. doi: 10.1111/jgh.12856. |
| 341 | Zobair M Younossi, Yushan Jiang, Nathaniel Smith, Maria Stepanova, Rachel Beckerman. Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States, Hepatology. 2015 May;61(5):1471-8. doi: 10.1002/hep.27757. Epub 2015 Mar 23 |
| 342 | Patrick Austin, Lynn Gerber, Azza Karrar. Fatigue in Chronic Liver Disease: Exploring the Role of the Autonomic Nervous System, Liver International. DOI:10.1111/liv.12784 Liver Int. 2015; 35: 1489â1491 |
| 343 | James M. Estep, Zachary Goodman, Haveesh Sharma, Elena Younossi, Hazem Elariny, Ancha Baranova, Zobair M Younossi. Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD, Liver International. Liver Int. 2015 Apr;35(4):1367-72. doi: 10.1111/liv.12555. Epub 2014 Apr 23. |
| 344 | Aybike Birerdinc, Zobair M Younossi. Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?, Journal of Hepatology. 2015 Apr;62(4):761-2. doi: 10.1016/j.jhep.2015.01.005. Epub 2015 Jan 17 |
| 345 | Monica Shah, Zobair M Younossi. Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--diagnosis and management., American Journal of Managed Care. 2015 Mar;21(5 Suppl):s86-96 |
| 346 | Zobair M Younossi, Li Zheng, Maria Stepanova, Linda Henry, Chapy Venkatesan, Alita Mishra. Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease, Journal of Clinical Gastroenterology. 2015 Mar;49(3):222-7 |
| 347 | Zobair M Younossi, Haesuk Park, Sammy Saab, Aijaz Ahmed, Douglas T. Dieterich, Stuart C. Gordon. Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection, Alimentary Pharmacology & Therapeutics. 2015 Mar;41(6):544-63. doi: 10.1111/apt.13081. Epub 2015 Jan 26 |
| 348 | Zobair M Younossi, Linda Henry. Systematic review: patient-reported outcomes in chronic hepatitis C--the impact of liver disease and new treatment regimens, Alimentary Pharmacology & Therapeutics. 2015 Mar;41(6):497-520. doi: 10.1111/apt.13090. Epub 2015 Jan 23 |
| 349 | Maria Stepanova, Zobair M Younossi. The association of hepatitis C virus infection and post-liver transplant diabetes - authors' reply, Alimentary Pharmacology & Therapeutics. 2015 Mar;41(5):489. doi: 10.1111/apt.13072 |
| 350 | Munkhzul Otgonsuren, Linda Henry, Sharon Hunt, Chapy Venkatesan, Alita Mishra, Zobair M Younossi. Resource Utilization and Survival Among Medicare Patients with Advanced Liver Disease., Digestive Diseases And Sciences. 2015 Feb;60(2):320-32. doi: 10.1007/s10620-014-3318-9. Epub 2014 Aug 10 |
| 351 | Rohini Mehta, Arpan Neupane, Lei Wang, Zachary Goodman, Ancha Baranova, Zobair M Younossi. Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects, BMC Gastroenterology. 2014 Dec 16;14:208. doi: 10.1186/s12876-014-0208-8 |
| 352 | Zobair M Younossi, Linda Henry. The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C, Digestive and Liver Disease. 2014 Dec 15;46 Suppl 5:S186-96. doi: 10.1016/j.dld.2014.09.025. Epub 2014 Nov 10 |
| 353 | Munkhzul Otgonsuren, James M. Estep, Noreen Hossain, Elena Younossi, Spencer Frost, Linda Henry, Sharon Hunt, Yun Fang, Zachary Goodman, Zobair M Younossi. A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), Journal of Gastroenterology and Hepatology. J Gastroenterol Hepatol . 2014 Dec;29(12):2006-13. doi: 10.1111/jgh.12665. |
| 354 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Linda Henry. The Association of Hepatitis C Virus Infection and Post-Liver Transplant Diabetes: Data from 17,000 HCV-infected Transplant Recipients, Alimentary Pharmacology & Therapeutics. 21 NOV 2014 DOI: 10.1111/apt.130272014, |
| 355 | Maria Stepanova, Zobair M Younossi. Editorial: Patientsâ preferences and health utility assessment in those with HCV treated with sofosbuvir â stating the obvious? Authorsâ reply, Alimentary Pharmacology & Therapeutics. 3 OCT 2014 DOI: 10.1111/apt.12955 |
| 356 | Zobair M Younossi. Curing Chronic Hepatitis C With Sofosbuvir-Based Regimens, American Journal of Managed Care. Oct 2014, Volume 20, Special Issue 15 |
| 357 | Timothy Leslie, Lisa Pawloski, Jillian Kallman Price, Carey Escheik, Noreen Hossain, Yun Fang, Lynn Gerber, Zobair M Younossi. Survey of Health Status, Nutrition and Geography of Food Selection of Chronic Liver Disease Patients, Annals of Hepatology. Ann Hepatol . 2014 Sep-Oct;13(5):533-40. |
| 358 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Shirley Kalwaney, Stephen C. Clement, Linda Henry, Spencer Frost, Sharon Hunt. The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US, Alimentary Pharmacology & Therapeutics. 2014 Sep;40(6):676-85. doi: 10.1111/apt.12880. Epub 2014 Jul 15 |
| 359 | Sammy Saab, Stuart C. Gordon, Haesuk Park, Mark S. Sulkowski, Aijaz Ahmed, Zobair M Younossi. Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavririn in the treatment of chronic hepatitis C virus genotype 1 infection, Alimentary Pharmacology & Therapeutics. Volume 40, Issue 6, pages 657â675, September 2014 |
| 360 | Brian P. Lam, Linda Henry, Zobair M Younossi. Sofosbuvir (Sovaldi) for the treatment of hepatitis C, Expert Review of Clinical Pharmacology. 2014 Sep;7(5):555-66. doi: 10.1586/17512433.2014.928196. Epub 2014 Jun 11 |
| 361 | Linda Henry, Zobair M Younossi. Hepatitis. Chronic HCV infection, diabetes and liver-related outcomes, Nature Reviews Gastroenterology & Hepatology. 2014 Sep;11(9):520-1. doi: 10.1038/nrgastro.2014.122. Epub 2014 Jul 1 |
| 362 | Maria Stepanova, Fatema Nader, Sandrine Cure, Francois Bourhis, Sharon Hunt, Zobair M Younossi. Patients' Preferences and Health Utility Assessment with SF-6D and EQ-5D in Patients with Chronic Hepatitis C Treated with Sofosbuvir Regimens, Alimentary Pharmacology & Therapeutics. 2014 Sep;40(6):676-85. doi: 10.1111/apt.12880. Epub 2014 Jul 15 |
| 363 | Zobair M Younossi, Maria Stepanova, Linda Henry, Edward J. Gane, Eric Lawitz, David R. Nelson, Lynn Gerber, Fatema Nader, Sharon Hunt. Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C, Clinical Gastroenterology And Hepatology. 2014 Aug;12(8):1349-59.e13. doi: 10.1016/j.cgh.2013.11.032. Epub 2013 Dec 6. PubMed PMID: 24316172 |
| 364 | Maria Stepanova, Homan Wai, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. The portrait of an adult liver transplant recipient in the United States from 1987 to 2013, Journal of American Medical Association Internal Medicine. 2014 Aug;174(8):1407-9. doi: 10.1001/jamainternmed.2014.2903 |
| 365 | Zobair M Younossi, Linda Henry, E Mendel Singer. Reply to: "Cost-effectiveness of upcoming treatments for hepatitis C: we need to get the models right"., Journal of Hepatology. 2014 Aug;61(2):454-5. doi: 10.1016/j.jhep.2014.05.006. Epub 2014 May 10 |
| 366 | Zobair M Younossi, Maria Stepanova, Stefan Zeuzem, Geoffrey Dusheiko, Rafael Esteban, Christophe Hezode, Hendrik W. Reesink, Ola Weiland, Fatema Nader, Sharon Hunt. Patient-Reported Outcomes Assessment in Chronic Hepatitis C Treated with Sofosbuvir and Ribavirin: The VALENCE Study, Journal of Hepatology. 2014 Aug;61(2):228-34. doi: 10.1016/j.jhep.2014.04.003. Epub 2014 Apr 5 |
| 367 | Robert John Wong, Fasiha Kanwal, Zobair M Younossi, Aijaz Ahmed. Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature., Digestive Diseases And Sciences. 2014 Jul;59(7):1586-93. doi: 10.1007/s10620-014-3222-3. Epub 2014 Jun 4 |
| 368 | Zobair M Younossi, Linda Henry. Monitoring and Treatment of Inactive Chronic Hepatitis B: IS it Cost-Effective?, Hepatology. 2014 Jul;60(1):19-21. doi: 10.1002/hep.27062. Epub 2014 May 27. PubMed PMID: 24504789 |
| 369 | Janus P. Ong, Zobair M Younossi. Editorial: Probiotics in NASH - more studies needed, Alimentary Pharmacology & Therapeutics. 19 JUN 2014 DOI: 10.1111/apt.12812 |
| 370 | Anthony Loria, Katherine Doyle, Ali Weinstein, Patrice Winter, Carey Escheik, Jillian Kallman Price, Lei Wang, Aybike Birerdinc, Ancha Baranova, Lynn Gerber, Zobair M Younossi. Multiple Factors Predict Physical Performance in People with Chronic Liver Disease, American Journal of Physical Medicine and Rehabilitation. 2014 Jun;93(6):470-6. doi: 10.1097/PHM.0000000000000050. PubMed PMID: 24398583 |
| 371 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Ira M. Jacobson, Edward J. Gane, David R. Nelson, Eric Lawitz, Sharon Hunt. Patient-reported Outcomes in Chronic Hepatitis C Patients with Cirrhosis Treated with Sofosbuvir-containing Regimens, Hepatology. 2014 Jun;59(6):2161-9. doi: 10.1002/hep.27161. Epub 2014 Apr 30 |
| 372 | Zobair M Younossi, Li Zheng, Maria Stepanova, Chapy Venkatesan, Alita Mishra. Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study (spelling is European), British Medical Journal-Open. 2014 May 16;4(5):e004318. doi: 10.1136/bmjopen-2013-004318 |
| 373 | Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, Zareen Arsalla, Maria Stepanova, Alita Mishra, Chapy Venkatesan, Sharon Hunt. Inpatient Resource Utilization, Disease Severity, Mortality and Insurance Coverage for Patients Hospitalized for Hepatitis C Virus in the United States, Journal of Viral Hepatitis. 2014 May 12. doi: 10.1111/jvh.12262 |
| 374 | Rohini Mehta, Aybike Birerdinc, Lei Wang, Zahra Younoszai, Amir Moazzez, Hazem Elariny, Zachary Goodman, Vikas Chandhoke, Ancha Baranova, Zobair M Younossi. Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease, BMC Gastroenterology. 2014 Apr 9;14:72. doi: 10.1186/1471-230X-14-72 |
| 375 | Zobair M Younossi, Maria Stepanova, Linda Henry, Edward J. Gane, Ira M. Jacobson, Eric Lawitz, David R. Nelson, Fatema Nader, Sharon Hunt. Minimal Impact of Sofosbuvir and Ribavirin on Health Related Quality of Life in Chronic Hepatitis C (CH-C), Journal of Hepatology. 2014 Apr;60(4):741-7. doi: 10.1016/j.jhep.2013.12.006. Epub 2013 Dec 11. PubMed PMID: 24333184 |
| 376 | Elzafir Elsheikh Abdelrahman. Current status of nonalcoholic fatty liver disease, Expert Review of Endocrinology and Metabolism. |
| 377 | James M. Estep, Zachary Goodman, Haveesh Sharma, Elena Younossi, Hazem Elariny, Ancha Baranova, Zobair M Younossi. Adipocytokine Expression Associated with miRNA Regulation and Diagnosis in Obese Patients with NAFLD, Liver International. 2014 Mar 29. doi: 10.1111/liv.12555. [Epub ahead of print] PubMed PMID: 24684403 |
| 378 | Zobair M Younossi, Fasiha Kanwal, Sammy Saab, K. A. Brown, H.B. El-Serag, W.R. Kim, Aijaz Ahmed, Marcelo Kugelmas, Stuart C. Gordon. The impact of hepatitis C burden: an evidence-based approach, Alimentary Pharmacology & Therapeutics. 2014 Mar;39(5):518-31. doi: 10.1111/apt.12625 |
| 379 | Zobair M Younossi, E Mendel Singer, Heshaam Mir, Linda Henry, Sharon Hunt. Impact of Interferon Free Regimens on Clinical and Cost Outcomes for chronic hepatitis C genotype I patients: A Decision Analytic Assessment , Journal of Hepatology. 2014 Mar;60(3):530-7. doi: 10.1016/j.jhep.2013.11.009. Epub 2013 Nov 19. PubMed PMID: 24269472 |
| 380 | Yusuf Yilmaz, Zobair M Younossi. Obesity-associated nonalcoholic Fatty liver disease, Clinics In Liver Disease. 2014 Feb;18(1):19-31. doi: 10.1016/j.cld.2013.09.018. Epub 2013 Oct 24. Review. PubMed PMID: 24274862 |
| 381 | Zobair M Younossi. Obesity and Liver Disease, Clinics In Liver Disease. 2014 Feb;18(1):xiii-xiv. doi: 10.1016/j.cld.2013.09.020. Epub 2013 Oct 25. PubMed PMID: 24274879 |
| 382 | Zahra Younoszai, Li Zheng, Maria Stepanova, Madeline Erario, Rebecca Cable, Zobair M Younossi. Statin use is not associated with liver related mortality, Annals of Hepatology. 2013 Jan-2014 Feb;13(1):84-90 |
| 383 | Nila Rafiq, Maria Stepanova, Brian P. Lam, Fatema Nader, Manirath Srishord, Zobair M Younossi. Predictors of chronic liver disease in individuals with human immunodeficiency virus infection, Annals of Hepatology. 2013 Jan-2014 Feb;13(1):60-4 |
| 384 | Rohini Mehta, Aybike Birerdinc, Zobair M Younossi. Host Genetic Variants in Obesity-Related Non-Alcoholic Fatty Liver Disease (NAFLD), Clinics In Liver Disease. 2014 Feb;18(1):249-67. doi: 10.1016/j.cld.2013.09.017. Epub 2013 Oct 24. Review. PubMed PMID: 24274878 |
| 385 | C. McGown, Aybike Birerdinc, Zobair M Younossi. Adipose Tissue as an Endocrine Organ, Clinics In Liver Disease. 2014 Feb;18(1):41-58. doi: 10.1016/j.cld.2013.09.012. Review. PubMed PMID: 24274864 |
| 386 | Zobair M Younossi, Reyes , Alita Mishra, Rohini Mehta, Linda Henry. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets, Alimentary Pharmacology & Therapeutics. 2014 Jan;39(1):3-14. doi: 10.1111/apt.12543 |
| 387 | Homan Wai, Maria Stepanova, Sammy Saab, Madeline Erario, Manirath Srishord, Zobair M Younossi. Inpatient Economic and Mortality Assessment for Liver Transplantation: A Nationwide Study of the United States Data from 2005 to 2009, Transplantation. 2014 Jan 15;97(1):98-103. doi: 10.1097/TP.0b013e3182a716ac. PubMed PMID: 24056627 |
| 388 | Elzafir Elsheikh Abdelrahman, Zahra Younoszai, Munkhzul Otgonsuren, Sharon Hunt, Bryan Raybuck, Zobair M Younossi. Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease, Journal of Gastroenterology and Hepatology. 2014;29(7):1528-34 |
| 389 | Zobair M Younossi, Linda Henry, Maria Stepanova. A New Comorbidity Model for Predicting Mortality in Patients With Cirrhosis: Does It Work? , Gastroenterology. 2014 Jan;146(1):19-24. doi: 10.1053/j.gastro.2013.11.026. Epub 2013 Nov 25. PubMed PMID: 24287302 |
Presentations
| Num | Title |
|---|---|
| 1 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. DEVELOPMENT OF A PRIMARY BILIARY CHOLANGITIS (PBC)-SPECIFIC VERSION OF CHRONIC LIVER DISEASE QUESTIONNAIRE: CLDQ-PBC, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 2 | Maria Stepanova, Katherine Elizabeth Eberly, Dipam Shah, Reem Al Shabeeb, Veronica Nguyen, Janus P. Ong, Saleh Alqahtani, Linda Henry, Zobair M Younossi. LIVER TRANSPLANTATION FOR PRIMARY BILIARY CHOLANGITIS IN THE U.S. IN 2008-2022, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 3 | James Minhui Paik, Rebecca Cable, Linda Henry, Leyla de Avila, Huong T. Pham, Zobair M Younossi. ASSESSMENT OF HOSPITAL READMISSION RATES, RISK FACTORS, CAUSES AND COST AFTER DISCHARGE WITH CHRONIC LIVER DISEASE: ANALYSIS OF THE US NATIONWIDE READMISSIONS DATABASE, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 4 | Zobair M Younossi, James M. Estep, Sean C. Felix, Brian P. Lam, Elena Younossi, Nagashree Gundurao, Leyla de Avila, Huong T. Pham, Rebecca Cable, Jillian Kallman Price, Andrei Racila, Maria Stepanova. PNPLA3-rs738409 CG/GG GENOTYPE IS STRONGLY ASSOCIATED WITH ADVANCED HISTOLOGIC FIBROSIS AND HIGH RISK ENHANCED LIVER FIBROSIS (ELF) SCORE, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 5 | Zobair M Younossi, Yusuf Yilmaz, Jian-Gao Fan, Ming-Hua Zheng, Khaled Alswat, Saleh Alqahtani, Mohamed El Kassas, Laurent Castera, Jesus Funuyet-Salas, Manuel Romero-Gomez, Vincent Wai-Sun Wong, Shira Zelber-Sagi, Sombat Treeprasertsuk, Alina M. Allen, Hirokazu Takahashi, Takumi Kawaguchi, Sven Francques, Marlen Castellanos-Fernandez, Ajay Duseja, Jorn M. Schattenberg, Patrizia Burra, Maria Patrizia Carrieri, Marco Arrese, Mary E. Rinella, Ashwani K. Singal, Stuart C. Gordon, Michael Fuchs, Wayne Eskridge, Naim Alkhouri, Kenneth Cusi, Rohit Loomba, Jane Ranagan, Achim Kautz, Janus P. Ong, Marcelo Kugelmas, Yuichiro Eguchi, Moises Diago, Philip N Newsome, Ming-Lung Yu, Lynn Gerber, Brian P. Lam, Lisa Fornaresio, Fatema Nader, Linda Henry, Andrei Racila, Pegah Golabi, Maria Stepanova, Jeffrey V. Lazarus. STIGMA IS A PREDICTOR OF IMPAIRMENT OF HEALTH RELATED QUALITY OF LIFE AMONG PATIENTS WITH NAFLD, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 6 | James Minhui Paik, Dipam Shah, Katherine Elizabeth Eberly, Pegah Golabi, Zobair M Younossi. ALCOHOLIC LIVER DISEASE AND NON-ALCOHOLIC FATTY LIVER DISEASE WERE THE MAIN DRIVERS OF CIRRHOSIS RELATED DEATHS BEFORE AND DURING THE COVID-19 PANDEMIC IN THE UNITED STATES, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 7 | James Minhui Paik, Richard Duong, Shira Zelber-Sagi, Jeffrey V. Lazarus, Linda Henry, Zobair M Younossi. FOOD INSECURITY AND HOUSEHOLD INCOME SUBSTANTIALLY INCREASE THE RISK OF NAFLD AMONG ADOLESCENT CHILDREN IN THE UNITED STATES, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 8 | Zobair M Younossi, Pegah Golabi, Jillian Kallman Price, Soroor Owrangi, Nagashree Gundurao, Romona D. Satchi, James Minhui Paik. A RAPID RISE IN THE GLOBAL PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) AMONG PATIENTS WITH TYPE 2 DIABETES (T2D), American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 9 | Pegah Golabi, James M. Estep, Sean C. Felix, Maria Stepanova, Soroor Owrangi, Brian P. Lam, Maria Joao Meneses, Andrei Racila, Laurent Castera, Maria Paula Macedo, Zobair M Younossi. FIBROTIC NASH INDEX (FNI) IN DIABETICS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 10 | Zobair M Younossi, James Minhui Paik, Linda Henry, Richard F Pollock, Maria Stepanova, Fatema Nader. COST-EFFECTIVENESS OF IDENTIFYING HIGH-RISK NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS IN THE UNITED STATES (U.S), American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 11 | Zobair M Younossi, Reem Al Shabeeb, Katherine Elizabeth Eberly, Dipam Shah, Veronica Nguyen, Janus P. Ong, Saleh Alqahtani, Linda Henry, Maria Stepanova. NON-ALCOHOLIC STEATOHEPATITIS (NASH) HAS BECOME THE MOST COMMON INDICATION FOR LIVER TRANSPLANTATION AMONG CANDIDATES WITH HEPATOCELLULAR CARCINOMA IN THE UNITED STATES, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 12 | Zobair M Younossi, Yusuf Yilmaz, Jian-Gao Fan, Ming-Hua Zheng, Khaled Alswat, Saleh Alqahtani, Mohamed El Kassas, Laurent Castera, Jesus Funuyet-Salas, Manuel Romero-Gomez, Vincent Wai-Sun Wong, Shira Zelber-Sagi, Sombat Treeprasertsuk, Alina M. Allen, Hirokazu Takahashi, Takumi Kawaguchi, Sven Francques, Marlen Castellanos-Fernandez, Ajay Duseja, Jorn M. Schattenberg, Patrizia Burra, Maria Patrizia Carrieri, Marco Arrese, Mary E. Rinella, Jane Ranagan, Achim Kautz, Janus P. Ong, Marcelo Kugelmas, Yuichiro Eguchi, Moises Diago, Philip N Newsome, Andrei Racila, Pegah Golabi, Maria Stepanova, Jeffrey V. Lazarus. THE GLOBAL SURVEY OF DISEASE BURDEN AND STIGMA AMONG PATIENTS WITH NAFLD AND THEIR HEALTHCRAE PROVIDERS, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 13 | Ali Weinstein, Leyla de Avila, Jillian Kallman Price, Carey Escheik, Pegah Golabi, Lynn Gerber, Zobair M Younossi. INDIVIDUALS WITH ADVANCED FIBROSIS HAVE WORSE FINE MOTOR PERFORMANCE, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 14 | Zobair M Younossi, Reem Al Shabeeb, Katherine Elizabeth Eberly, Janus P. Ong, Saleh Alqahtani, Maria Stepanova. LIVER TRANSPLANTATION PROFILE AMONG TEENAGERS IN THE UNITED STATES, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 15 | Mohamed El Kassas, Yusuf Yilmaz, Chun-Jen Liu, Marlen Fernandez, Wah Kheong Chan, Georgios Papatheodoridis, Mohammed Ahmed Medhat Nasr, Fatema Nader, Andrei Racila, Maria Stepanova, Zobair M Younossi. A GLOBAL SURVEY OF PHYSICIAN KNOWLEDGE ABOUT MANAGEMENT OF CHRONIC HEPATITIS C, American Association for the Study of Liver Diseases. Boston, MA. 2023 |
| 16 | Jillian Kallman Price, Lynn Gerber, Maria Stepanova, Leyla de Avila, Ali Weinstein, Huong T. Pham, Zobair M Younossi. Severe, Persistent, Disruptive Fatigue Higher in Young Women Among Community-based Post SARS-CoV-2 Study, American Congress of Rehabilitation Medicine. Atlanta, GA. 2023 |
| 17 | Zobair M Younossi, James Minhui Paik. Socio-economic disparities drive the prevalence of non-alcoholic Fatty Liver Disease (NAFLD) among teenagers in the United States, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 18 | Zobair M Younossi, Maria Stepanova, James Minhui Paik, Fatema Nader, Linda Henry, Richard F Pollock. Health economics of the enhanced liver fibrosis test in the detection of advanced liver fibrosis in patients with non-alcoholic fatty liver disease in the UK, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 19 | Pegah Golabi, James Minhui Paik, Ameeta Kumar, Nagashree Gundurao, Kenneth Cusi, Zobair M Younossi. Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis among Subjects without Type 2 Diabetes (T2D), American Diabetes Association. San Diego, CA 2023 |
| 20 | Zobair M Younossi, James M. Estep, Sean C. Felix, Brian P. Lam, Elena Younossi, Nagashree Gundurao, Leyla de Avila, Huong T. Pham, Rebecca Cable, Jillian Kallman Price, Andrei Racila, Maria Stepanova. Associations of Genetic Risk Panel with Enhanced Liver Fibrosis Scores Among Patients with Non-alcoholic Fatty Liver Disease, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 21 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vasily Isakov, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Yuichiro Eguchi, Nahum Mendez-Sanchez, Ajay Duseja, Jacob George, Elisabetta Bugianesi, Ashwani K. Singal, Saeed S Hamid, Jian-Gao Fan, Khaled Alswat, Georgios Papatheodoridis, Mohamed El Kassas, Wah Kheong Chan, Stuart C. Gordon, Manuel Romero-Gomez, Stuart Roberts, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Saleh Alqahtani, Maria Stepanova. Prevalence and Predictors of Clinically Significant Pruritus in Patients with Non-alcoholic Fatty Liver Disease (NAFLD): Data from the Global NASH Registry (GNR), European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 22 | Maria Stepanova, Ameeta Kumar, Pamela Brandt, Nagashree Gundurao, Kenneth Cusi, Zobair M Younossi. The Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplants in the U.S., American Diabetes Association. |
| 23 | Maria Stepanova, Reem Al Shabeeb, Katherine Elizabeth Eberly, Janus P. Ong, Saleh Alqahtani, Zobair M Younossi. The Impact of Hepatitis B and C Serologies on the Outcomes of Non-liver Solid Organ Transplantation, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 24 | Zobair M Younossi, Lee Feinman, Amarita S. Randhawa, Rina Leyva, Maria Stepanova, Sangeeta Sawhney. Incidence and median times to onset and resolution of pruritus adverse events in a phase 3 study of obeticholic acid in patients with nonalcoholic steatohepatitis, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 25 | Zobair M Younossi, James Minhui Paik. Prevalence and mortality of non-alcoholic fatty liver disease (NAFLD) in non-diabetics, pre-diabetics, and diabetics in the United States, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 26 | Zobair M Younossi, Katherine Elizabeth Eberly, Reem Al Shabeeb, Ameeta Kumar, Pamela Brandt, Nagashree Gundurao, Janus P. Ong, Kenneth Cusi, Saleh Alqahtani, Maria Stepanova. The Growing Prevalence and Impact of Type 2 Diabetes among Liver Transplant Candidates in the United States, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 27 | Zobair M Younossi, Yusuf Yilmaz, Jian-Gao Fan, Vincent Wai-Sun Wong, Mohamed El Kassas, Shira Zelber-Sagi, Alina M. Allen, Mary E. Rinella, Ashwani K. Singal, Stuart C. Gordon, Michael Fuchs, Wayne Eskridge, Naim Alkhouri, Khaled Alsawat, Hirokazu Takahashi, Takumi Kawaguchi, Jane Ranagan, Ming-Hua Zheng, Ajay Duseja, Patrizia Burra, Maria Patrizia Carrieri, Marco Arrese, Achim Kautz, Janus P. Ong, Laurent Castera, Sven Francques, Marcelo Kugelmas, Yuichiro Eguchi, Sombat Treeprasertsuk, Marlen Castellanos-Fernandez, Manuel Romero-Gomez, Philip N Newsome, Kenneth Cusi, Rohit Loomba, Jorn M. Schattenberg, Ming-Lung Yu, Moises Diago, Lynn Gerber, Brian P. Lam, Lisa Fornaresio, Fatema Nader, Linda Henry, Andrei Racila, Pegah Golabi, Maria Stepanova, Saleh Alqahtani, Jeffrey V. Lazarus. Stigma in NAFLD and NASH: A Global Survey of Patients and Providers, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 28 | Zobair M Younossi, James Minhui Paik, Shira Zelber-Sagi, Jeffrey V. Lazarus, Pegah Golabi, Janus P. Ong, Saleh Alqahtani, Linda Henry. The growing global burden of non-alcoholic fatty liver disease (NAFLD) among teenagers, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 29 | Lakshmi Alaparthi, Gary Bratthauer, Aybike Birerdinc, Fanny Monge, Cassandra Sharp, Daisong Tan, Hala Abdelaal, Zachary Goodman. Characterization of portal inflammation and hepatic fibrosis in non-alcoholic fatty liver disease, European Association for the Study of the Liver. Vienna, Austria. 2023 |
| 30 | Jillian Kallman Price, Lynn Gerber, Maria Stepanova, Leyla de Avila, Ali Weinstein, Huong T. Pham, Wisna'odom Keo, Andrei Racila, Suzannah Gerber, Brian P. Lam, Zobair M Younossi. POST-ACUTE SARS-COV-2 SYMPTOMS ARE FEWER AND LESS INTENSE IN PEOPLE TREATED WITH MONO-CLONAL ANTIBODIES FOR ACUTE INFECTION THAN THOSE UNTREATED, International Society of Physical and Rehabilitation Medicine. Cartegena, Columbia |
| 31 | Jillian Kallman Price, Lynn Gerber, Maria Stepanova, Leyla de Avila, Ali Weinstein, Huong T. Pham, Wisna'odom Keo, Andrei Racila, Suzannah Gerber, Brian P. Lam, Zobair M Younossi. SEVERE, PERSISTENT FATIGUE IS THE MOST PREVALENT SYMPTOM POST-SARS-COV-2 INFECTION, International Society of Physical and Rehabilitation Medicine. Cartegana, Columbia |
| 32 | Zobair M Younossi, Marlen Castellanos-Fernandez, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Vasily Isakov, Vincent Wai-Sun Wong, Yuichiro Eguchi, Khaled Alswat, Nahum Mendez-Sanchez, Ajay Duseja, Maria Buti, Georgios Papatheodoridis, Saeed S Hamid, Jacob George, Elisabetta Bugianesi, Wah Kheong Chan, Ashwani K. Singal, Stuart C. Gordon, Jian-Gao Fan, Manuel Romero-Gomez, Stuart Roberts, Janus P. Ong, Brian P. Lam, Marcelo Kugelmas, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani. CLINICALLY SIGNIFICANT PRURITUS IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (GLR), Digestive Disease Week. Chicago, IL 2023 |
| 33 | Pegah Golabi, James Minhui Paik, Ameeta Kumar, Nagashree Gundurao, Kenneth Cusi, Zobair M Younossi. PREVALANCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND HEPATIC FIBROSIS AMONG PATIENTS WITH PRE-DIABETES, Digestive Disease Week. Chicago, IL 2023 |
| 34 | James Minhui Paik, Ariana Ghafouri, Dipam Shah, Reem Al Shabeeb, Saleh Alqahtani, Zobair M Younossi. GLOBAL BURDEN OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE ELDERLY, Digestive Disease Week. Chicago, IL 2023 |
| 35 | Jillian Kallman Price, Maria Stepanova, Leyla de Avila, Brian P. Lam, Ali Weinstein, Huong T. Pham, Wisna'odom Keo, Zaid Younossi, Mariam Afendy, Kathy Terra, Suzannah Gerber, James M. Estep, Pegah Golabi, Manisha Verma, Fatema Nader, Andrei Racila, Lynn Gerber, Zobair M Younossi. Health Behavior Change Following Post-Acute SARS-CoV-2: Insights from 6 months of Follow-up, Society of Behavioral Medicine. Phoenix, AZ. 2023. |
| 36 | Suzannah Gerber, Lilly A. Talal, Lynn Gerber, Jillian Kallman Price, Brian P. Lam, Andrei Racila, Zobair M Younossi. Patient-Reported Diet Indicators and Disease Severity for Patients with NAFLD, Society of Behavioral Medicine. Phoneix, AZ. 2023 |
| 37 | Suzannah Gerber, Jillian Kallman Price, Lynn Gerber, Ali Weinstein, Zobair M Younossi. Diet satisfaction and adequate food intake in Patients with Chronic Liver Diseases (CLD), Society of Behavioral Medicine. |
| 38 | Fatimah Nour, Ali Weinstein, Leyla de Avila, Jillian Kallman, Lynn Gerber, Zobair M Younossi. A Pilot Investigation of the Relationship between Fine Motor Performance and Glucose Regulation, American Psychosomatic Society. San Juan, Puerto Rico 2023 |
| 39 | Zobair M Younossi, Pegah Golabi, James Minhui Paik, Catherine Van Dongen, Katherine Elizabeth Eberly, Linda Henry. EPIDEMIOLOGY AND DISEASE BURDEN OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN ASIA: A SYSTEMATIC REVIEW, Asian Pacific Association for the Study of Liver. Taipei, Tawan. 2023 |
| 40 | James Minhui Paik, Katherine Elizabeth Eberly, Austin Henry, Pegah Golabi, Fatema Nader, Zobair M Younossi. The Burden of Non-alcoholic Fatty Liver Disease (NAFLD) in Asia, Asian Pacific Association for the Study of Liver. Taipei, Taiwan. 2023 |
| 41 | James Minhui Paik, Katherine Elizabeth Eberly, Ameeta Kumar, Austin Henry, Pegah Golabi, Zobair M Younossi. NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND HEPATIC FIBROSIS IN ADULT NON-DIABETIC AND PRE-DIABETIC UNITED STATES POPULATION, American Association for the Study of Liver Diseases. |
| 42 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. DEVELOPMENT AND VALIDATION OF A PRIMARY SCLEROSING CHOLANGITIS (PSC)-SPECIFIC HEALTH-RELATED QUALITY OF LIFE INSTRUMENT: CLDQ-PSC, American Association for the Study of Liver Diseases. Washington, D.C. 2022 |
| 43 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Fernandez, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, Georgios Papatheodoridis, Maria Buti, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Gamal Esmat, Marcelo Kugelmas, Janus P. Ong, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova, Saleh Alqahtani. NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH SIGNIFICANT IMPAIRMENT OF WORK PRODUCTIVITY: DATA FROM THE GLOBAL NASH REGISTRY, American Association for the Study of Liver Diseases. |
| 44 | Maria Stepanova, Marlen Fernandez, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Vasily Isakov, Vincent Wai-Sun Wong, Yuichiro Eguchi, Khaled Alswat, Nahum Mendez-Sanchez, Ajay Duseja, Maria Buti, Georgios Papatheodoridis, Saeed S Hamid, Jacob George, Elisabetta Bugianesi, Wah Kheong Chan, Ashwani K. Singal, Stuart C. Gordon, Jian-Gao Fan, Manuel Romero-Gomez, Ziad Younes, Stuart Roberts, Aijaz Ahmed, Janus P. Ong, Brian P. Lam, Marcelo Kugelmas, Saleh Alqahtani, Issah Younossi, Fatema Nader, Andrei Racila, Zobair M Younossi. DEPRESSION AND EMOTIONAL DISTRESS IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (GLR), American Association for the Study of Liver Diseases. Washington, D.C. 2022 |
| 45 | Austin Henry, James Minhui Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, Lynn Gerber, Zobair M Younossi. VIGOROUS PHYSICAL ACTIVITY PROVIDES PROTECTION AGAINST PREMATURE ALL-CAUSE DEATHS AMONG ADULTS PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Washington, D.C. 2022 |
| 46 | Sean C. Felix, Elena Younossi, Thomas Jeffers, Brian P. Lam, Amish Gandhi, Evis Hudson, Nagashree Gundurao, Z Chris, Maria Castillo-Catoni, Maria Ramirez, Mehreen Husain, Evangeline Delgado, Ambika R. Baru, Merica Shrestha, Romona D. Satchi, Yemsrach Gami, Pegah Golabi, Andrei Racila, Fatema Nader, Maria Stepanova, Zobair M Younossi. HIGH-RISK PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) FROM PRIMARY CARE AND ENDOCRINOLOGY PRACTICES CAN BE IDENTIFIED USING A SIMPLE ALGORITHM BASED ON NON-INVASIVE TESTS (NITS), American Association for the Study of Liver Diseases. Washington, D.C. 2022 |
| 47 | Jillian Kallman Price, Leyla de Avila, Maria Stepanova, Huong T. Pham, Manisha Verma, Carey Escheik, Lynn Gerber, Zobair M Younossi. CHRONIC LIVER DISEASE (CLD) PATIENTS ARE AT RISK FOR SYMPTOM PROFILE AFTER SARS-COV-2 (COVID-19) INFECTION, American Association for the Study of Liver Diseases. Washington, D.C. 2022. |
| 48 | James Minhui Paik, Dipam Shah, Katherine Elizabeth Eberly, Zaid Younossi, Pegah Golabi, Zobair M Younossi. CHANGES IN MORTALITY DUE TO CHRONIC LIVER DISEASES (CLD) DURING THE COVID-19 PANDEMIC: DATA FROM THE UNITED STATES NATIONAL VITAL STATISTICS SYSTEM, American Association for the Study of Liver Diseases. Washington, D.C. 2022 |
| 49 | Catherine Van Dongen, James Minhui Paik, Michael Harring, Youssef Younossi, Jillian Kallman, Khaled W. Kabbara, Pegah Golabi, Zobair M Younossi. THE IMPACT OF SARCOPENIA IN CAUSE-SPECIFIC MORTALITY AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Washington, D.C. 2022 |
| 50 | James Minhui Paik, Dipam Shah, Katherine Elizabeth Eberly, Zaid Younossi, Pegah Golabi, Zobair M Younossi. FACTORS ASSOCIATED WITH HIGH ACTIVITY AND FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES POPULATION: THE ROLE OF ASSESSMENT BY FIBROSCAN-AST (FAST) SCORES, American Association for the Study of Liver Diseases. Washington, D.C. 2022 |
| 51 | Zobair M Younossi. THE RELATIONSHIP BETWEEN LIVER HISTOLOGY AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A REAL-WORLD COHORT STUDY, American Association for the Study of Liver Diseases. Washington, D.C., 2022 |
| 52 | James Minhui Paik, Katherine Elizabeth Eberly, Ameeta Kumar, Austin Henry, Pegah Golabi, Zobair M Younossi. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Fibrosis in Adult Non-Diabetic and Pre-Diabetic United States Population, American Association of Liver Disease-Hep C. Washington D.C. 2022 |
| 53 | Zobair M Younossi, Reem Al Shaheeb, Michael Harring, Janus P. Ong, Saleh Alqahtani, Youssef Younossi, Gregory Trimble, Linda Henry, Maria Stepanova. NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS RAPIDLY BECOMING THE MOST COMMON INDICATION FOR LIVER TRANSPLANTATION IN THE CANDIDATES WITH HEPATOCELLULAR CARCINOMA (HCC) IN THE UNITED STATES (U.S.), American Association for the Study of Liver Diseases. Washington, D.C. 2022 |
| 54 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Khaled Alswat, Maria Buti, Marlen Castellanos-Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay Duseja, Stuart C. Gordon, Vasily Isakov, Stuart Roberts, Jian-Gao Fan, Yuichiro Eguchi, Ashwani K. Singal, Manuel Romero-Gomez, Brian P. Lam, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOME (PRO) PROFILE OF PATIENTS WITH HEPATITIS B VIRAL (HBV) INFECTION FROM THE GLOBAL LIVER REGISTRY (GLR), American Association for the Study of Liver Diseases. Washington, D.C. 2022 |
| 55 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Fernandez, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, Georgios Papatheodoridis, Maria Buti, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Gamal Esmat, Marcelo Kugelmas, Janus P. Ong, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova, Saleh Alqahtani. Non-alcoholic Fatty Liver Disease (NAFLD) is Associated with Significant Impairment of Work Productivity: Data from the Global NASH Registry, American Association for the Study of Liver Diseases. |
| 56 | Ali Weinstein, Leyla de Avila, Jillian Kallman, Carey Escheik, Pegah Golabi, James M. Estep, Lynn Gerber, Zobair M Younossi. Visual Scanning Performance is Related to Fatigue, Physical Activity, and Weight Status, International Society of Physical and Rehabilitation Medicine. Lisboa, Portugal. July 3, 2022. |
| 57 | Zobair M Younossi, Reem Al Shabeeb, Michael Harring, Janus P. Ong, Saleh Alqahtani, Linda Henry, Maria Stepanova. Liver Transplantation (LT) and Ethnicity in the United States, European Association for the Study of the Liver. London, UK 2022 |
| 58 | Zobair M Younossi, Reem Al Shaheeb, Michael Harring, Janus P. Ong, Saleh Alqahtani, Linda Henry, Maria Stepanova. The Portrait of Adult Liver Transplant Recipients in the United States from 2002-2020, European Association for the Study of the Liver. London, UK. June 25, 2022. |
| 59 | James Minhui Paik, Linda Henry, Youssef Younossi, Janus P. Ong, Saleh Alqahtani, Zobair M Younossi. The Global Burden of Liver Cancer (LC) and Chronic Liver Diseases (CLD) is Driven by Non-Alcoholic Steatohepatitis (NASH) and Alcohol Liver Disease (ALD), European Association for the Study of the Liver. London, UK. June 24, 2022. |
| 60 | Zobair M Younossi, Maria Stepanova, Sean C. Felix, Thomas Jeffers, Elena Younossi, Brian P. Lam, Linda Henry. Performance of the Enhanced Liver Fibrosis (ELF) Test in Real World Practice versus Clinical Trials of Non-Alcoholic Steatohepatitis, European Association for the Study of the Liver. London, UK. June 24, 2022. |
| 61 | Zobair M Younossi, Maria Stepanova, Robert P. Myers, Reem Al Shaheeb, Issah Younossi, Linda Henry. The Potential Role of Fatigue in Identifying Patients with NASH and Advanced Fibrosis who Experience Disease Progression, European Association for the Study of the Liver. London, UK 2022 |
| 62 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Andrei Racila, Brian P. Lam, Maria Stepanova. The Combination of the ELF and FIB-4 Scores have High Predictive Performance for Significant Fibrosis in Patients with NAFLD, European Association for the Study of the Liver. London, UK. June 24, 2022. |
| 63 | Sean C. Felix, Elena Younossi, Thomas Jeffers, Brian P. Lam, Amish Gandhi, Evis Hudson, Nagashree Gundurao, Z Chris, Maria Castillo-Catoni, Maria Ramirez, Mehreen Husain, Evangeline Delgado, Ambika R. Baru, Merica Shrestha, Romona D. Satchi, Yemsrach Gami, Pegah Golabi, Andrei Racila, Fatema Nader, Maria Stepanova, Zobair M Younossi. Shear Wave Elastography, Transient Elastography and Enhanced Liver Fibrosis Test Use in the Assessment of Non-alcoholic Fatty Liver Disease (NAFLD) in Real-World Practices, European Association for the Study of the Liver. London, UK 2022 |
| 64 | Zobair M Younossi, Kamal Kant Mangla, Abhishek Shankar Chandramouli, Jeffrey V. Lazarus. Total healthcare cost and characteristics associated with higher change in cost in patients with non-alcoholic steatohepatitis, European Association for the Study of the Liver. London, UK 2022 |
| 65 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Castellanos-Fernandez, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, George A Papandreou, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. Lean Non-Alcoholic Fatty Liver Disease Patients from the Global NASH Registry, European Association for the Study of the Liver. London, UK. June 23, 2022. |
| 66 | Zobair M Younossi, James Minhui Paik, Pegah Golabi, Youssef Younossi, Linda Henry, Fatema Nader. The Impact of Fatigue on Mortality of Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Data from National Health and Nutrition Examination Survey (NHANES) 2005-2018, European Association for the Study of the Liver. London, UK. June 23, 2022. |
| 67 | Zobair M Younossi, Pegah Golabi, James Minhui Paik, Austin Henry, Catherine Van Dongen, Linda Henry. The Most Recent and in-depth meta-analytic Assessment of the Global Epidemiology of Non-alcoholic Fatty Liver Disease (NAFLD), European Association for the Study of the Liver. London, UK 2022 |
| 68 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Janus P. Ong, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova. Negative Impact of COVID-19 Infection Related to Life Disruption Events and Health Scores on Patients with Chronic Liver Disease, European Association for the Study of the Liver. London, UK. June 23, 2022. |
| 69 | Zobair M Younossi, James Minhui Paik, Issah Younossi, Pegah Golabi, Michael Harring, Linda Henry. Long Term Outcomes of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Associated Fatty Liver Disease (MAFLD), European Association for the Study of the Liver. London, UK. June 23, 2022. |
| 70 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Andrei Racila, Brian P. Lam, Maria Stepanova. The Combination of the ELF and FIB-4 Scores have High Predictive Performance for Significant or Advanced Fibrosis in Patients with NAFLD, American Diabetes Association. New Orleans, LA. June 4, 2022. |
| 71 | Sean C. Felix, Elena Younossi, Thomas Jeffers, Brian P. Lam, Amish Gandhi, Evis Hudson, Nagashree Gundurao, Z Chris, Maria Castillo-Catoni, Maria Ramirez, Mehreen Husain, Evangeline Delgado, Ambika R. Baru, Merica Shrestha, Romona D. Satchi, Pratima Fozdar, Yemsrach Gami, Pegah Golabi, Andrei Racila, Fatema Nader, Maria Stepanova, Zobair M Younossi. IDENTIFICATION OF HIGH-RISK PATIENTS WITH NON-ALCOHOLOC FATTY LIVER DISEASE (NAFLD) USING NON-INVASIVE TESTS FROM ENDOCRINOLOGY AND PRIMARY CARE PRACTICES, Digestive Disease Week. San Diego, CA. May 23, 2022. |
| 72 | Zobair M Younossi, James Minhui Paik, Linda Henry, Joe Yang, Gail Fernandes, Maria Stepanova, Fatema Nader. THE GROWING BURDEN OF NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES, Digestive Disease Week. San Diego, CA. May 23, 2022. |
| 73 | James Minhui Paik, Reem Al Shaheeb, Dipam Shah, Pegah Golabi, Zobair M Younossi. HEALTHY EATING PATTERN IS ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND SIGNIFICANT FIBROSIS, Digestive Disease Week. San Diego, CA. May 22, 2022. |
| 74 | Ali Weinstein, Leyla de Avila, Jillian Kallman, Pegah Golabi, Carey Escheik, Maria Stepanova, Lynn Gerber, Zobair M Younossi. FATIGUE IN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS STILL PRESENT IN THOSE WITHOUT SLEEP DISTURBANCES, Digestive Disease Week. San Diego, CA. May 22, 2022. |
| 75 | Jillian Kallman, Carey Escheik, Patrick Austin, Lynn Gerber, Zobair M Younossi. SHORT-FORM HUMAN ACTIVITY PROFILE (HAP-A) PERFORMS SIMILARLY TO FULL HAP AND RETAINS SIGNIFICANT CORRELATION WITH FATIGUE METRIC WHEN TESTED IN PEOPLE WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. San Diego, CA. May 21, 2022. |
| 76 | Maria Stepanova, Denise Mohess, Khaled W. Kabbara, Alva Roche-Green, Manisha Verma, Manirath Srishord, Zobair M Younossi. NASH is the most common indication for Liver Transplantation among Elderly, American Geriatrics Society. Orlando, FL 2022 |
| 77 | Manisha Verma, Maria Stepanova, Denise Mohess, Alva Roche-Green, Felix Rivera, Marika Haranis, Lynn Gerber, Zobair M Younossi. Predictors and Mortality among >=65 infected with COVID-19, American Geriatrics Society. Orlando, FL 2022 |
| 78 | Zobair M Younossi, James Minhui Paik, Linda Henry, Joe Yang, Gail Fernandes, Maria Stepanova, Fatema Nader. BURDEN OF ILLNESS AND ECONOMIC IMPACT OF NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES ACCORDING TO THE PRESENCE OF OBESITY, American Association for the Study of Liver Diseases. |
| 79 | Zobair M Younossi. IMPACT OF MODEST WEIGHT REDUCTION ON SERUM MARKERS, LIVER HISTOLOGY, AND DISEASE PROGRESSION IN PATIENTS WITH ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH), American Association for the Study of Liver Diseases. Amsterdam, Netherlan. 2021. |
| 80 | James M. Estep, Jillian Kallman Price, Patrick Austin, Takumi Kawaguchi, Ryuki Hashida, Pegah Golabi, Lynn Gerber, Zobair M Younossi. MARKED FATIGUE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH A LOW CIRCULATING SERUM FRACTALKINE, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 81 | Zobair M Younossi. CLINICAL MANIFESTATIONS AND PREDICTORS OF OUTCOMES FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 82 | Zobair M Younossi. A PHASE 3, DOUBLE-BLIND, RANDOMIZED, MULTICENTER STUDY OF OBETICHOLIC ACID IN PATIENTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH): STUDY DESIGN AND BASELINE PATIENT CHARACTERISTICS OF THE REVERSE TRIAL, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 83 | Zobair M Younossi. MINIMIZING VARIABILITY AND INCREASING CONCORDANCE FOR NASH HISTOLOGICAL SCORING IN NASH CLINICAL TRIALS, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 84 | Zobair M Younossi. THE COMPLEXITY OF BALLOONED HEPATOCYTE IDENTIFICATION: TIME TO RETHINK TRIAL ENDPOINTS FOR NONALCOHOLIC STEATOHEPATITIS?, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 85 | Zobair M Younossi. A RELATIONSHIP BETWEEN ACTIVITY AND BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 86 | Zobair M Younossi. LIVER STIFFNESS-BASED AGILE SCORES PREDICT DISEASE PROGRESSION IN PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 87 | Zobair M Younossi, Yusuf Yilmaz, Vincent Wai-Sun Wong, Marlen Fernandez, Elisabetta Bugianesi, Patrizia Burra, Ming-Lung Yu, Wah Kheong Chan, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Jacob George, Jian-Gao Fan, Georgios Papatheodoridis, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. FATIGUE AND NON-ALCOHOLIC FATTY LIVER DISEASE: DATA FROM THE GLOBAL NASH REGISTRY, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 88 | Sean C. Felix, Brian P. Lam, Thomas Jeffers, Zachary Goodman, Maria Stepanova, Zobair M Younossi. ASSOCIATIONS OF ENHANCED LIVER FIBROSIS (ELF) AND PRO-C3 WITH STAGE OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 89 | Ali Weinstein, Dung Ngo, Leyla de Avila, Jillian Kallman, Pegah Golabi, Patrick Austin, Carey Escheik, Lynn Gerber, Zobair M Younossi. NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH IMPAIRMENT IN COGNITIVE PROCESSING SPEED, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 90 | Zobair M Younossi, Andrei Racila, Fatema Nader, Issah Younossi, Linda Henry, Maria Stepanova. THE IMPACT OF FATIGUE ON PATIENT-REPORTED OUTCOMES (PROs) AND HEALTH UTILITIES IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 91 | Maria Stepanova, Khaled W. Kabbara, Denise Mohess, Alva Roche-Green, Manisha Verma, Zobair M Younossi. NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS THE MOST COMMON INDICATION FOR LIVER TRANSPLANTATION (LT) AMONG THE ELDERLY: DATA FROM THE UNITED STATES SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 92 | Zobair M Younossi, Michael Herring, Khaled W. Kabbara, Katherine Elizabeth Eberly, Youssef Younossi, Janus P. Ong, Saleh Alqahtani, Maria Stepanova. THE IMPACT OF HEPATOCELLULAR CARCINOMA (HCC) ON LIVER TRANSPLANTATION (LT) IN THE UNITED STATES (U.S.), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 93 | Elisabeth Eberly, Khaled W. Kabbara, Michael Harring, James Minhui Paik, Manisha Verma, Youssef Younossi, Zobair M Younossi, Huong T. Pham. NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ALCOHOLIC LIVER DISEASE (ALD) ARE THE MOST COMMON CAUSES OF 30-DAY HOSPITAL READMISSION AMONG PATIENTS WITH CHRONIC LIVER DISEASES (CLDS) IN THE UNITED STATES (U.S.), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 94 | Zobair M Younossi, Daisong Tan, Hala Abdelaal, Lakshmi Alaparthi, Fanny Monge, Robert P. Myers, Fatema Nader, Zachary Goodman, Maria Stepanova. ASSOCIATIONS OF ENHANCED LIVER FIBROSIS SCORE (ELF) WITH HEPATIC COLLAGEN QUANTITATION AND DISEASE ACTIVITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 95 | Patrick Austin, Ron Nachum, Jillian Kallman, Leyla de Avila, Carey Escheik, Lynn Gerber, Zobair M Younossi. CORRELATION OF FITBIT INTENSITY CLASSIFICATIONS WITH METABOLIC MARKERS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 96 | Leyla de Avila, Ali Weinstein, Cassie Hartle, Lynn Gerber, Jillian Kallman, Carey Escheik, James M. Estep, Pegah Golabi, Patrick Austin, Zobair M Younossi. EXECUTIVE FUNCTION (EF) IN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 97 | Pegah Golabi, James Minhui Paik, Linda Henry, Fatema Nader, Lynn Gerber, Zobair M Younossi. AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PRESENCE OF FATIGUE IS ASSOCIATED WITH HIGHER MORTALITY, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 98 | James Minhui Paik, Catherine Van Dongen, Khaled W. Kabbara, Michael Herring, Youssef Younossi, Pegah Golabi, Jillian Kallman Price, Suzannah Gerber, Zobair M Younossi. SARCOPENIA, HEALTHY LIVING AND MORTALITY IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 99 | James Minhui Paik, Elena Younossi, Wisna'odom Keo, Hussain Allawi, Linda Henry, Zobair M Younossi. HIGH RISK FIBROSIS 4-SCORE IS PREDICTIVE OF ALL CAUSE, CARDIOVASCULAR AND LIVER-RELATED MORTALITY AMONG ADULTS NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES (U.S.), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 100 | Jillian Kallman Price, Carey Escheik, Patrick Austin, Leyla de Avila, Maria Stepanova, Ali Weinstein, Lynn Gerber, Zobair M Younossi. DEVELOPMENT OF AN ABRIDGED HUMAN ACTIVITY PROFILE (HAP-A) FOR CHRONIC LIVER DISEASE (CLD), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 101 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Janus P. Ong, Issah Younossi, Andrei Racila, Mariam Ziayee, Arian Afendy, Maria Stepanova. COVID-19 PANDEMIC AND CHRONIC LIVER DISEASE (CLD), American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 102 | Pegah Golabi, James Minhui Paik, Rebecca Cable, Andrei Racila, Manirath Srishord, Zobair M Younossi. SARCOPENIA AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH ADVANCED FIBROSIS, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 103 | Zobair M Younossi, James Minhui Paik, Mariam Afendy, Issah Younossi, Pegah Golabi, Alita Mishra, Linda Henry. FATTY LIVER DISEASE (FLD), NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD): CLINICAL DATA AND LONG-TERM OUTCOMES, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 104 | James Minhui Paik, Austin Henry, Youssef Younossi, Janus P. Ong, Linda Henry, Zobair M Younossi. THE BURDEN OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RAPIDLY GROWING IN EVERY REGION OF THE WORLD, American Association for the Study of Liver Diseases. Virtual, November 2021 |
| 105 | Ali Weinstein, Leyla de Avila, Jillian Kallman, Pegah Golabi, Patrick Austin, Carey Escheik, Dung Ngo, Lynn Gerber, Zobair M Younossi. ASSOCIATION OF PHYSICAL ACTIVITY AND FINE MOTOR SPEED IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Academy of Physical Medicine and Rehabilitation. Virtual, November 2021 |
| 106 | Zobair M Younossi, Radhika Tampi, Christopher T Fernandes, Joe Yang, Adnan Alsumali, Hardik Goswami, Fatema Nader. Modelling clinical outcomes of NASH in the United States stratified by presence of type 2 diabetes, European Association for the Study of the Liver. Virtual, June 2021 |
| 107 | Zobair M Younossi, Maria Stepanova, Khaled W. Kabbara, Elisabeth Eberly, Michael Herring, Saleh Alqahtani. Changes in the profile and outcomes of paediatric liver transplantation in the United States Liver transplantation and hepatobiliary surgery: Clinical aspects, European Association for the Study of the Liver. Virtual, June 2021 |
| 108 | Zobair M Younossi, Thomas Jeffers, Aybike Birerdinc, Sean C. Felix, James M. Estep, Brian P. Lam, Bijal Rajout, Pegah Golabi, Arathi Krishnakumar, Elizabeth Brown, Qing Xiao, Samuel Hellings, Ashok Dongre, John Thompson, Yi Luo, Edgar Charles, Lei Zhao, David Gordon, Azza Karrar, Fatema Nader, Zachary Goodman, Maria Stepanova. Proteomics Signature of Advanced Fibrosis in Non-alcoholic Steatohepatitis (NASH) using Data-independent Acquisition (DIA) Mass Spectrometry, European Association for the Study of the Liver. Virtual, June 2021 |
| 109 | James Minhui Paik, Rakesh Biswas, Tamoore Arshad, Saleh Alqahtani, Zobair M Younossi, Alita Mishra. Poor Awareness of Non Alcoholic Fatty Liver Disease (NAFLD) Among Adults in the United States, European Association for the Study of the Liver. Virtual, June 2021 |
| 110 | James Minhui Paik, Khaled W. Kabbara, Elisabeth Eberly, Michael Harring, Janus P. Ong, Zobair M Younossi. The Association of Dietary Factors and Physical Activity with Sarcopenia in Non-Alcoholic Fatty Liver Disease (NAFLD), European Association for the Study of the Liver. Virtual, June 2021 |
| 111 | Aybike Birerdinc, Sean C. Felix, James M. Estep, Fanny Monge, Lakshmi Alaparthi, Maria Stepanova, Brian P. Lam, Bijal Rajput, Pegah Golabi, Thomas Jeffers, Samuel Hellings, Elizabeth Brown, Thomas Spires, Mellisa Yarde, Yi Luo, Anthony Sanfiz, John Thompson, Mary Ellen Cvijic, Edgar Charles, Lei Zhao, David Gordon, Azza Karrar, Daisong Tan, Hala Abdelaal, Fatema Nader, Zachary Goodman, Zobair M Younossi. Fibrosis Biomarkers CA15-3 and Thrombospondin-2 are Associated with Higher Hepatic Collagen Content in Non-alcoholic Steatohepatitis (NASH)-related Fibrosis, European Association for the Study of the Liver. Virtual, June 2021 |
| 112 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova. The Impact of COVID-19 Pandemic on Patients with Chronic Liver Disease (CLD): Data from the Global Registry, European Association for the Study of the Liver. Virtual, June 2021 |
| 113 | Ming-Lung Yu, Mohamed El Kassas, Yusuf Yilmaz, Marlen Castellanos-Fernandez, Maria Buti, George A Papandreou, Ajay Duseja, Khaled Alswat, Vasily Isakov, Wah Kheong Chan, Saeed S Hamid, Stuart C. Gordon, Jian-Gao Fan, Yuichiro Eguchi, Ashwani K. Singal, Aijaz Ahmed, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Zobair M Younossi. CLINICAL PRESENTATION AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS: DATA FROM THE GLOBAL LIVER REGISTRY, Digestive Disease Week. Virtual, May 2021 |
| 114 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Zachary Goodman. PATIENTS WITH EARLY NON-ALCOHOLIC STEATOHEPATITIS REGRESSION OF FIBROSIS IS ASSOCIATED WITH IMPROVEMENT OF PATIENT REPORTED OUTCOMES (PROS), Digestive Disease Week. Virtual, May 2021 |
| 115 | Brian P. Lam, Thomas Jeffers, Sean C. Felix, Elena Younossi, Henry A. Tran, Maria Stepanova, Fatema Nader, Zobair M Younossi. CARDIAC SERUM BIOMARKERS PREDICTING SEVERE CORONARY ARTERY DISEASE (CAD) AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Virtual, May 2021 |
| 116 | James Minhui Paik, Khaled W. Kabbara, Katherine Elizabeth Eberly, Youssef Younossi, Linda Henry, Zobair M Younossi. NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS DRIVING THE GLOBAL BURDEN OF CHRONIC LIVER DISEASE (CLD) AMONG ADOLESCENTS AND YOUNG ADULTS, Digestive Disease Week. Virtual, May 2021 |
| 117 | Zobair M Younossi, Hirokazu Takahashi, Yuichiro Eguchi, Yusuf Yilmaz, Mohamed El Kassas, Maria Buti, Moises Diago, Ming-Hua Zheng, Jian-Gao Fan, Vincent Wai-Sun Wong, Khaled Alswat, Wah Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay Duseja, Jacob George, Georgios Papatheodoridis, Saeed S Hamid, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Janus P. Ong, Manuel Romero-Gomez, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. A GLOBAL SURVEY OF PHYSICIANS KNOWLEDGE ABOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Virtual, May 2021 |
| 118 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Fernandez, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, Georgios Papatheodoridis, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. CLINICAL PRESENTATION OF LEAN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY, Digestive Disease Week. Virtual, May 2021 |
| 119 | Brian P. Lam, Thomas Jeffers, Sean C. Felix, Elena Younossi, Henry A. Tran, Maria Stepanova, Fatema Nader, Zobair M Younossi. Cardiac Serum Biomarkers Predicting Severe Coronary Artery Disease among Patients with Non-Alcoholic Fatty Liver Disease, Digestive Disease Week. Virtual, May 2021 |
| 120 | Leyla de Avila, Ali Weinstein, Jillian Kallman, Julia Hakeem, Myrna Namman, Gayathri Ganganaboina, Pegah Golabi, Carey Escheik, Lynn Gerber, Zobair M Younossi. DIFFERENCE BETWEEN SHORT-TERM AND LONG-TERM VISUAL MEMORY IS GREATER IN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), International Society of Physical and Rehabilitation Medicine. Virtual, June 2021 |
| 121 | Jillian Kallman, Natalie VanderNoot, Carey Escheik, Patrick Austin, James M. Estep, Lynn Gerber, Zobair M Younossi. ASSOCIATION OF SARCOPENIA, FATIGUE, AND SERUM MYOKINES IN PATIENTS WITH CHRONIC LIVER DISEASE, Digestive Disease Week. Virtual, May 2021 |
| 122 | Katherine Elizabeth Eberly, Khaled W. Kabbara, James Minhui Paik, Youssef Younossi, Huong T. Pham, Zobair M Younossi. RECENT TRENDS IN HOSPITAL READMISSIONS AMONG PATIENTS WITH CHRONIC LIVER DISEASES (CLDS) IN THE UNITED STATES (U.S.), Digestive Disease Week. Virtual, May 2021 |
| 123 | James Minhui Paik, Khaled W. Kabbara, Katherine Elizabeth Eberly, Youssef Younossi, Linda Henry, Zobair M Younossi. PREVALENCE OF HIGH AND MODERATE RISK NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AMONG ADULTS IN THE UNITED STATES (U.S.), 1999-2016, Digestive Disease Week. Virtual, May 2021 |
| 124 | Jillian Kallman, Natalie VanderNoot, Carey Escheik, Patrick Austin, James M. Estep, Lynn Gerber, Zobair M Younossi. ASSESSMENT OF SECODARY SARCOPENIA IN CHRONIC LIVER DISEASE (CLD): HOW GOOD ARE OUR CRITERIA MEASURES?, Digestive Disease Week. Virtual, May 2021 |
| 125 | James M. Estep, Natalie VanderNoot, Jillian Kallman, Patrick Austin, Carey Escheik, Sean C. Felix, Lynn Gerber, Zobair M Younossi. CIRCULATING ONCOSTATIN CONCENTRATIONS ARE LOWER IN NAFLD PATIENTS COMPARED TO CHRONIC HEPATITIS-C PATIENTS OR CONTROLS, Digestive Disease Week. Virtual, May 2021 |
| 126 | Jillian Kallman, Natalie VanderNoot, Carey Escheik, Patrick Austin, James M. Estep, Lynn Gerber, Zobair M Younossi. PRINCIPAL COMPONENTS ANALYSIS (PCA) IN CHRONIC LIVER DISEASE (CLD) REVEALS THREE COMPONENT MODEL HIGHLIGHTING DISCRETE CONTRIBUTIONS BY SARCOPENIA CRITERIA MEASURES AND SERUM MYOKINES, Digestive Disease Week. Virtual, May 2021 |
| 127 | Denise Mohess. Teaching communication in the era of social distancing: Implementing a skills-based communication curriculum for medical students, Not Applicable. |
| 128 | James Minhui Paik, Seema Mir, Saleh Alqahtani, Youssef Younossi, Janus P. Ong, Zobair M Younossi. DIETARY RISKS FOR LIVER RELATED MORTALITY AMONG NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): DATA FROM THE GLOBAL BURDEN OF DISEASE (GBD) 2017, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 129 | James M. Estep, Leyla de Avila, Ali Weinstein, Jillian Kallman, Carey Escheik, Aybike Birerdinc, Ingrid Schneider, Lynn Gerber, Zobair M Younossi. CIRCULATING KYNURENINE IS ASSOCIATED WITH DEPRESSION IN SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 130 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Rebecca Cable, Sean C. Felix, Thomas Jeffers, Elena Younossi, Huong T. Pham, Manirath Srishord, Patrick Austin, James M. Estep, Kathy Terra, Carey Escheik, Leyla de Avila, Pegah Golabi, Andrej Kolacevski, Andrei Racila, Lynn Gerber. COVID-19 INFECTION AND INPATIENT MORTALITY AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 131 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Martin Bonacci, Bruce Wong, Rohit Loomba, Mary E. Rinella, Mazen Noureddin, Stephen A. Harrison. ASSESSMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN A LARGE COHORT OF NASH PATIENTS WITHOUT CIRRHOSIS, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 132 | Lynn Gerber, James Minhui Paik, Elena Younossi, Natalie VanderNoot, Pegah Golabi, Zobair M Younossi. ASSOCIATION BETWEEN DIETARY FACTORS AND SARCOPENIA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 133 | Ali Weinstein, Leyla de Avila, Lynn Gerber, Ingrid Schneider, Jillian Kallman, Carey Escheik, James M. Estep, Pegah Golabi, Patrick Austin. ASSOCIATION OF HEPATIC FAT QUANTIFICATION AND COGNITIVE PERFORMANCE, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 134 | Khaled W. Kabbara, James Minhui Paik, Katherine Elizabeth Eberly, Leyla de Avila, Linda Henry, Zobair M Younossi. ASSOCIATIONS BETWEEN DIETARY FACTORS AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 135 | Jillian Kallman Price, Patrick Austin, Carey Escheik, Suzannah Gerber, Ali Weinstein, Lynn Gerber, Zobair M Younossi. BASELINE HEALTH INTERVENTION STUDY GOAL-SETTING IN PATIENTS WITH INSULIN RESISTANCE AND NAFLD ENROLLED IN A PERSONALIZED HEALTH GOAL SUPPORT INTERVENTION, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 136 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vasily Isakov, Ajay Duseja, Yuichiro Eguchi, Jacob George, Elisabetta Bugianesi, Georgios Papatheodoridis, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Aijaz Ahmed, Brian P. Lam, Saleh Alqahtani, Issah Younossi, Fatema Nader, Janus P. Ong, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOMES DATA OF NON-ALCOHOLIC FATTY LIVER DISEASE: LONGITUDINAL DATA FROM THE GLOBAL NASH REGISTRY, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 137 | Suzannah Gerber, Jillian Kallman Price, Carey Escheik, Manirath Srishord, Lynn Gerber, Zobair M Younossi. FOOD SATISFACTION AND SATIETY AND HEALTH RELATED QUALITY OF LIFE (HRQL) IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 138 | Zobair M Younossi, Huong T. Pham, Sean C. Felix, Thomas Jeffers, Elena Younossi, Brian P. Lam, Fatema Nader, Henry A. Tran, Ingrid Schneider, Maria Stepanova. HIGH-SENSITIVITY CARDIAC TROPONIN I INDEPENDENTLY PREDICTS PRESENCE OF CORONARY ARTERY DISEASE (CAD) AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 139 | Maria Stepanova, Khaled W. Kabbara, Saleh Alqahtani, Issah Younossi, Alita Mishra, Zobair M Younossi. LIVER TRANSPLANT (LT) CENTER SIZE AND THE IMPACT ON THE CLINICAL OUTCOMES AND RESOURCE UTILIZATION, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 140 | Leyla de Avila, Ali Weinstein, Lynn Gerber, Ingrid Schneider, Jillian Kallman, Carey Escheik, James M. Estep, Pegah Golabi, Patrick Austin, Azza Karrar, Zobair M Younossi. LOWER COGNITIVE PERFORMANCE SCORES IN INDIVIDUALS WITH THE COMBINATION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND TYPE II DIABETES (T2DM), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 141 | Azza Karrar, Natalie VanderNoot, Jillian Kallman, Patrick Austin, Carey Escheik, Leyla de Avila, Ali Weinstein, Lynn Gerber, Zobair M Younossi. LOWER HUMAN ACTIVITY PROFILES ARE ASSOCIATED WITH HIGHER FATIGUE SCORE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND HEPATITIS C VIRUS (HCV), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 142 | Ming-Lung Yu, Mohamed El Kassas, Brian P. Lam, Gamal Esmat, Marlen Fernandez, Maria Buti, Georgios Papatheodoridis, Vasily Isakov, Ajay Duseja, Yusuf Yilmaz, Stuart C. Gordon, Saeed S Hamid, Manuel Romero-Gomez, Wah Kheong Chan, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Janus P. Ong, Saleh Alqahtani, Zobair M Younossi. PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS ?: DATA FROM THE GLOBAL LIVER REGISTRY, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 143 | Patrick Austin, Ron Nachum, Kyle Jackson, Carey Escheik, Zoran Duric, Ali Weinstein, Lynn Gerber, Zobair M Younossi. PERSONALIZED INTERVENTION INCREASES FREE-LIVING PHYSICAL ACTIVITY IN SEDENTARY INDIVIDUALS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 144 | Rakesh Biswas, James Minhui Paik, Tamoore Arshad, Pegah Golabi, Linda Henry, Zobair M Younossi. POOR LIVER DISEASE AWARENESS AMONG ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 145 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Martin Bonacci, Bruce Wong, Rohit Loomba, Mary E. Rinella, Mazen Noureddin, Stephen A. Harrison. PRURITUS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 146 | Leyla de Avila, Ali Weinstein, Lynn Gerber, Ingrid Schneider, Jillian Kallman, Carey Escheik, James M. Estep, Pegah Golabi, Patrick Austin, Azza Karrar, Zobair M Younossi. RELATIONSHIPS BETWEEN PHYSICAL ACTIVITY AND COGNITIVE PERFORMANCE IN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE PRESENCE OR ABSENCE OF TYPE II DIABETES MELLITUS (T2DM), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 147 | Zobair M Younossi, Hirokazu Takahashi, Yuichiro Eguchi, Yusuf Yilmaz, Mohamed El Kassas, Ming-Hua Zheng, Jian-Gao Fan, Vincent Wai-Sun Wong, Khaled Alswat, Wah Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay Duseja, Maria Buti, Moises Diago, Manuel Romero-Gomez, Jacob George, Georgios Papatheodoridis, Saeed S Hamid, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Janus P. Ong, Mariam Ziayee, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. SIGNIFICANT KNOWLEDGE GAP ABOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN REAL-WORLD PRACTICES: A GLOBAL SURVEY OF HEPATOLOGISTS, GASTROENTEROLOGISTS, ENDOCRINOLOGISTS AND PRIMARY CARE PHYSICIANS, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 148 | Yusuf Yilmaz, Ming-Lung Yu, Brian P. Lam, Maria Buti, Georgios Papatheodoridis, Wah Kheong Chan, Ajay Duseja, Khaled Alswat, Mohamed El Kassas, Saeed S Hamid, Vasily Isakov, Stuart C. Gordon, Stuart Roberts, Jian-Gao Fan, Yuichiro Eguchi, Aijaz Ahmed, Ashwani K. Singal, Manuel Romero-Gomez, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Janus P. Ong, Saleh Alqahtani, Zobair M Younossi. THE IMPACT OF CHRONIC HEPATITIS B ON PATIENT-REPORTED OUTCOMES FROM THE GLOBAL LIVER REGISTRY, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 149 | James Minhui Paik, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Lynn Gerber, Zobair M Younossi. THE IMPACT OF VIGOROUS LEISURE-TIME PHYSICAL ACTIVITY ON THE MORTALITY OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 150 | Tamoore Arshad, James Minhui Paik, Rakesh Biswas, Saleh Alqahtani, Linda Henry. TRENDS IN THE PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AMONG ADOLESCENTS AND YOUNG ADULTS IN THE UNITED STATES, 2007-2016, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 151 | Zobair M Younossi, Maria Stepanova, Naim Alkhouri, Mazen Noureddin, Kris V. Kowdley, Anita Kohli, Aasim M. Sheikh, Guy Neff, Bal Raj Bhandari, Nadege T Gunn, Caldwell. Stephen H. , Ryan S Huss, Robert P. Myers, Ziad Younes, Magdy Elkhashab, Peter Ruane, Mitchell L. Shiffman, Simone Strasser, Vincent Wai-Sun Wong, Zachary Goodman, Rohit Loomba. FIBROSIS REGRESSION AND IMPROVEMENT IN DISEASE ACTIVITY ARE ASSOCIATED WITH IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH): DATA FROM THE PHASE 2 ATLAS TRIAL, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 152 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. DEVELOPMENT AND VALIDATION OF A HEPATITIS B (HBV)-SPECIFIC HEALTH-RELATED QUALITY OF LIFE INSTRUMENT: CLDQ-HBV, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 153 | James Minhui Paik, Issah Younossi, Katherine Elizabeth Eberly, Tamoore Arshad, Rakesh Biswas, Zobair M Younossi. CHANGES IN HEALTH-RELATED QUALITY OF LIFE AFTER DIAGNOSIS OF LIVER CANCER, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 154 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Huong T. Pham, Arian Afendy, Rebecca Cable, Andrei Racila, Zahra Younoszai, Brian P. Lam, Pegah Golabi, Linda Henry, Maria Stepanova. PERFORMANCE OF ENHANCED LIVER FIBROSIS (ELF) TEST TO PREDICT ADVANCED FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 155 | James Minhui Paik, Youssef Younossi, Linda Henry, Alita Mishra, Zobair M Younossi. RECENT TRENDS IN THE GLOBAL BURDEN OF HEPATITIS B VIRUS (HBV): 2007-2017, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 156 | Zobair M Younossi, Stephen A. Harrison, Philip N Newsome, Wah Kheong Chan, Yusuf Yilmaz, Ming-Hua Zheng, Vincent Wai-Sun Wong, Magdy Elkhashab, Kathryn Kersey, Robert P. Myers, Julie Foucquier, Aymeric Labourdette, Marie Destro, Celine Fournier, Veronique Miette, Laurent Sandrin, Arun J. Sanyal. IMPROVING DIAGNOSIS OF CIRRHOSIS IN PATIENTS WITH NAFLD BY COMBINING LIVER STIFFNESS MEASUREMENT (LSM) BY VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY (VCTE) AND ROUTINE BIOMARKERS: A GLOBAL DERIVATION AND VALIDATION STUDY, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 157 | Zobair M Younossi, Maria Stepanova, Rebecca A Taub, Jordan Mark Barbone, Sam Moussa, Stephen A. Harrison. IMPROVEMENT OF HEALTH-RELATED QUALITY OF LIFE IS ASSOCIATED WITH IMPROVEMENT OF FAT FRACTION BY MRI-PDFF IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS TREATED WITH RESMETIROM, American Association for the Study of Liver Diseases. Virtual, November 2020 |
| 158 | Zobair M Younossi, Quentin Anstee, Stephen A. Harrison, Michael Trauner, Eric Lawitz, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gomez, William Alazawi, Yevgeniy Gindin, Jing Zhu Zhou, Marianne Camargo, Kathryn Kersey, Chuhan Chung, Mani Subramanian, Robert P. Myers, Zachary Goodman, Rohit Loomba, William Rosenberg, Arun J. Sanyal. Improvements in the ELF test are associated with widespread changes in the hepatic transcriptome in patients with advanced fibrosis due to non-alcoholic steatohepatitis, European Association for the Study of the Liver. Virtual, August 2020 |
| 159 | Zobair M Younossi, Radhika Tampi, Leyla de Avila, Rebecca Cable, Fatema Nader, Issah Younossi, Andrei Racila. Estimating the clinical and economic burden of chronic hepatitis B (CHB) in the United States, European Association for the Study of the Liver. Virtual, August 2020 |
| 160 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Vincent Wai-Sun Wong, Ajay Duseja, Nahum Mendez-Sanchez, Jacob George, Wah Kheong Chan, Laurent Castera, Marco Arrese, Khaled Alswat, Hirokazu Takahashi, Manuel Romero-Gomez, Janus P. Ong, Mariam Ziayee, Issah Younossi, Andrei Racila, Maria Stepanova. Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: A global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians, European Association for the Study of the Liver. Virtual, August 2020 |
| 161 | Zobair M Younossi, Rohit Loomba. Obeticholic Acid Improves Hepatic Fibroinflammation as Assessed by Multiparametric Magnetic Resonance Imaging: Interim Results of the REGENERATE Trial, European Association for the Study of the Liver. Virtual, August 2020 |
| 162 | Zobair M Younossi, Jerome Boursier. Obeticholic acid improves experimental non-invasive markers of non-alcoholic steatohepatitis and advanced fibrosis: a secondary analysis of the phase 3 regenerate study, European Association for the Study of the Liver. Virtual, August 2020 |
| 163 | Zobair M Younossi. Obesity-specific health-related quality of life in patients with non-alcoholic steatohepatitis: results from the REGENERATE study, European Association for the Study of the Liver. Virtual, August 2020 |
| 164 | James Minhui Paik, Pegah Golabi, Youssef Younossi, Manirath Srishord, Alita Mishra, Zobair M Younossi. The Growing Burden of Disability Related to Non-alcoholic Fatty Liver Disease: Data from Global Burden of Disease 2007-2017, European Association for the Study of the Liver. Virtual, August 2020 |
| 165 | Elizabeth Brown, Azza Karrar, Samuel Hellings, Maria Stepanova, Bethanne Warrack, Brian P. Lam, Joelle Onorato, Sean C. Felix, Abraham Apfel, Thomas Jeffers, Bijal Rajput, Edgar Charles, Fatema Nader, Yi Luo, Michael Reily, Lei Zhao, John Thompson, Zachary Goodman, Zobair M Younossi. Metabolomics composite biomarkers selected by machine learning predict NASH, European Association for the Study of the Liver. Virtual, August 2020 |
| 166 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Jian-Gao Fan, Elisabetta Bugianesi, Yuichiro Eguchi, Ziad Younes, Manuel Romero-Gomez, Stuart Roberts, Stuart C. Gordon, Saeed S Hamid, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Mariam Ziayee, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova. The clinical and patient reported outcomes (pros) profile of patients with non-alcoholic fatty liver disease (nafld) from real-world practices varies across the world, European Association for the Study of the Liver. Virtual, August 2020 |
| 167 | James Minhui Paik, Pegah Golabi, Leyla de Avila, Saleh Alqahtani, Andrei Racila, Zobair M Younossi. Causes of Death in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Data from National Vital Statistics System (NVSS), European Association for the Study of the Liver. Virtual, August 2020 |
| 168 | Zobair M Younossi, Stephen A. Harrison, Quentin Anstee, Eric Lawitz, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Michael Trauner, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Mani Subramanian, Robert P. Myers, Zachary Goodman, Maria Stepanova. Fibrosis non-invasive tests capture changes in patient-reported outcomes of patients with advanced nonalcoholic steatohepatitis, European Association for the Study of the Liver. Virtual, August 2020 |
| 169 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Huong T. Pham, Arian Afendy, Rebecca Cable, Andrei Racila, Linda Henry, Maria Stepanova. Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease (NAFLD), American Diabetes Association. Virtual, June 2020 |
| 170 | Zobair M Younossi. The Enhanced Liver Fibrosis (ELF) Score Predicts Adverse Clinical and Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH), American Diabetes Association. Virtual, June 2020 |
| 171 | Patrick Austin, Jillian Kallman Price, Carey Escheik, Lynn Gerber, Zobair M Younossi. No difference in Heart Rate Recovery during Graded Treadmill Testing in Patients with and without Nonalcoholic Fatty Liver Disease (NAFLD), American College of Sports Medicine. Virtual, 2020 |
| 172 | James M. Estep, Leyla de Avila, Ali Weinstein, Jillian Kallman, Carey Escheik, Aybike Birerdinc, Azza Karrar, Victoria Pasmanik, Patrick Austin, Ingrid Schneider, Lynn Gerber, Zobair M Younossi. DYSREGULATION OF INSULIN-LIKE GROWTH FACTOR 1 (IGF1), IGF BINDING PROTEIN 3 (IGFBP3), AND ALPHA-1-ACID GLYCOPROTEIN (AGP) IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Virtual, May 2020 |
| 173 | Ali Weinstein, Leyla de Avila, James Minhui Paik, Jillian Kallman, Carey Escheik, Lynn Gerber, Zobair M Younossi. HIGHER PREVALANCE OF DEPRESSION SYMPTOMS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN A COMMUNITY SAMPLE FROM THE UNITED STATES, Digestive Disease Week. Virtual, May 2020 |
| 174 | Lynn Gerber, James Minhui Paik, Carey Escheik, Leyla de Avila, Pegah Golabi, Zobair M Younossi. THE CONTRIBUTION OF SARCOPENIA AND PHYSICAL INACTIVITY TO MORTALITY IN PEOPLE WITH NON-ALCOHOLIC FATTY LIVER DISEASE, Digestive Disease Week. Virtual, May 2020 |
| 175 | Victor de Avila, James Minhui Paik, Leyla de Avila, Linda Henry, Denise Mohess, Alva Roche-Green, Zobair M Younossi. HOSPICE CARE UTILIZATION AMONG ELDERLY PATIENTS FROM THE UNITED STATES (U.S.) WHO DIED WITH HEPATOCELLULAR CARCINOMA (HCC), Digestive Disease Week. Virtual, May 2020 |
| 176 | Leyla de Avila, James Minhui Paik, Rustin Abedi, Zahra Younoszai, Ali Weinstein, Zobair M Younossi. CAUSES OF CANCER DEATH IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): DATA FROM RANCHO BERNARDO STUDY (RBS), Digestive Disease Week. Virtual, May 2020 |
| 177 | Zobair M Younossi, Azza Karrar, Maria Stepanova, Brian P. Lam, Bijal Rajput, Sean C. Felix, Thomas Jeffers, Samuel Hellings, Elizabeth Brown, Anthony Sanfiz, Mette J. Nielsen, Natasja Gudmann, Diana J. Leeming, Thomas Spires, Mellisa Yarde, Yi Luo, Leonid Zhelnin, Mary Ellen Cvijic, Edgar Charles, Sumanta Mukherjee, Lei Zhao, Morten A. Karsdal, David Gordon, Fatema Nader, Zachary Goodman. COLLAGEN NEO-EPITOPE RATIOS ARE ASSOCIATED WITH SIGNIFICANT WEIGHT LOSS, AND IMPROVEMENT OF NON-INVASIVE TEST (NIT) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH), Digestive Disease Week. Virtual, May 2020 |
| 178 | Pegah Golabi, James Minhui Paik, Leyla de Avila, Sohailla Noor, Samir Nader, Zobair M Younossi. NONINVASIVE LIVER FIBROSIS TESTS PERFORMANCE IN MORBIDLY OBESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Virtual, May 2020 |
| 179 | Patrick Austin, Jillian Kallman, Carey Escheik, Saisruthi Kannan, Pooja Agarwal, Lynn Gerber, Zobair M Younossi. RESTING METABOLIC RATE DOES NOT CORRELATE WITH PERFORMANCE DURING GRADED TREADMILL TESTING IN INDIVIDUALS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Virtual, May 2020 |
| 180 | Jillian Kallman, James M. Estep, Carey Escheik, Patrick Austin, Rohini Mehta, Lynn Gerber, Zobair M Younossi. ACTIVITY SELF-REPORT DERIVED CALCULATION LINKS FATIGUE AND PERCEIVED EXERTION TO PHYSICAL PERFORMANCE CAPACITY BUT NOT METABOLIC MEASURES, Digestive Disease Week. Virtual, May 2020 |
| 181 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Rohit Loomba, Quentin Anstee, Vlad Ratziu, Stephen A. Harrison, Arun J. Sanyal, Jacob George, Susanne Beckebaum, David Orr, Giuseppe Mazzella, Victor Vargas, Lise L. Gluud, Rifaat Safadi, James F. Trotter, Jaideep Behari, David A. Sheridan, Muhammad Y. Sheikh, Martin Bonacci, Gail Cawkwell, Bruce Wong, Pierre Bedossa, Zachary Goodman, Mary E. Rinella. OBESITY-SPECIFIC HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: RESULTS FROM THE REGENERATE STUDY , Digestive Disease Week. Virtual, May 2020 |
| 182 | Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Mohamed El Kassas, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Jian-Gao Fan, Elisabetta Bugianesi, Yuichiro Eguchi, Ziad Younes, Manuel Romero-Gomez, Stuart Roberts, Stuart C. Gordon, Saeed S Hamid, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Mariam Ziayee, Issah Younossi, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. THE IMPACT OF FATIGUE ON PATIENT-REPORTED OUTCOMES (PRO) IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (GLR), Digestive Disease Week. Virtual, May 2020 |
| 183 | James M. Estep, Jillian Kallman, Leyla de Avila, Carey Escheik, Aybike Birerdinc, Rustin Abedi, Sean C. Felix, Thomas Jeffers, Ingrid Schneider, Ali Weinstein, Lynn Gerber, Zobair M Younossi. HUMAN ACTIVITY PROFILE IN THE CONTEXT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND TYPE II DIABETES MELLITUS (DM), Digestive Disease Week. Virtual, May 2020 |
| 184 | James Minhui Paik, Pegah Golabi, Youssef Younossi, Nazaneen Saleh, Annan Nhyira, Zobair M Younossi. THE GROWING BURDEN OF DISABILITY RELATED TO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES (U.S.): DATA FROM GLOBAL BURDEN OF DISEASE (GBD) 2007-2017, Digestive Disease Week. Virtual, May 2020 |
| 185 | Zobair M Younossi, Radhika Tampi, Leyla de Avila, Rebecca Cable, Fatema Nader, Issah Younossi, Andrei Racila. MODELING THE CLINICAL AND ECONOMIC EFFECTS OF ANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS B (CHB) IN THE UNITED STATES (U.S.), Digestive Disease Week. Virtual, May 2020 |
| 186 | Vincent Wai-Sun Wong, Zobair M Younossi. Modelling Quality-Adjusted Life Years (QALYs) for Patients with Non-alcoholic Fatty Liver Disease (NAFLD) in Hong Kong, Asian Pacific Association for the Study of Liver. Virtual, September 2020 |
| 187 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Jian-Gao Fan, Elisabetta Bugianesi, Yuichiro, Eguchi, Ziad Younes, Manuel Romero-Gomez, Stuart Roberts, Stuart C. Gordon, Saeed S Hamid, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Mariam Ziayee, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova. The Clinical and Patient-Reported Outcomes (PRO) Profile of Patients with Chronic Liver Disease (CLD) in Asian Countries: Data from Real-World Practices Varies Across the World, Asian Pacific Association for the Study of Liver. Virtual, September 2020 |
| 188 | Zobair M Younossi. Burden of Chronic Liver Diseases (CLD) in Asia: The Growing Impact of Non-alcoholic Fatty Liver Diseases (NAFLD), Asian Pacific Association for the Study of Liver. Virtual, September 2020 |
| 189 | Ali Weinstein, Leyla de Avila, Jillian Kallman Price, Carey Escheik, Lynn Gerber, Zobair M Younossi. Differential Relationships between Physical Activity Levels and Fine Motor Performance in Individuals with and without Diabetes Mellitus Type II, American Academy of Physical Medicine and Rehabilitation. |
| 190 | Jillian Kallman Price, Rohini Mehta, Patrick Austin, Carey Escheik, Lynn Gerber, Zobair M Younossi. Orosomucoid (ORM) is Associated with Decreased Daily Activity Level and Resting O2 Volume, American Academy of Physical Medicine and Rehabilitation. |
| 191 | Ali Weinstein, Leyla de Avila, Carey Escheik, Jillian Kallman Price, Pegah Golabi, Lynn Gerber, Zobair M Younossi. Differential Fine Motor Performance and Perceptual Reasoning in Individuals with and without Type II Diabetes, American Academy of Physical Medicine and Rehabilitation. |
| 192 | Lynn Gerber, Azza Karrar, Aybike Birerdinc, James Minhui Paik, Elzafir Elsheikh Abdelrahman, Sean C. Felix, Thomas Jeffers, Zahra Younoszai, Andrei Racila, Brian P. Lam, Zachary Goodman, Zobair M Younossi. LOW LEVELS OF CIRCULATING FATTY ACID BINDING PROTEIN 4 ARE ASSOCIATED WITH THE PRESENCE OF LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 193 | Rohini Mehta, James M. Estep, Gary Bratthauer, Aybike Birerdinc, James Minhui Paik, Daisong Tan, Nisarg Jethi, Fanny Monge, Zachary Goodman, Zobair M Younossi. LOWER HEPATOCYTE BI-NUCLEATION IS ASSOCIATED WITH BALLOONING DEGENERATION AND MODERATE TO SEVERE STEATOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 194 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Robert P. Myers, Stephen Djedjos, Stephen A. Harrison, Zachary Goodman. PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) AND COMPENSATED CIRRHOSIS (CC): DATA FROM THE STELLAR-4 PHASE 3 CLINICAL TRIAL , American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 195 | Patrick Austin, James Minhui Paik, Carey Escheik, Jillian Kallman Price, Lynn Gerber, Zobair M Younossi. PERCEPTION OF EFFORT DURING GRADED TREADMILL TESTING IS INCREASED IN INDIVIDUALS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 196 | James M. Estep, Leyla de Avila, Ali Weinstein, Pratyusha Chaluvadi, Carey Escheik, Pegah Golabi, Rohini Mehta, Brian P. Lam, Ingrid Schneider, Lynn Gerber, Zobair M Younossi. POLYMORPHISM FOR SEROTONIN RECEPTOR 5HTR2C IS ASSOCIATED WITH COGNITIVE PERFORMANCE AND NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 197 | Zobair M Younossi, Azza Karrar, Brian P. Lam, Sean C. Felix, Thomas Jeffers, Samuel Hellings, Elizabeth Brown, John Thompson, Yi Luo, Anthony Sanfiz, Leonid Zhelnin, Edgar Charles, Sumanta Mukherjee, Lei Zhao, David Gordon, Fatema Nader, Zachary Goodman. THE ROLE OF COLLAGEN NEO-EPITOPE BIOMARKERS IN PREDICTING ADVANCED HISTOLOGIC FIBROSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 198 | Lynn Gerber, Azza Karrar, Aybike Birerdinc, Henry A. Tran, Elzafir Elsheikh Abdelrahman, James Minhui Paik, Sean C. Felix, Thomas Jeffers, Zahra Younoszai, Andrei Racila, Brian P. Lam, Zachary Goodman, Zobair M Younossi. HIGH LEVELS OF TROPONIN I ARE ASSOCIATED WITH LIVER FIBROSIS IN NONALCOHOLIC STEATOHEPATITIS (NASH), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 199 | Aybike Birerdinc, Edgar Rodriguez, Rohini Mehta, Fanny Monge, Lakshmi Alaparthi, Hala Abdul-Al, Thomas Jeffers, Sean C. Felix, Zahra Younoszai, Brian P. Lam, Daisong Tan, Nisarg Jethi, Zachary Goodman, Vikas Chandhoke, Zobair M Younossi. GENE EXPRESSION AND TISSUE EXTRACT LEVELS OF INTERLEUKIN (IL)-8 AND TRANSFORMING GROWTH FACTOR Beta1 (TGF-ß1) IN THE VISCERAL ADIPOSE TISSUE (VAT) IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 200 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Rohit Loomba, Quentin Anstee, Vlad Ratziu, Stephen A. Harrison, Arun J. Sanyal, James F. Trotter, Aasim M. Sheikh, Aldo J Montano-Loza, Antonio Olveria, Laura M. Stinton, David A. Sheridan, Victor Vargas, Lise L. Gluud, Rifaat Safadi, Jorn M. Schattenberg, Mandana Khalili, David Orr, Markus Peck-Radosavljevic, Michael E. Allison, Gail Cawkwell, Bruce Wong, Pierre Bedossa, Zachary Goodman. ASSESSMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA): RESULTS FROM REGENERATE PHASE 3 CLINICAL TRIAL, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 201 | Jillian Kallman Price, Carey Escheik, Patrick Austin, Lynn Gerber, Zobair M Younossi. LOW INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) LEVEL IS ASSOCIATED WITH LOWER DAILY ACTIVITY SCORES (AAS), LOWER PARASYMPATHETIC FUNCTION AND PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 202 | Zobair M Younossi, Harsha Pokkalla, Kishalve Pethia, Benjamin Glass, Jennifer K Kerner, Yevgeniy Gindin, Ling Han, Ryan S Huss, Chuhan Chung, Stephen Djedjos, Mani Subramanian, Robert P. Myers, Aditya Khosla, Murray Resnick, Stephen A. Harrison, Quentin Anstee, Vincent Wai-Sun Wong, Ilan Wapinski, Andrew Beck, Zachary Goodman. MACHINE LEARNING FIBROSIS MODELS BASED ON LIVER HISTOLOGY IMAGES ACCURATELY CHARACTERIZE THE HETEROGENEITY OF CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 203 | Zobair M Younossi, Eric Lawitz, Quentin Anstee, Naim Alkhouri, Nadege T Gunn, Natalie Bzowej, Raj Vuppalanchi, Ziad Younes, Anita Kohli, Shiv Sarin, Ling Han, Marianne Camargo, Georgia Li, Kathryn Kersey, Stephen Djedjos, Robert P. Myers, Mani Subramanian, Zachary Goodman, Aasim M. Sheikh, Mitchell L. Shiffman, Zachary Henry, Manuel Romero-Gomez, Michael Trauner, Takeshi Okanoue, Stephen A. Harrison, Vincent Wai-Sun Wong. NONINVASIVE TESTS (NITS) MORE ACCURATELY CAPTURE SURROGATES OF CLINICAL RESPONSE THAN LIVER HISTOLOGY IN NASH PATIENTS WITH ADVANCED FIBROSIS, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 204 | James Minhui Paik, Pegah Golabi, Youssef Younossi, Manirath Srishord, Alita Mishra, Zobair M Younossi. CHANGES IN THE GLOBAL BURDEN OF CHRONIC LIVER DISEASES (CLD) FROM 2012 TO 2017, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 205 | Pegah Golabi, James Minhui Paik, Tamoore Arshad, Mariam Afendy, Chapy Venkatesan, Zobair M Younossi. FACTORS ASSOCIATED WITH MORTALITY IN LEAN, OVERWEIGHT AND OBESE NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 206 | Zobair M Younossi, Azza Karrar, Maria Stepanova, Brian P. Lam, Sean C. Felix, Thomas Jeffers, Samuel Hellings, Elizabeth Brown, John Thompson, Thomas Spires, Mellisa Yarde, Yi Luo, Anthony Sanfiz, Leonid Zhelnin, Mary Ellen Cvijic, Edgar Charles, Sumanta Mukherjee, Lei Zhao, David Gordon, Zachary Goodman. IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE, SIGNIFICANT WEIGHT LOSS, AND IMPROVEMENT OF NON-INVASIVE TEST (NITS) ARE ASSOCIATED WITH COLLAGEN DEGRADATION PROFILES, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 207 | Zobair M Younossi, Azza Karrar, Maria Stepanova, Brian P. Lam, Sean C. Felix, Thomas Jeffers, Samuel Hellings, John Thompson, Joelle Onorato, Michael Reily, Bethanne Warrack, Yi Luo, Leonid Zhelnin, Edgar Charles, Sumanta Mukherjee, Lei Zhao, David Gordon, Fatema Nader, Zachary Goodman. METABOLOMICS PROFILE OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 208 | Brian P. Lam, Huong T. Pham, Elena Younossi, Thomas Jeffers, Arian Afendy, Sean C. Felix, Fatema Nader, Maria Stepanova, Nila Rafiq, Z Chris, Madeline Erario, Yasser Ousman, Nahrain Al-Zubaidi, Zobair M Younossi. SCREENING AND LINKAGE TO CARE ALGORITHM TO IDENTIFY PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) WITH ADVANCED FIBROSIS IN THE PRIMARY CARE AND ENDOCRINOLOGY SETTINGS - THE PRELIMINARY ANALYSIS, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 209 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Rohit Loomba, Quentin Anstee, Vlad Ratziu, Stephen A. Harrison, Arun J. Sanyal, Jacob George, Susanne Beckebaum, David Orr, Giuseppe Mazzella, Victor Vargas, Lise L. Gluud, Rifaat Safadi, James F. Trotter, Jaideep Behari, David A. Sheridan, Muhammad Y. Sheikh, Gail Cawkwell, Bruce Wong, Pierre Bedossa, Zachary Goodman, Mary E. Rinella. THE IMPACT OF PRURITUS ON PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA) , American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 210 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Aliya Gulamhusein, Bilal Hameed, Douglas Thorburn, Kris V. Kowdley, Michael Trauner. PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC) DURING TREATMENT WITH CILOFEXOR (GS-9674) , American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 211 | Lynn Gerber, James Minhui Paik, Rati Deshpande, Leyla de Avila, Pegah Golabi, Zobair M Younossi. SARCOPENIA IS ASSOCIATED WITH MORTALITY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 212 | Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveriro, Rafael Esteban, Zobair M Younossi. HEPATITIS DELTA INFECTION IS ASSOCIATED WITH IMPAIRMENT OF PATIENT REPORTED OUTCOMES (PROs), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 213 | Issah Younossi, Maria Stepanova, Linda Henry, Arian Afendy, Zobair M Younossi, Mercedes Walters. IMPAIRMENT OF HEALTH-RELATED QUALITY OF LIFE (HRQL) AND HEALTH CARE RESOURCE UTILIZATION (HCRU) IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD) AND PRIMARY LIVER CANCER (LC) IN THE UNITED STATES (U.S.): DATA FROM THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 214 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian Aresse, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOMES DATA FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 215 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian Aresse, Mary E. Rinella, Saeed S Hamid, Issah Younossi, Brian P. Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 216 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Gregory Trimble, Aijaz Ahmed, Saleh Alqahtani, Issah Younossi, Andrei Racila. NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS THE MOST RAPIDLY GROWING CAUSE OF LISTING FOR LIVER TRANSPLANTATION: THE SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR) DATA FROM 1994 TO 2018, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 217 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian-Gao Fan, Yuichiro Eguchi, Stuart C. Gordon, Aijaz Ahmed, Janus P. Ong, Ira M. Jacobson, Marco Arrese, Mary E. Rinella, Saeed S Hamid, Issah Younossi, Brian P. Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. DIFFERENCES IN THE CLINICAL PROFILE OF THE MOST COMMON CAUSES OF CHRONIC LIVER DISEASE (CLD) ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY. , American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 218 | Lynn Gerber, James Minhui Paik, Jillian Kallman Price, Rakesh Biswas, Rebecca Cable, Zobair M Younossi. ENGAGING IN IDEAL (IDPA) VERSUS INTERMEDIATE ACTIVITY (INPA) LEVEL CONFERS A SIGNIFICANT LONGEVITY BENEFIT IN CARDIOVASCULAR (CVD) AND ALL-CAUSE MORTALITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 219 | Radhika Tampi, Vincent Wai-Sun Wong, Issah Younossi, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Zobair M Younossi. MODELLING THE ECONOMIC AND CLINICAL BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS IN EAST ASIA: DATA FROM HONG KONG , American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 220 | James Minhui Paik, Rati Deshpande, Pegah Golabi, Issah Younossi, Linda Henry, Zobair M Younossi. MODIFIABLE CARDIOVASCULAR (CV) RISK FACTORS ARE ASSOCIATED WITH LONG-TERM OUTCOMES OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 221 | Jillian Kallman Price, Rohini Mehta, Carey Escheik, Patrick Austin, Lynn Gerber, Zobair M Younossi. SERUM OROSOMUCOID (ORM) DISTINGUISHES PEOPLE WITH AND WITHOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CORRELATES WITH LOW DAILY ACTIVITY LEVEL AND RESTING V02, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 222 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian-Gao Fan, Yuichiro Eguchi, Stuart C. Gordon, Aijaz Ahmed, Janus P. Ong, Ira M. Jacobson, Marco Arrese, Mary E. Rinella, Saeed S Hamid, Issah Younossi, Brian P. Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. SEVERE IMPAIRMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY, American Association for the Study of Liver Diseases. Boston, MA. 2019. |
| 223 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Arian Afendy, Ira M. Jacobson, Andrew J. Muir, Stanislas Pol, Stefan Zeuzem, Eric Lawitz, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader. CHRONIC HEPATITIS C (CHC) PATIENTS WHO DO NOT ACHIEVE SUSTAINED VIROLOGIC RESPONSE (SVR) EXPERIENCE WORSENING OF THEIR HEALTH-RELATED QUALITY OF LIFE (HRQL), Digestive Disease Week. San Diego, CA. May 21, 2019. |
| 224 | Leyla de Avila, Ali Weinstein, James M. Estep, Maria Stepanova, Pegah Golabi, Jillian Kallman, Carey Escheik, Lynn Gerber, Zobair M Younossi. IN COMPARISON TO CHRONIC HEPATITIS C INFECTION (CHC), PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) HAVE SIGNIFICANTLY MORE PHYSICAL AND FATIGUE RELATED IMPAIRMENTS: PATIENT REPORTED OUTCOMES (PROS), SERUM NEUROTRANSMITTER AND CHEMOKINE DATA, Digestive Disease Week. San Diego, CA, May 21, 2019 |
| 225 | Maria Stepanova, Elliot B. Tapper, Edward J. Gane, Mark S. Sulkowski, Marc Bourliere, Zobair M Younossi. FACTORS ASSOCIATED WITH LACK OF IMPROVEMENT OF PATIENT REPORTED OUTCOMES (PRO) IN CHRONIC HEPATITIS C (CHC) PATIENTS WITH SUSTAINED VIROLOGIC RESPONSE (SVR), Digestive Disease Week. San Diego, CA. May 21, 2019. |
| 226 | Rati Deshpande, Maria Stepanova, Pegah Golabi, Chapy Venkatesan, Kimberly Brown, Zobair M Younossi. PREVALENCE, MORTALITY AND HEALTH CARE UTILIZATION OF HEPATITS C INFECTION (HCV) AMONG MEDICARE BENIFICIARIES RECEIVING CHRONIC HEMODIALYSIS (HD), Digestive Disease Week. San Diego, CA. 5/21/2019. |
| 227 | Mehmet Sayiner, Pegah Golabi, James Minhui Paik, Wisna'odom Keo, Madeline Erario, Zobair M Younossi. EXTRAHEPATIC MANIFESTATIONS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) POSE SIGNIFICANT CLINICAL AND ECONOMIC BURDEN ON THE MEDICARE POPULATION, Digestive Disease Week. San Diego, CA. May 20, 2019 |
| 228 | Zobair M Younossi, Maria Stepanova, Wirth Stefan , William Balistreri, Schwarz William F., Philip Rosenthal, Regino Gonzalez-Peralta, Sanjay Bansal, Karen Murray, Fatema Nader. HEALTH-RELATED QUALITY OF LIFE IN YOUNG CHILDREN WITH HEPATITIS C TREATED WITH SOFOSBUVIR AND RIBAVIRIN AND SOFOSBUVIR/LEDIPASVIR, Digestive Disease Week. San Diego, CA. May 20, 2019 |
| 229 | Pegah Golabi, James Minhui Paik, Jessica P. Hwang, Su H. Wang, Hannah Lee, Zobair M Younossi. TYPE 2 DIABETES IS INDEPENDENTLY ASSOCIATED WITH CARDIOVASCULAR DISEASE AND ADVANCED FIBROSIS AMONG ASIAN AMERICANS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. San Diego, CA. May 19, 2019. |
| 230 | Rohini Mehta, James M. Estep, Pegah Golabi, James Minhui Paik, Sean C. Felix, Hussain Allawi, Ingrid Schneider, Brian P. Lam, Huong T. Pham, Zobair M Younossi. ORAL AND GUT MICROBIOME DIVERSITY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND HEPATIC FIBROSIS, Digestive Disease Week. San Diego, CA. May 19, 2019. |
| 231 | James Minhui Paik, Rati Deshpande, Issah Younossi, Pegah Golabi, Chapy Venkatesan, Zobair M Younossi. CARDIOVASCULAR HEALTH METRICS PREDICT OUTCOMES IN NON-ALCOHOLIC FATTY LIVER DISEASE, Digestive Disease Week. San Diego, CA. May 19, 2019. |
| 232 | Zobair M Younossi, Maria Stepanova, Alnoor Ramji, K. Rajender Reddy, Ira M. Jacobson, Issah Younossi, Fatema Nader. SOME PATIENTS WITH CHRONIC HEPATITIS C (CHC) MAY EXPERIENCE IMPROVEMENT OF HEALTH RELATED QUALITY OF LIFE WITH LONGER FOLLOW UP AFTER SUSTAINED VIROLOGIC RESPONSE (SVR), Digestive Disease Week. San Diego, CA. May 19, 2019. |
| 233 | Zobair M Younossi, Radhika Tampi, Fatema Nader, Issah Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. THE VALUE OF CURING ADVANCED NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES, Digestive Disease Week. San Diego, CA. May 18, 2019 |
| 234 | James Minhui Paik, Linda Henry, Leyla de Avila, Elena Younossi, Andrei Racila, Zobair M Younossi. MORTALITY RELATED TO NON-ALCOHOLIC FATTY LIVER DISEASE IS INCREASING IN THE UNITED STATES OVER THE LAST DECADE, Digestive Disease Week. San Diego, CA. 5/18/2019. |
| 235 | Pegah Golabi, Mehmet Sayiner, James Minhui Paik, Leyla de Avila, Alita Mishra, Zobair M Younossi. ATHEROSCLEROTIC CARDIOVASCULAR DISEASE SCORE IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE, Digestive Disease Week. San Diego, CA. |
| 236 | Azza Karrar, Elzafir Elsheikh Abdelrahman, Bijal Rajput, Katherine Acosta, James Minhui Paik, Daisong Tan, Thomas Jeffers, Sean C. Felix, Fanny Monge, Lakshmi Alaparthi, Zachary Goodman, Zobair M Younossi. ADVANCED LIVER FIBROSIS IN NONALCOHOLIC STEATOHEPATITIS (NASH) IS ASSOCIATED WITH LOW LEVELS OF KEY MEMBERS OF MEMBRANE ATTACK COMPLEX, Digestive Disease Week. San Diego, CA. May 18, 2019. |
| 237 | Maria Stepanova, Alita Mishra, Issah Younossi, Chapy Venkatesan, Zobair M Younossi. The Association of Insurance Coverage with Outcomes of Liver Transplantation in the United States, International Liver Transplantation Society. |
| 238 | Zobair M Younossi, Azza Karrar, Maria Stepanova, Brian P. Lam, Sean C. Felix, Thomas Jeffers, Samuel Hellings, Elizabeth Brown, Thomas Spires, Mellisa Yarde, Yi Luo, Anthony Sanfiz, Leonid Zhelnin, Gabor Jarai, Mary Ellen Cvijic, Edgar Charles, Sumanta Mukherjee, Lei Zhao, David Gordon, Fatema Nader, Zachary Goodman. A simple biomarker panel predictive of advanced fibrosis in patients with non-alcoholic steatohepatitis, European Association for the Study of the Liver. Vienna, Austria. April 13, 2019. |
| 239 | Zobair M Younossi, Maria Stepanova, Quentin Anstee, Vincent Wai-Sun Wong, Stephen A. Harrison, Takeshi Okanoue, Manuel Romero-Gomez, Stephen Djedjos, Robert P. Myers, Andrei Racila, Fatema Nader. What are the Predictors of Impairment of Patient-reported Outcome in Non-alcoholic Steatohepatitis?, European Association for the Study of the Liver. Vienna, Austria. April 13, 2019. |
| 240 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Arian Afendy, Ira M. Jacobson, Andrew J. Muir, Stanislas Pol, Stefan Zeuzem, Eric Lawitz, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader. The sustained deleterious impact of viremia on patient reported outcomes in patients with chronic hepatitis C who don't achieve sustained virologic response, European Association for the Study of the Liver. Vienna, Austria. April 13, 2019. |
| 241 | James Minhui Paik, Pegah Golabi, Gregory Trimble, Leyla de Avila, Linda Henry, Zobair M Younossi. The increasing importance of non-alcoholic fatty liver disease in human deficiency virus (HIV) positive patients, European Association for the Study of the Liver. Austria, Vienna. April 13, 2019. |
| 242 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Ira M. Jacobson, Andrew J. Muir, Stefan Zeuzem, Eric Lawitz, Stanislas Pol, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader. Sustained virologic response in patients with cirrhosis from chronic hepatitis C leads to sustained and long-term improvement of health-related quality of life, fatigue, and work productivity, European Association for the Study of the Liver. Vienna, Austria. April 12, 2019. |
| 243 | Maria Stepanova, Alita Mishra, Issah Younossi, Donghee Kim, Aijaz Ahmed, Zobair M Younossi. Predictors of outcomes for patients with non-alcoholic steatohepatitis undergoing liver transplantation in the United States, European Association for the Study of the Liver. Vienna, Austria. April 12, 2019. |
| 244 | Zobair M Younossi, Pegah Golabi, Leyla de Avila, James Minhui Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader. The Global Epidemiology on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus: A systematic review and meta-analysis, European Association for the Study of the Liver. Vienna, Austria. April 11, 2019. |
| 245 | Leyla de Avila, Ali Weinstein, Michael P. Curry, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Association of patient-reported outcomes with cerebral metabolism in patients with chronic hepatitis C at baseline and post sustained virologic response, European Association for the Study of the Liver. Vienna, Austria. April 13, 2019. |
| 246 | Zobair M Younossi, Maria Stepanova, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Stephen Djedjos, Robert P. Myers, Issah Younossi, Andrei Racila, Fatema Nader. The presence of type 2 diabetes is independently associated with impairment of patient-reported outcomes in patients with non-alcoholic steatohepatitis, European Association for the Study of the Liver. Vienna, Austria. April 11, 2019. |
| 247 | Zobair M Younossi, Radhika Tampi, Andrei Racila, Ying Qiu, Leah Burns, Issah Younossi, Fatema Nader. Economic and clinical burden of non-alcoholic steatohepatitis in patients with type II diabetes in the United States, European Association for the Study of the Liver. Vienna, Austria. April 11, 2019. |
| 248 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, K. Rajender Reddy, Vincent Wai-Sun Wong, Alessandra Mangia, Andrew J. Muir, Stephen Djedjos, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader, Andrei Racila. Patients with non-alcoholic steatohepatitis experience severe impairment of health related quality of life, European Association for the Study of the Liver. Vienna, Austria. April 11, 2019. |
| 249 | Zobair M Younossi, Eric Lawitz, Naim Alkhouri, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Kathryn Kersey, Georgia Li, GM Subramanian, Robert P. Myers, CS Djedjos, Ling Han, G Chen, Tuan Nguyen, Anita Kohli, Natalie Bzowej, Ziad Younes, Shiv Sarin, Mitchell L. Shiffman, Stephen A. Harrison, Zachary Goodman, Nezam H. Afdhal, Maria Stepanova, Quentin Anstee. Algorithms Using Noninvasive Tests Can Accurately Identify Patients with Advanced Fibrosis Due to Nash: Data from the Stellar Clinical Trials, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 250 | Rohini Mehta, Sasha Stoddard, James M. Estep, Pegah Golabi, James Minhui Paik, Hussain Allawi, Brian P. Lam, Aybike Birerdinc, Wisna'odom Keo, Puneetinder Mann, Ingrid Schneider, Zobair M Younossi. Oral Fungal and Bacterial Proportions in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Hepatic Fibrosis, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 251 | Zobair M Younossi, Maria Stepanova, Arian Afendy, Fatema Nader, Aliya Gulamhusein, Bilal Hameed, Douglas Thorburn, Xiaomin Lu, Georgia Li, Chuhan Chung, GM Subramanian, Robert P. Myers, Christopher L. Bowlus, Kris V. Kowdley, Michael Trauner. Longitudinal Evaluation of Patient-Reported Outcomes (PROs) in Patients with Primary Sclerosing Cholangitis (PSC), American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 252 | Zobair M Younossi, Maria Stepanova, Quentin Anstee, Eric Lawitz, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Kathryn Kersey, Georgia Li, GM Subramanian, Robert P. Myers, CS Djedjos, Takeshi Okanoue, Michael Trauner, Stephen A. Harrison, Zachary Goodman. Advanced Fibrosis Based on Noninvasive Tests in Nonalcoholic Steatohepatitis (NASH) Is Associated with Impairment of Patient-Reported Outcomes, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 253 | Zobair M Younossi, Maria Stepanova, Fanny Monge, Lakshmi Alaparthi, Daisong Tan, Hala Abdul-Al, Hala Abdelaal, Bryan McColgan, GM Subramanian, Robert P. Myers, Vlad Ratziu, Nezam H. Afdhal, Stephen A. Harrison, Arun J. Sanyal, Zachary Goodman. Independent Predictors of Spontaneous Progression and Regression in Nonalcoholic Steatohepatitis (NASH), American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 254 | Jillian Kallman Price, Patrick Austin, Carey Escheik, Shruthi Prabhakar, A. Rose Srishord, Henry A. Tran, Carla Porter, Lynn Gerber, Zobair M Younossi. Performance Outcomes in Ischemic Cardiac Disease (ICD) Patients Referred for Cardiac Rehabilitation (CR) Were Not Negatively Impacted By Non-Alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 255 | Ali Weinstein, Leyla de Avila, James Minhui Paik, Pegah Golabi, Carey Escheik, Haley Bush, Nila Rafiq, Lynn Gerber, Zobair M Younossi. Cognitive Performance in Individuals with Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 256 | Omer Shahab, Danubia Hester, James Minhui Paik, Ansha Goel, Issah Younossi, Pegah Golabi, Mariam Afendy, Zobair M Younossi. In Medicare Patients with Hepatocellular Carcinoma (HCC), Non-Alcoholic Fatty Liver Disease (NAFLD) Is Among the Top Causes for Mortality and Resource Utilization, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 257 | Azza Karrar, Anatoly Ulyanov, Mariaelena Pierobon, Maria Stepanova, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Bijal Rajput, Jeiran Kianoush, Alex Hodge, Weidong Zhou, Zachary Goodman, Emanuel F. Petricoin, Zobair M Younossi. Signature of Circulating Proteome Associated with Non-Alcoholic Steatohepatitis (NASH) As Detected By Nano LC- Mass Spectrometry, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 258 | Pegah Golabi, James Minhui Paik, Elisabetta Bugianesi, Gregory Trimble, Alita Mishra, Zobair M Younossi. Prevalence and Long-Term Outcomes of Non-Alcoholic Fatty Liver Disease (NAFLD) Among Elderly Individuals from the United States, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018. |
| 259 | James M. Estep, Leyla de Avila, Ali Weinstein, Carey Escheik, Pegah Golabi, Jillian Kallman Price, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. The Increase in the Circulating Chemokine Ligand 2 (CCL2) Levels in Patients with Chronic Hepatitis C Post Sustained Virologic Response (SVR) Is Not Associated with Detrimental Impact on Health-Related Quality of Life, American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 260 | Leyla de Avila, James M. Estep, Ali Weinstein, Carey Escheik, Pegah Golabi, Aybike Birerdinc, Maria Stepanova, Trevor Gogoll, Lynn Gerber, Zobair M Younossi. Improvements in Patient Reported Outcomes after Sustained Virologic Response in Patients with Hepatitis C Virus Infection Correlates with Increases in Serotonin and Catechol-O-Methyltransferase (COMT), American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 261 | Zobair M Younossi. Routinely Available Noninvasive Tests Discriminate Advanced Fibrosis Due to NASH in the Phase 3 Stellar Trials of the ASK1 Inhibitor Selonsertib, American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 262 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Yusuf Yilmaz, Ajay Duseja, Yuichiro Eguchi, Mohamed El Kassas, Marlen Fernandez, Jacob George, Ira M. Jacobson, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Marco Arrese, Victor de Ledinghen, Manuel Romero-Gomez, Nahum Mendez-Sanchez, Aijaz Ahmed, Robert John Wong, Georgios Papatheodoridis, Lawrence Serfaty, Philippe Mathurin, Issah Younossi, Fatema Nader, Mariam Ziayee, Arian Afendy. Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcoholic Fatty Liver Disease (AFLD): The Impact of Alcohol Consumption and Metabolic Syndrome on Mortality, American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 263 | Aybike Birerdinc, Kyle Kurzke, Sasha Stoddard, Rohini Mehta, James M. Estep, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Fanny Monge, Lakshmi Alaparthi, Hala Abdul-Al, Zachary Goodman, Vikas Chandhoke, Zobair M Younossi. Severity of Non-Alcoholic Liver Disease (NAFLD) As Assessed By Percent Collagen Deposition with Morphometry Shows a Gender-Specific Pattern of Serum Cytokine Expression., American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 264 | Zobair M Younossi, Radhika Tampi, Fatema Nader, Issah Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. Estimating the Impact of Hypothetical Treatment for Patients with Advanced Non-Alcoholic Steatohepatitis (NASH) on Clinical Outcomes, American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 265 | Zobair M Younossi. Disparities in Accessing HCV Care Under Medicaid Programs across the United States; Experience from the Trio Network , American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 266 | James M. Estep, Rohini Mehta, Gary Bratthauer, Lakshmi Alaparthi, Fanny Monge, Daisong Tan, Hala Abdul-Al, Hala Abdelaal, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Aimal Arsalla, Zachary Goodman, Zobair M Younossi. Sonic Hedgehog (SHH) Signal in Non-Alcoholic Steatohepatitis (NASH) Patients with Cirrhosis Is Dynamic and Correlates with Mallory-Denk Bodies, American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 267 | Aybike Birerdinc, Kyle Kurzke, Sasha Stoddard, Rohini Mehta, James M. Estep, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Fanny Monge, Lakshmi Alaparthi, Hala Abdul-Al, Zachary Goodman, Vikas Chandhoke, Zobair M Younossi. Assessment of Percent Hepatic Fat Determined By Morphometry May Provide More Specific Information in the Inflammatory Signaling Associated with Non-Alcoholic Fatty Liver Disease (NAFLD)., American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 268 | Pegah Golabi, James Minhui Paik, Rashmi Reddy, Gregory Trimble, Chapy Venkatesan, Zobair M Younossi. Prevalence and Long-Term Outcomes of Non-Alcoholic Fatty Liver Disease (NAFLD) Among Lean Individuals without Any Components of Metabolic Syndrome, American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 269 | Zobair M Younossi, Maria Stepanova, Quentin Anstee, Eric Lawitz, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Kathryn Kersey, GM Subramanian, Robert P. Myers, CS Djedjos, Takeshi Okanoue, Michael Trauner, Stephen A. Harrison, Zachary Goodman. Severe Impairment of Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Non-Alcoholic Steatohepatitis (NASH), American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018. |
| 270 | Elzafir Elsheikh Abdelrahman, Henry A. Tran, James Minhui Paik, Sean C. Felix, Thomas Jeffers, Zahra Younoszai, Hussain Allawi, Andrei Racila, Brian P. Lam, Ingrid Schneider, Lynn Gerber, Zobair M Younossi. Serum Biomarkers Associated with Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. San Francisco, CA. November 10, 2018. |
| 271 | Zobair M Younossi. Identification and Characterization of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Liver Fibrosis Identified Using Noninvasive Test (NIT) of Hepatic Fibrosis: Real-World Results of 3,421 Patients , American Association for the Study of Liver Diseases. San Francisco, CA. November 10, 2018. |
| 272 | Tamoore Arshad, Pegah Golabi, James Minhui Paik, Omer Shahab, Madeline Erario, Zobair M Younossi. Prevalence and Long-Term Outcomes of Non-Alcoholic Fatty Liver Disease (NAFLD) in Female Subjects in the United States, American Association for the Study of Liver Diseases. San Francisco, CA. November 9, 2018. |
| 273 | Zobair M Younossi. PREFERENCES IN CLINICAL PRACTICE WITH GLECAPREVIR/PIBRENTASVIR (GLE-PIB), LEDIPASVIR/SOFOSBUVIR (LDV-SOF), AND SOFOSBUVIR/VELPATASVIR (SOF-VEL); DATA FROM THE TRIO NETWORK, American Association for the Study of Liver Diseases. San Francisco, CA. November 9, 2018. |
| 274 | Pegah Golabi, James Minhui Paik, Jessica P. Hwang, Su H. Wang, Hannah Lee, Zobair M Younossi. PREVALENCE AND OUTCOMES OF NON-ALCOHOLIC FAT-TY LIVER DISEASE (NAFLD) AMONG ASIAN AMERICAN ADULTS IN THE UNITED STATES, American Association for the Study of Liver Diseases. San Francisco, CA. November 9, 2018. |
| 275 | Zobair M Younossi. SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR (SOF/VEL/VOX) IN CARE OF CHRONIC HEPA-TITIS C PATIENTS; CLINICAL PRACTICE EXPERIENCE FROM THE TRIO NET-WORK, American Association for the Study of Liver Diseases. San Francisco, CA. November 9, 2018. |
| 276 | Zobair M Younossi. Effectiveness of 8-Week Glecaprevir/Pibrentasvir (G/P) for Treatment Naive, Non-Cirrhotic Patients with HCV Infection in the Trio Health Network , American Association for the Study of Liver Diseases. San Francisco, CA. November 9, 2018. |
| 277 | James Minhui Paik, Pegah Golabi, Mehmet Sayiner, Rakesh Biswas, Saleh Alqahtani, Chapy Venkatesan, Zobair M Younossi. THE INCREASE IN MORTALITY RELATED TO CHRONIC LIV-ER DISEASE IS EXPLAINED BY NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. San Francisco, CA |
| 278 | Zobair M Younossi. Change in Demographics of Direct-Acting Antiviral (DAA) Prescribed HCV Patients from 2013 to 2018; Data from 19,994 Patients in the Trio Network , American Association for the Study of Liver Diseases. San Francisco, CA. November 9, 2018. |
| 279 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Extensive Validation of a Disease-Specific Health Related Quality of Life Instrument in Patients with Biopsy-proven Non-alcoholic Steatohepatitis (NASH): Chronic Liver Disease Questionnaire-NASH (CLDQ-NASH), American College Gastroenterology. Philadelphia, PA. October 10, 2018. |
| 280 | Azza Karrar, Anatoly Ulyanov, Maria Stepanova, Daisong Tan, Kira Tokarz, Thomas Jeffers, Sean C. Felix, Zachary Goodman, Zobair M Younossi. Epithelial-Mesenchymal Cell Transition (EMT) Stimulation Is Associated With Hepatic Fibrosis in Non-Alcoholic Steatohepatitis (NASH): Pathway Analysis of MicroRNA and Phosphoproteomics Data , American College Gastroenterology. Philadelphia, PA. October 7, 2018. |
| 281 | Jillian Kallman Price, Patrick Austin, Carey Escheik, Lynn Gerber, Zobair M Younossi. Observed research participation does not significantly change activity scores, physical performance or cardiac measures in hepatitis C (HCV) and non-alcoholic fatty liver disease (NAFLD), International Society of Physical and Rehabilitation Medicine. |
| 282 | Elzafir Elsheikh Abdelrahman, Henry A. Tran, James Minhui Paik, Sean C. Felix, Thomas Jeffers, Zahra Younoszai, Cameron T. Locklear, Hussain Allawi, Yun Fang, Aimal Arsalla, Bashir Noor, Kourosh Kalachi, Andrei Racila, Brian P. Lam, Zachary Goodman, Lynn Gerber, Zobair M Younossi. ARE BIOMARKERS FOR CARDIOVASCULAR DISEASE INCREASED IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)?, Digestive Disease Week. Washington D.C., June 5, 2018. |
| 283 | Jillian Kallman, Patrick Austin, Carey Escheik, Puneetinder Mann, Manirath Srishord, Lynn Gerber, Zobair M Younossi. HEALTH FACTORS PREDICTIVE OF ONE YEAR FOLLOW-UP COMPLETION IN CHRONIC LIVER DISEASE (CLD) SUBJECTS, Digestive Disease Week. Washington D.C., June 5, 2018. |
| 284 | Rohini Mehta, James M. Estep, Sean C. Felix, Hussain Allawi, Brian P. Lam, James Minhui Paik, Ingrid Schneider, Zobair M Younossi. MICROBIOME DIVERSITY AND PRESENCE OF EXTRACELLULAR DNA IN STOOL SAMPLES OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND HEPATIC FIBROSIS, Digestive Disease Week. Washington D.C., June 5, 2018. |
| 285 | Sasha Stoddard, Kyle Kurzke, Fanny Monge, Lakshmi Alaparthi, Hala Abdul-Al, Hala Abdelaal, Wisna'odom Keo, Zachary Goodman, Vikas Chandhoke, Aybike Birerdinc, Zobair M Younossi. LIVER FIBROSIS AS ASSESSED BY PERCENT COLLAGEN DEPOSITION BY MORPHOMETRY SHOWS AN INVERSE CORRELATION TO BOTH IL-7 AND INF-G IN OBESE NON-ALCOHOLIC LIVER DISEASE (NAFLD) PATIENTS., Digestive Disease Week. Washington D.C., June 5, 2018. |
| 286 | Edgar Rodriguez, Kameron Tavakolian, Rohini Mehta, James Minhui Paik, Nila Rafiq, Zachary Goodman, Vikas Chandhoke, Aybike Birerdinc, Zobair M Younossi. SERUM CYTOKINES AND THEIR ASSOCIATIONS WITH HISTOLOGICAL FEATURES OF NON-ALCOHOLIC STEATOHEPATITIS (NASH), Digestive Disease Week. Washington D.C., June 5, 2018. |
| 287 | Omer Shahab, Mehmet Sayiner, James Minhui Paik, Sean C. Felix, Pegah Golabi, Zobair M Younossi. TEN YEAR BURDEN OF PRIMARY BILIARY CHOLANGITIS AMONG INPATIENT POPULATION IN THE UNITED STATES (2005-2014), Digestive Disease Week. Washington D.C., June 5, 2018. |
| 288 | Pegah Golabi, James Minhui Paik, Haley Bush, Rebecca Cable, Andrei Racila, Zobair M Younossi. AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), STATINS DO NOT REDUCE CARDIOVASCULAR OR ALL-CAUSE MORTALITY, Digestive Disease Week. Washington D.C., June 5, 2018. |
| 289 | James Minhui Paik, Pegah Golabi, Zahra Younoszai, Alita Mishra, Gregory Trimble, Zobair M Younossi. RENAL IMPAIRMENT IS AN EXTRAHEPATIC MANIFESTATION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) WHICH IS INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY, Digestive Disease Week. Washington D.C., June 5, 2018. |
| 290 | Omar Ahmed, James Minhui Paik, Huong T. Pham, Daisong Tan, Pegah Golabi, Zobair M Younossi. NON-ALCOHOLIC FATTY LIVER (NAFLD) PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) HAVE HIGHER RISK OF MORTALITY: AN ANALYSIS OF THE MEDICARE DATA FROM THE UNITED STATES (US), Digestive Disease Week. Washington D.C., June 5, 2018. |
| 291 | Haley Bush, James Minhui Paik, Pegah Golabi, Leyla de Avila, Carey Escheik, Zobair M Younossi. INSURANCE COVERAGE AND MORTALITY IN PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION IN THE UNITED STATES (U.S.), Digestive Disease Week. Washington D.C., June 5, 2018. |
| 292 | Rohini Mehta, Maya Sproelich, Sarah Bondurant, James M. Estep, Hala Abdul-Al, James Minhui Paik, Sean C. Felix, Zobair M Younossi. MITOCHONDRIAL DNA CONTENT IS ASSOCIATED WITH ADVANCED FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Washington D.C., June 4, 2018. |
| 293 | Zobair M Younossi, Maria Stepanova, Robert S. Epstein, Marcie Strauss, Pegah Golabi, Fatema Nader, Andrei Racila. FACTORS ASSOCIATED WITH PROGRESSIVE COURSE OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS IN THE UNITED STATES: DATA FROM A LARGE-REAL WORLD DATABASE, Digestive Disease Week. Washington D.C., June 4, 2018. |
| 294 | Zobair M Younossi, Maria Stepanova, Linda Henry, Zhongping Duan, Qing Xie, Jin Lin Hou, Jidong Jia, Lai Wei. HIGH EFFICACY AND SUBSTANTIAL IMPROVEMENT OF HEALTH-RELATED QUALITY OF LIFE (HRQL) IN CHINESE PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION TREATED WITH LEDIPASVIR AND SOFOSBUVIR (LDV/SOF). (DDW), Digestive Disease Week. Washington D.C., June 4, 2018. |
| 295 | Elzafir Elsheikh Abdelrahman, Robin Couch, Allyson Dailey, Sean C. Felix, Thomas Jeffers, Zahra Younoszai, Hussain Allawi, Trevor Gogoll, Mina Younossi, James Minhui Paik, Brian P. Lam, Henry A. Tran, Ingrid Schneider, Vikas Chandhoke, Lynn Gerber, Zobair M Younossi. NON-TARGETED METABOLOMICS PROFILE CAN DIFFERENTIATE NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WITH CORONARY ARTERY DISEASE (CAD), Digestive Disease Week. Washington D.C., June 3, 2018. |
| 296 | Zobair M Younossi, Maria Stepanova, Linda Henry, Christophe Hezode, Armand Abergel, Stanislas Pol, Marc Bourliere. PATIENT REPORTED OUTCOMES IN CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS C: THE IMPACT OF PLACEBO, ACTIVE TREATMENT AND SUSTAINED VIRAL ERADICATION, Digestive Disease Week. Washington D.C., June 3, 2018. |
| 297 | Leyla de Avila, Ali Weinstein, James Minhui Paik, Carey Escheik, Lynn Gerber, Zobair M Younossi. COGNITIVE FUNCTION AND DEPRESSION IN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND TYPE 2 DIABETES MELLITUS (T2DM): ANALYSIS OF THE 2011-2014 NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES), Digestive Disease Week. Washington D.C., June 3, 2018. |
| 298 | Azza Karrar, Bijal Rajput, Katherine Barker, Katherine Acosta, James Minhui Paik, Daisong Tan, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Zachary Goodman, Zobair M Younossi. HEPATOKINES, METALLOPROTEASES AND THEIR TISSUE INHIBITORS PROVIDE PREDICTIVE ASSESSMENT FOR LIVER FIBROSIS IN NON ALCOHOLIC FATTY LIVER DISEASE, Digestive Disease Week. Washington D.C., June 3, 2018. |
| 299 | Min Kim, James Minhui Paik, Pegah Golabi, Chapy Venkatesan, Madeline Erario, Zobair M Younossi. RESOURCE UTILIZATION AND OUTCOMES OF PATIENTS WITH CHRONIC HEPATITIS B (HBV) IN THE UNITED STATES, Digestive Disease Week. Washington D.C., June 2, 2018. |
| 300 | James M. Estep, Rohini Mehta, Sean C. Felix, Justin Nguyen, Paige Epler, Simran Singh, Aybike Birerdinc, Zachary Goodman, Zobair M Younossi. INTEGRIN BETA 3 SUBUNIT LEU48->PRO POLYMORPHISM IS POSITIVELY ASSOCIATED WITH PERICELLULAR FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Washington D.C., June 2, 2018. |
| 301 | Edgar Rodriguez, Kameron Tavakolian, Rohini Mehta, James Minhui Paik, Zachary Goodman, Vikas Chandhoke, Aybike Birerdinc, Zobair M Younossi. LOCAL AND EXOGENOUS CYTOKINES CONTRIBUTE TO THE VISCERAL ADIPOSE (VAT) DERIVED INFLAMMATORY CASCADE OBSERVED IN OBESE NON-ALCOHOLIC LIVER DISEASE (NAFLD) SUBJECTS., Digestive Disease Week. Washington D.C., June 2, 2018. |
| 302 | Jillian Kallman Price, Carey Escheik, Patrick Austin, Lynn Gerber, Zobair M Younossi. Predictors Of Performance At Anaerobic Threshold (AT) In Patients With Chronic Liver Disease (CLD), American College of Sports Medicine. |
| 303 | Lynn Gerber, Samuel Powers, Carey Escheik, Jillian Kallman Price, Patrick Austin. Influence of Metabolic Syndrome on Response to Cardiac Rehabilitation, American College of Sports Medicine. |
| 304 | Pegah Golabi, James Minhui Paik, Leyla de Avila, Natsu Fukui, Manirath Srishord, Zobair M Younossi. The Worldwide Prevalence of Non-alcoholic Steatohepatitis (NASH) in Patients with Type 2 Diabetes Mellitus (DM), European Association for the Study of the Liver. |
| 305 | Zobair M Younossi, Maria Stepanova, Stephen A. Harrison, Arun J. Sanyal, Vlad Ratziu, Bryan McColgan, Robert P. Myers, Nezam H. Afdhal, Manal F. Abdelmalek, Zachary Goodman. The Conundrum of Cryptogenic Liver Disease with Advanced Fibrosis: Poor Clinical Outcomes without Treatment Options, European Association for the Study of the Liver. |
| 306 | Zobair M Younossi, Maria Stepanova, Robert S. Epstein, Marcie Strauss, Pegah Golabi, Fatema Nader, Andrei Racila. Independent Predictors of Primary Biliary Cholangitis (PBC) at High Risk for Progressive Course in the United States: Data from a Large - Real World Database, European Association for the Study of the Liver. Paris, France. April 13, 2018. |
| 307 | Zobair M Younossi, Azza Karrar, Kira Tokarz, Mariaelena Pierobon, Anatoly Ulyanov, Maria Stepanova, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Daisong Tan, Jeiran Kianoush, Alex Hodge, Ahmad Moin. Hepatic microRNA and phosphoproteomic analysis provide insights about hepatic collagen deposition and stage of fibrosis in non-alcoholic steatohepatitis, European Association for the Study of the Liver. |
| 308 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Issah Younossi, Fatema Nader, Andrew J. Muir, Marc Bourliere, Alessandra Mangia. Sustainable Improvement of Patient-Reported Outcomes (PROs) in Cirrhotic Patients with Hepatitis C (HCV) who Achieved Sustained Virologic Response (SVR), European Association for the Study of the Liver. Paris, France. April 13, 2018. |
| 309 | Zobair M Younossi, Maria Stepanova, Leyla de Avila, Lynn Gerber, Eric Lawitz, Steven L. Flamm, Bernard Willems. The Impact of Sustained Virologic Response on Severe Fatigue in Patients with Chronic Hepatitis C: The Role of HCV Viremia and Co-Morbidities, European Association for the Study of the Liver. |
| 310 | Leyla de Avila, Ali Weinstein, Michael P. Curry, Pegah Golabi, James M. Estep, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Changes in Serum Neurotransmitters (NTs) are Associated with Changes in Patient Report Outcomes (PROs) and Neurocognitive Performance (NP) in patients with Hepatitis C Virus (HCV)-Genotype 1 (GT1) who achieved Sustained Virologic Response (SVR), European Association for the Study of the Liver. |
| 311 | Zobair M Younossi, Maria Stepanova, Michael Manns, K. Rajender Reddy, Stuart C. Gordon, Marc Bourliere. Patient-Reported Outcomes in Chronic Hepatitis C: The Impact of Placebo, Active Treatment, and Sustained Viral Eradication, European Association for the Study of the Liver. |
| 312 | Zobair M Younossi, Maria Stepanova, Linda Henry, Zhongping Duan, Qing Xie, Jin Lin Hou, Jidong Jia, Wei MD Lai. High Efficacy and Substantial Improvement of Health-Related Quality of Life (HRQL) in Chinese Patients with Hepatitis C Virus (HCV) Infection Treated with Ledipasvir and Sofosbuvir (LDV/SOF) (APASL), Asian Pacific Association for the Study of Liver. |
| 313 | Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching-Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei MD Lai. Sofosbuvir (SOF) and Ledipasvir (LDV) Combination is Associated with High Sustained Virologic Response (SVR) and Improvement of Health-Related Quality of Life (HRQL) in East Asian Patients with Hepatitis C Virus (HCV) Infection, Asian Pacific Association for the Study of Liver. |
| 314 | Zobair M Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young-Suk Lim, Ming-Lung Yu, Maria Stepanova, Yock Young Dan. A Systematic Review of the Extrahepatic Manifestations of Hepatitis C Infection in East Asia, Asian Pacific Association for the Study of Liver. |
| 315 | Maria Stepanova, Issah Younossi, Fatema Nader, Naoky Tsai, Mindie H. Nguyen, Edward J. Gane, Kosh Agarwal, Harry Janssen. Patient-Reported Outcomes in Viral Hepatitis without Advanced Fibrosis: Chronic Hepatitis B vs. Hepatitis C Infection, Asian Pacific Association for the Study of Liver. |
| 316 | Zobair M Younossi, Maria Stepanova, Harry Janssen, Kosh Agarwal, Mindie H. Nguyen, Edward J. Gane, Naoky Tsai, Issah Younossi, Sharon Hunt. The impact of treatment of chronic hepatitis B (CHB) on patient-reported outcomes (PROs), American Association for the Study of Liver Diseases. |
| 317 | Zobair M Younossi, Maria Stepanova, Zachary Goodman, Eric Lawitz, Michael R. Charlton, Rohit Loomba, Robert P. Myers, Mani Subramanian, John McHutchison, Sharon Hunt. Improvements of Hepatic Fibrosis and Hepatic Collagen Deposition in Non-Alcoholic Steatohepatitis (Nash) Treated with Selonsertib are Associated with Improvement of Patient-Reported Outcomes (PROs), American Association for the Study of Liver Diseases. |
| 318 | Zobair M Younossi, Maria Stepanova, Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Bryan McColgan, Robert P. Myers, Mani Subramanian, John McHutchison, Nezam H. Afdhal, Manal F. Abdelmalek, Jaime Bosch, Zachary Goodman. Predictors of Fibrosis Progression and Regression by Histology and Morphometrically Quantified Collagen in Patients with Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis, American Association for the Study of Liver Diseases. |
| 319 | Zobair M Younossi, Azza Karrar, Kira Tokarz, Anatoly Ulyanov, Maria Stepanova, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Daisong Tan, Ahmad Moin, Ramaswamy Iyer, John Deeken, Zachary Goodman. Hepatic Signature Expression of miR-199a-5p, miR-21-3p, miR-224-5p, and miR-150-5p Detected by NextSeq Technology are Independently Associated with Fibrosis in Non-alcoholic Steatohepatitis (NASH) and Non-alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. |
| 320 | Zobair M Younossi, Maria Stepanova, Thomas Saenz, Gayle Cooper, Christa Schmidt, Steve Petruccelli. A National Survey of Physicians Regarding Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH): The Disease and Clinical Trial Awareness Program for NASH, American Association for the Study of Liver Diseases. |
| 321 | Jillian Kallman Price, Patrick Austin, Katherine Thomas, Zeba Ejaz, Megan Gooding, Carey Escheik, Lynn Gerber, Zobair M Younossi. Exercise Tolerance is Frequently Preserved in Presence of Exercise Performance Deficits in Non-Alcoholic Fatty Liver Disease (NAFLD): Implications for Exercise Intervention, American Association for the Study of Liver Diseases. |
| 322 | Jillian Kallman Price, Patrick Austin, Carey Escheik, Haley Bush, Lynn Gerber, Zobair M Younossi. Fatigue and Activity Level Self-Reports Do Not Predict Exercise Tolerance in Subjects with Non-alcoholic Fatty Liver Disease (NAFLD) Patients, American Association for the Study of Liver Diseases. |
| 323 | Patrick Austin, Jillian Kallman Price, Megan Gooding, Carey Escheik, Lynn Gerber, Zobair M Younossi. Onset of, but not Capacity beyond, Anaerobic Threshold (AT) during Graded Treadmill Testing is reduced in Patients with Nonalcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. |
| 324 | Patrick Austin, Jillian Kallman Price, Carey Escheik, Katherine Thomas, Zeba Ejaz, Lynn Gerber, Zobair M Younossi. No differences in Physiological Response during Cardiopulmonary Exercise Testing in Patients with and without Non-alcoholic Fatty Liver Disease, American Association for the Study of Liver Diseases. |
| 325 | Zobair M Younossi, Masoom Priyadarshini, Mariam Afendy, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova. Burden of Illness Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States, American Association for the Study of Liver Diseases. Washington D.C. October 23, 2017. |
| 326 | Aybike Birerdinc, Edgar Rodriguez, Sasha Stoddard, James Minhui Paik, Zahra Younoszai, Rohini Mehta, James M. Estep, Zachary Goodman, Vikas Chandhoke, Zobair M Younossi. Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Depression Have Altered TGF-b Signaling in their Visceral Adipose Tissue (VAT), American Association for the Study of Liver Diseases. |
| 327 | Pegah Golabi, Omer Shahab, Maria Stepanova, Mehmet Sayiner, Stephen C. Clement, Zobair M Younossi. Long-Term Outcomes of Diabetic Patients with Non-alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. |
| 328 | Pegah Golabi, Natsu Fukui, Leyla de Avila, James Minhui Paik, Manirath Srishord, Zobair M Younossi. The Global Epidemiology of Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis, American Association for the Study of Liver Diseases. |
| 329 | Zobair M Younossi, Maria Stepanova, Pegah Golabi, Huong T. Pham, Rebecca Cable, James Cooper, Nila Rafiq, Haley Bush, Puneetinder Mann, Trevor Gogoll. Presumed Non-alcoholic Steatofibrosis Can Independently Predict Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. |
| 330 | Rohini Mehta, Hala Abdul-Al, James M. Estep, Maria Stepanova, Sean C. Felix, Zahra Younoszai, Thomas Jeffers, Zachary Goodman, Zobair M Younossi. Polymorphisms in TFAM (rs1937) and NOS2 (rs2297518) Which Are Markers of Mitochondrial Dysfunction Are Associated with Significant Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. |
| 331 | Zobair M Younossi, Maria Stepanova, Stephen A. Harrison, Arun J. Sanyal, Vlad Ratziu, Bryan McColgan, Robert P. Myers, Mani Subramanian, John McHutchison, Nezam H. Afdhal, Manal F. Abdelmalek, Jaime Bosch, Zachary Goodman. Subjects with Non-alcoholic Fatty Liver Disease and Severe Fibrosis Face a Significant Number of Adverse Events: Cryptogenic Cirrhosis and Severe Steatofibrosis, American Association for the Study of Liver Diseases. |
| 332 | Zobair M Younossi, Arian Afendy, Maria Stepanova, Andrei Racila, Fatema Nader, Rachel Gomel, Ricky Safer, Robert P. Myers, Mani Subramanian, John McHutchison, Cynthia Levy, Christopher L. Bowlus, Kris V. Kowdley, Andrew J. Muir. Development and Validation of a Primary Sclerosing Cholangitis Patient-Reported Outcome (PSC-PRO) Instrument, American Association for the Study of Liver Diseases. Washington D.C. October 22, 2017. |
| 333 | Zobair M Younossi, Atsushi Tanaka, Yuichiro Eguchi, Linda Henry, Rachel Beckerman, Masashi Mizokami. Treatment of Hepatitis C Virus Leads to Economic Gain Related to Reduction in Cases of Hepatocellular Carcinoma (HCC) in Japan, American Association for the Study of Liver Diseases. |
| 334 | Zobair M Younossi, Maria Stepanova, Cameron T. Locklear, Ira M. Jacobson, Alita Mishra, Gregory Trimble, Madeline Erario, Chapy Venkatesan, Issah Younossi, Aimal Arsalla, Wisna'odom Keo, Zachary Goodman. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Non-alcoholic Steatohepatitis (NASH) Cirrhosis: Twenty-Two Years Data from the Scientific Registry of Transplant Recipients (SRTR), American Association for the Study of Liver Diseases. |
| 335 | Zobair M Younossi, Maria Stepanova, Edward J. Gane, Ira M. Jacobson, David R. Nelson, Ashley S. Brown, Issah Younossi, Linda Henry. Significant and Sustained Improvement of Health-Related Quality of Life (HRQL) Scores in Patients with Hepatitis C (HCV) and Sustained Virologic Response (SVR), American Association for the Study of Liver Diseases. |
| 336 | Zobair M Younossi, Maria Stepanova, Elliot B. Tapper, Linda Henry, Aasim M. Sheikh, Mindie H. Nguyen, Nancy Reau, Eric Lawitz. Long-Term Follow-Up of Patient-Reported Outcomes (PROs) in Chronic Hepatitis C (HCV) Patients with Compensated and Decompensated Cirrhosis with Sustained Virologic Response (SVR), American Association for the Study of Liver Diseases. |
| 337 | Zobair M Younossi, Bruce R. Bacon, Michael P. Curry, Douglas T. Dieterich, Steven L. Flamm, Kris V. Kowdley, Scott Milligan, Naoky Tsai, Nezam H. Afdhal. Cure denied and cure delayed in Chronic Hepatitis C; monitoring non-start rates and increased time to start using real-world data from the TRIO Network., American Association for the Study of Liver Diseases. |
| 338 | Zobair M Younossi, Maria Stepanova, Tarik Asselah, Graham R. Foster, Keyur Patel, Norbert Brau, Mark G. Swain, Tram T. Tran, Rafael Esteban, Massimo Colombo, Stephen Pianko, Linda Henry, Marc Bourliere. Hepatitis C (HCV) in Patients Without Fibrosis or with Minimal Fibrosis: The Impact of Treatment and Sustained Virologic Response (SVR) on Patient-Reported Outcomes (PROs), American Association for the Study of Liver Diseases. |
| 339 | James M. Estep, Pegah Golabi, Brian P. Lam, Rohini Mehta, Sean C. Felix, Aybike Birerdinc, Lynn Gerber, Zobair M Younossi. Circulating Kynurenic Acid Correlates with Improvement in the Fatigue Component of the FACIT Questionnaire in Chronic CH-C Patients Undergoing Treatment., American Association for the Study of Liver Diseases. |
| 340 | Leyla de Avila, Ali Weinstein, Michael P. Curry, Pegah Golabi, James M. Estep, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Changes in Serum Neurotransmitters (NTs) and Patient-Reported Outcomes (PROs) and Neurocognitive Performance (NCP) After Viral Eradication of Hepatitis C Virus (HCV)-Genotype 1 (GT1), American Association for the Study of Liver Diseases. |
| 341 | Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh Nguyen Van, Ching-Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei MD Lai. Health-Related Quality of Life (HRQL) in East Asian Patients with Hepatitis C Virus (HCV) Infection: The Impact of Treatment and Sustained Virologic Response (SVR), American Association for the Study of Liver Diseases. |
| 342 | Zobair M Younossi, Robert S. Epstein, Marcie Strauss, Shailja Dixit. Unmet Need of Patients with Primary Biliary Cholangitis (PBC) Based on Alkaline Phosphatase (ALP) Threshold Using Large Database with Electronic Medical Records (EMRs) and Claims Data: A Cross-sectional Analysis, American Association for the Study of Liver Diseases. |
| 343 | Zobair M Younossi, Maria Stepanova, Leyla de Avila, Aijaz Ahmed, Robert John Wong, Sammy Saab, Kris V. Kowdley, Kimberly Brown, Marcelo Kugelmas, Andrei Racila. Liver Transplant (LT) Candidates with Primary Biliary Cholangitis (PBC) Experience Higher Wait List Mortality: Data from the Scientific Registry of Transplant Recipients (SRTR), American Association for the Study of Liver Diseases. Washington D.C. October 20, 2017. |
| 344 | James M. Estep, Rohini Mehta, Sean C. Felix, Aybike Birerdinc, Elzafir Elsheikh Abdelrahman, Zachary Goodman, Zobair M Younossi. Single Nucleotide Polymorphism (SNPs) Related to Stellate Cell Activation: Is there an Association with Lower Risk of Pericellular Fibrosis in Diabetics with Non-alcoholic Fatty Liver Disease (NAFLD)?, American Association for the Study of Liver Diseases. |
| 345 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Maria Stepanova, Jeiran Kianoush, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Alex Hodge, Dinan Abdelatif, Fanny Monge, Lakshmi Alaparthi, Aybike Birerdinc, Zachary Goodman, Vikas Chandhoke, Emanuel F. Petricoin. Apoptosis Signal-regulating Kinase1-MAPKinase p38 (ASK1-p38) Pathway Associated with IL-10 is Independently Correlated to Higher Percent (%) Collagen in Patients with Non-alcoholic Steatohepatitis (NASH), American Association for the Study of Liver Diseases. |
| 346 | Leyla de Avila, Ali Weinstein, Michael P. Curry, Pegah Golabi, Carey Escheik, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Relationship between Neurocognitive Performance (NCP) and Patient-Reported Outcomes (PROs) in Patients with Genotype 1 (GT1) Hepatitis C Virus (HCV) With or Without Viremia, American Association for the Study of Liver Diseases. |
| 347 | Patrice Cacoub, Marc Bourliere, Tarik Asselah, Victor de Ledinghen, Philippe Mathurin, Christophe Hezode, Linda Henry, Maria Stepanova, Zobair M Younossi. French Hepatitis C (HCV) Patients Treated with Anti-viral Combinations Containing Pegylated Interferon (IFN), Ribavirin (RBV), Sofosbuvir (SOF), Ledipasvir (LDV), Velpatasvir (VEL) and/or Voxilaprevir (VOX): The Impact of Treatment on Patient-Reported Outcomes (PROs), American Association for the Study of Liver Diseases. |
| 348 | Maria Stepanova, Alexander Thompson, Joseph S. Doyle, Leyla de Avila, Issah Younossi, Linda Henry, Zobair M Younossi. Hepatitis C Virus (HCV)-Infected Patients Receiving Opioid Substitution Therapy (OST) Experience Significant Increases in Patient-Reported Outcomes (PROs) Following Treatment with Anti-Viral Regimens, American Association for the Study of Liver Diseases. |
| 349 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Andrei Racila. Primary Biliary Cholangitis (PBC) is Associated with Significant Mortality and Health Care Utilization (HCU) in Medicare Population, American College Gastroenterology. Orlando, Florida October 16, 2017 |
| 350 | Elzafir Elsheikh Abdelrahman, Henry A. Tran, Azza Karrar, James M. Estep, Sean C. Felix, Thomas Jeffers, Zahra Younoszai, Andrei Racila, Yun Fang, Munkhzul Otgonsuren, Brian P. Lam, Hala Abdul-Al, Zachary Goodman, Lynn Gerber, Zobair M Younossi. The Serum Biomarkers of Cardiovascular Disease Are Elevated in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) with Advanced Fibrosis and Histologically-proven Non-alcoholic Steatohepatitis (NASH), American College Gastroenterology. Orlando, Florida October 16, 2017 |
| 351 | Zobair M Younossi, Azza Karrar, Kira Tokarz, Anatoly Ulyanov, Maria Stepanova, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Daisong Tan, Ahmad Moin, Ramaswamy Iyer, John Deeken, Zachary Goodman. Signature of Circulating microRNA (miR) Detected by NextSeq Differentiates Non-alcoholic Fatty Liver Disease (NAFLD) Patients with Higher Percentage Hepatic Collagen: A Potential Role for A Prognostic Biomarker, American College Gastroenterology. Orlando, Florida October 10, 2017 |
| 352 | James M. Estep, Pegah Golabi, Rohini Mehta, Brian P. Lam, Aybike Birerdinc, Sean C. Felix, Zahra Younoszai, Thomas Jeffers, Rebecca Cable, Huong T. Pham, Mariam Afendy, James Cooper, Lynn Gerber, Zobair M Younossi. Decreased Circulating Kynurenine is Associated with Post-Treatment Resolution of Fatigue as Measured by the FACIT-F in Ch-C patients, Digestive Disease Week. Chicago, IL, May 9, 2017 |
| 353 | Natsu Fukui, Pegah Golabi, Cameron T. Locklear, Alita Mishra, Munkhzul Otgonsuren, Puneetinder Mann, Chapy Venkatesan, Zobair M Younossi. Demographics, Resource Utilization and Outcomes of Patients with Chronic Liver Disease Receiving Hospice Care in the United States, Digestive Disease Week. McCormick Place, Chicago, IL, May 9, 2017 |
| 354 | Haley Bush, Pegah Golabi, Munkhzul Otgonsuren, Brian P. Lam, Manirath Srishord, Nila Rafiq, Zobair M Younossi. Non-alcoholic Fatty Liver Is Increasingly Contributing the Number of Cases of Liver Disease (LD) Seen in the Emergency Departments (ED) in the United States (U.S.), Digestive Disease Week. McCormick Place, Chicago, IL, May 9, 2017 |
| 355 | Zobair M Younossi, Aybike Birerdinc, Azza Karrar, Mariaelena Pierobon, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Maria Stepanova, Jeiran Kianoush, Alex Hodge, Fanny Monge, Lakshmi Alaparthi, James M. Estep, Dinan Abdelatif, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. Pathway Analysis of Serum Analytes and Phosphorylated Proteins and their Involvement in Regulatory Pathways in Patients with Non-alcoholic Steatohepatitis (NASH), Digestive Disease Week. McCormick Place, Chicago, IL, May 9, 2017 |
| 356 | Cameron T. Locklear, Pegah Golabi, Natsu Fukui, Leyla de Avila, Munkhzul Otgonsuren, Mariam Afendy, Rebecca Cable, Zobair M Younossi. Psoriasis is Independently Associated with Non-alcoholic Fatty Liver Disease, Digestive Disease Week. McCormick Place, Chicago, IL, May 9, 2017 |
| 357 | Lynn Gerber, Azza Karrar, Maria Stepanova, Carey Escheik, Patrick Austin, Sarah Bondurant, Shaun Meyer, Indie Srishord, Xiaochen Zhu, Ramona Raya, Zobair M Younossi. Associations of Obesity-related Non-alcoholic Fatty Liver Disease (NAFLD) and Autoimmune Diseases: A Secondary Data Analysis of the National Health and Nutrition Examination Survey (NHANES) 1999-2014, Digestive Disease Week. McCormick Place in Chicago, IL, May 8, 2017 |
| 358 | Pegah Golabi, Munkhzul Otgonsuren, Daisong Tan, Leyla de Avila, Cameron T. Locklear, Natsu Fukui, Aimal Arsalla, Trevor Gogoll, Zobair M Younossi. Are there Different Predictors of Mortality in Lean and Obese/Overweight Patients with Non-alcoholic Fatty Liver Disease (NAFLD)?, Digestive Disease Week. McCormick Place in Chicago, IL, May 8, 2017 |
| 359 | A Shaw, Rohini Mehta, Munkhzul Otgonsuren, Aybike Birerdinc, Vikas Chandhoke, Zobair M Younossi. Haplotype analysis of the RAGE gene: identification of a haplotype marker for non-alcoholic steatohepatitis (NASH)., Digestive Disease Week. McCormick Place, Chicago, IL, May 8, 2017 |
| 360 | Elzafir Elsheikh Abdelrahman, James M. Estep, Sean C. Felix, Hussain Allawi, Thomas Jeffers, Zahra Younoszai, Pegah Golabi, Kourosh Kalachi, Bashir Noor, Daisong Tan, Munkhzul Otgonsuren, Andrei Racila, Brian P. Lam, Jason Poff, Lynn Gerber, Zobair M Younossi. Inducible Nitric Oxide Synthase is Independently Associated with the Increased Hepatic |
| 361 | Aybike Birerdinc, Azza Karrar, Elzafir Elsheikh Abdelrahman, Rohini Mehta, James M. Estep, Mariaelena Pierobon, Maria Stepanova, Leo Druker, Jeiran Kianoush, Alex Hodge, Fanny Monge, Lakshmi Alaparthi, Dinan Abdelatif, Zachary Goodman, Emanuel F. Petricoin, Zobair M Younossi. The Molecular Crosstalk Between Hepatic Tissue and Visceral Adipose Tissue in Patients with Obesity-related Non-Alcoholic Fatty Liver Disease (NAFLD): The Interactions Between Inflammation and Immune Activation, Digestive Disease Week. McCormick Place, Chicago, IL, May 8, 2017 |
| 362 | Zobair M Younossi, Maria Stepanova, Ira M. Jacobson, Stefan Zeuzem, Marc Bourliere, Graham R. Foster, Stuart Roberts, Tarik Asselah, Alexander Thompson, Edward J. Gane, Bernard Willems, Eric Lawitz, Stuart C. Gordon, Michael Manns, K. Rajender Reddy, Curtis L. Cooper, Steven L. Flamm, Kris V. Kowdley, Sharon Hunt. Sofosbuvir/Velpatasvir (SOF/VEL) with or without Voxilaprevir (VOX) is Associated with Excellent Efficacy and Significant Improvements of Patient-Reported Outcomes (PROs) During Treatment and after Achieving Sustained Virologic Response (SVR), Digestive Disease Week. McCormick Place, Chicago, IL, May 8, 2017 |
| 363 | Leyla de Avila, Maria Stepanova, Elena Younossi, Andrei Racila, Pegah Golabi, Trevor Gogoll, Zobair M Younossi. Outcomes of wait-listed liver transplant (LT) candidates with hepatocellular carcinoma (HCC) in the United States from 2001 to 2014, Digestive Disease Week. McCormick Place, Chicago, IL, May 8, 2017 |
| 364 | Maria Stepanova, Leyla de Avila, Amanda Morgan, Mehmet Sayiner, Madeline Erario, Zobair M Younossi. Outcomes of Wait-listed Liver Transplant (LT) Candidates with Chronic Liver Disease (CLD) in the United States: The Impact of Model of End Stage Liver Disease (MELD) Scores and Disease Etiology, Digestive Disease Week. McCormick Place, Chicago, IL, May 7, 2017 |
| 365 | Zobair M Younossi, Bruce R. Bacon, Michael P. Curry, Douglas T. Dieterich, Steven L. Flamm, Kris V. Kowdley, Scott Milligan, Naoky Tsai, Nezam H. Afdhal. ACCESS TO HCV CARE IN THE UNITED STATES: REAL-WORLD EXPERIENCE FROM THE TRIO NETWORK, Digestive Disease Week. |
| 366 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Maria Stepanova, Jeiran Kianoush, Alex Hodge, Dinan Abdelatif, Fanny Monge, Lakshmi Alaparthi, Aybike Birerdinc, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. Association of Serum and Liver Proteomic Profiling of Patients with Non-alcoholic Fatty Liver Disease (NAFLD) Reveals Common Pathways Linking Non-alcoholic Steatohepatitis (NASH) and Metabolic Abnormalities, Digestive Disease Week. McCormick Place in Chicago, IL, May 6, 2017 |
| 367 | Azza Karrar, Sara Kim, Matin Mohammad, Sreya Addanki, Dinan Abdelatif, Daisong Tan, Maha Hassan, Tasneem Shaikh, Sean C. Felix, Zahra Younoszai, Thomas Jeffers, Munkhzul Otgonsuren, Zachary Goodman, Zobair M Younossi. Lower Levels of Hepatokines Angiopoietin-Like 4 and RBP-4 are Independently Associated with Non-Alcoholic Steatohepatitis (NASH), Digestive Disease Week. McCormick Place in Chicago, IL, May 6, 2017 |
| 368 | Zobair M Younossi, Maria Stepanova, Harry Janssen, Naoky Tsai, Kosh Agarwal, Mindie H. Nguyen, Magdy Elkhashab, Issah Younossi, Sharon Hunt. HEPATITIS B (HBV) VIRAL SUPPRESSION IS INDEPENDENTLY ASSOCIATED WITH BETTER PATIENT-REPORTED OUTCOMES (PROS), Digestive Disease Week. McCormick Place, Chicago, IL, May 6, 2017 |
| 369 | Zobair M Younossi, Maria Stepanova, Andrew J. Muir, Maria Buti, K. Rajender Reddy, Steven L. Flamm, Issah Younossi, Sharon Hunt. The long-term impact of sustained virologic response (SVR) on patient-reported outcomes in cirrhotics with Hepatitis C infection, European Association for the Study of the Liver. |
| 370 | Zobair M Younossi, Maria Stepanova, Harry Janssen, Kosh Agarwal, Edward J. Gane, Naoky Tsai, Issah Younossi, Sharon Hunt. Virally suppressed patients with chronic HBV infection without cirrhosis have better patient-reported outcomes (PROS), European Association for the Study of the Liver. |
| 371 | Zobair M Younossi, Maria Stepanova, Zachary Goodman, Eric Lawitz, Michael R. Charlton, Rohit Loomba, Sharon Hunt. Improvement of hepatic fibrosis in patients with non-alcoholic steatohepatitis treated with selonsertib is associated with improvement of patient-reported outcomes (PROS), European Association for the Study of the Liver. Amsterdam, Netherlands, April 21, 2017 |
| 372 | Zobair M Younossi, Maria Stepanova, Ira M. Jacobson, Stefan Zeuzem, Marc Bourliere, Graham R. Foster, Stuart Roberts, Tarik Asselah, Alexander Thompson, Edward J. Gane, Bernard Willems, Eric Lawitz, Stuart C. Gordon, Michael Manns, K. Rajender Reddy, Curtis L. Cooper, Steven L. Flamm, Kris V. Kowdley, Sharon Hunt. High Efficacy is Accompanied with Substantial Gains in Patient Reported Outcomes in Cirrhotic Patients with Chronic Hepatitis C Treated with Sofosbuvir (SOF), Velpatasvir with or without Voxilaprevir (VOX): Data from POLARIS 1, 2, 3 and 4, European Association for the Study of the Liver. |
| 373 | Zobair M Younossi, Maria Stepanova, Nila Rafiq, Pegah Golabi, Leyla de Avila, Fanny Monge, Zachary Goodman. Non-alcoholic Steatofibrosis is Independently Associated with both Overall Mortality and Liver related Mortality in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), European Association for the Study of the Liver. |
| 374 | Zobair M Younossi, Maria Stepanova, Wirth Stefan , Kathleen B. Schwarz, Philip Rosenthal, Regino Gonzalez-Peralta, Karen Murray, Sharon Hunt. Health-Related Quality of Life in Children with Hepatitis C Viral Infection Treated with Sofosbuvir and Ribavirin, European Association for the Study of the Liver. |
| 375 | Pegah Golabi, Natsu Fukui, Munkhzul Otgonsuren, Leyla de Avila, Mehmet Sayiner, Zobair M Younossi. Can atherosclerotic cardiovascular risk score (ASCVD) predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)?, European Association for the Study of the Liver. |
| 376 | Zachary Goodman. Hepatic Fibrosis is Associated With Histological Activity in Non-alcoholic Steatohepatitis: an Analysis From a Large Database of Screening Biopsies in the CENTAUR Trial , European Association for the Study of the Liver. |
| 377 | Zobair M Younossi, Bruce R. Bacon, Michael P. Curry, Douglas T. Dieterich, Steven L. Flamm, Kris V. Kowdley, Scott Milligan, Chizoba Nwankwo, Naoky Tsai, Nezam H. Afdhal. Elbasvir/Grazoprevir effectiveness in patients with Chronic Hepatitis C and Chronic Kidney Disease: Real-world experience from the TRIO Network, European Association for the Study of the Liver. |
| 378 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Zahra Younoszai, Sean C. Felix, Thomas Jeffers, Maria Stepanova, Jeiran Kianoush, Alex Hodge, Fanny Monge, Lakshmi Alaparthi, Dinan Abdelatif, Aybike Birerdinc, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. Nano LC- Mass Spectrometry Based Proteomic Profiling Associated with Significant Fibrosis and Collagen Deposition in Non-alcoholic Fatty Liver Disease (NAFLD), European Association for the Study of the Liver. |
| 379 | Zobair M Younossi, Maria Stepanova, Nila Rafiq, Pegah Golabi, Leyla de Avila, Fanny Monge, Zachary Goodman. Non-alcoholic steatofibrosis is independently associated with both overall mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD), European Association for the Study of the Liver. |
| 380 | Zobair M Younossi, Maria Stepanova, Leyla de Avila, Aijaz Ahmed, Robert John Wong, Sammy Saab, Kris V. Kowdley, Kimberly Brown, Marcelo Kugelmas, Andrei Racila. Inpatient Mortality, Payer Status and Length of Inpatient Stay (LoS) for United States (US) Liver Transplant (LT) Recipients with Primary Biliary Cholangitis (PBC): Data from the Scientific Registry of Transplant Recipients (SRTR), Academy of Managed Care Pharmacy. Denver, CO. March 27, 2017. |
| 381 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Henry Lik-Yuen Chan, Mei Hsuan Lee, Ming-Lung Yu, Yock Young Dan, Moon Seok Choi, Young-Suk Lim, Issah Younossi, Sharon Hunt. The Impact of all Oral Regimen Ledipasvir/Sofosbuvir (LDV/SOF) On Patient-reported Outcomes (PROs) of Asian Patients with Chronic Hepatitis C (CHC), Asian Pacific Association for the Study of Liver. Shanghai, February 18, 2017 |
| 382 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Jillian Kallman, Leyla de Avila, Andrei Racila. PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B WITH OR WITHOUT VIREMIA, Asian Pacific Association for the Study of Liver. Shanghai, China. February 16, 2017. |
| 383 | Zobair M Younossi, Maria Stepanova, Linda Henry, Issah Younossi, Atsushi Tanaka, Yuichiro, Eguchi, Norifumi Kawada, Andrei Racila, Sharon Hunt. The prevalence and costs associated with clinically overt extrahepatic manifestations of hepatitis C virus infection in Japan, Asian Pacific Association for the Study of Liver. Shanghai, China. February 16, 2017. |
| 384 | Zobair M Younossi, Munkhzul Otgonsuren, Wisna'odom Keo, Trevor Gogoll, Aimal Arsalla, Nina Badoe, Joel Ford, Puneetinder Mann, James Cooper, Andrei Racila. Is the Risk of Mortality increased in Lean Patients in Non-alcoholic Fatty Liver Disease (NAFLD)?, American Association for the Study of Liver Diseases. Boston, November 14, 2016 |
| 385 | Sophie K. Afdhal, Ali Weinstein, Christina Spataro, Carey Escheik, Patrick Austin, Lynn Gerber, Zobair M Younossi. Fatigue & Hepatitis C: A Focus Group Study, American Association for the Study of Liver Diseases. Boston, November 14, 2016 |
| 386 | Zobair M Younossi, Issah Younossi, Huong T. Pham, Maria Stepanova, Brian P. Lam, Sharon Hunt. Development and Validation of a Disease-Specific Health-Related Quality (HRQL) Instrument for Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH): The CLDQ-NAFLD, American Association for the Study of Liver Diseases. Boston, November 14, 2016 |
| 387 | Zobair M Younossi, Deidre Blissett, Rob Blissett, Maria Stepanova, Linda Henry, Youssef Younossi, Rachel Beckerman, Sharon Hunt. The Economic and Clinical Burden of Non-alcoholic Fatty Liver Disease (NAFLD) in the United States and Europe: A Steady-State Prevalence Model (abstract), American Association for the Study of Liver Diseases. Boston, November 14, 2016 |
| 388 | Maria Stepanova, Leyla de Avila, Mariam Afendy, Issah Younossi, Huong T. Pham, Rebecca Cable, Lynn Gerber, Zobair M Younossi. Extensive Economic and Quality of Life Burden of Viral Hepatitis (VH): The Data from the U.S. Medical Expenditure Panel Survey (MEPS), American Association for the Study of Liver Diseases. Boston, November 11, 2016 |
| 389 | Peter Masschelin, Kathleen Gwilliam, Rohini Mehta, Zobair M Younossi. In Hepatocytes, DNA Methylation and Hydroxymethylation Are Altered in Response to Oleic Acid Exposure: A Potential Mechanism for Non-alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. Boston, November 11, 2016 |
| 390 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Mark S. Sulkowski, Graham R. Foster, Alessandra Mangia, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Fatema Nader, Linda Henry, Sharon Hunt. Sofosbuvir/Velpatasvir (SOF/VEL)-Based Regimens are Associated with Excellent Efficacy and a Significant Improvement of Patients-Reported Outcomes (PROs) across Patient Populations: From Non-Cirrhotics to Compensated Cirrhotics to Decompensated Cirrhotics, American Association for the Study of Liver Diseases. Boston, November 13, 2016 |
| 391 | James M. Estep, Rohini Mehta, Gary Bratthauer, Lakshmi Alaparthi, Fanny Monge, Irfan Ali, Dinan Abdelatif, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Zachary Goodman, Zobair M Younossi. Hepatic Sonic Hedgehog (SHH) Expression Measured by Computer Assisted Morphometry Correlates Histologic Features of Non-Alcoholic Steatohepatitis (NASH) and Circulating Markers of Apoptosis and Cell Injury, American Association for the Study of Liver Diseases. |
| 392 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, David Wyles, Shyam Kottilil, Sharon Hunt. The Sofosbuvir (SOF) and Velpatasvir (VEL) Regimen is Associated with High Efficacy and Improvement of Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV): The Data from ASTRAL-5, American Association for the Study of Liver Diseases. Boston, November 13, 2016 |
| 393 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Maria Stepanova, Jeiran Kianoush, Alex Hodge, Fanny Monge, Lakshmi Alaparthi, Dinan Abdelatif, Aybike Birerdinc, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. Protein Pathway Activation Mapping of Non-alcoholic Steatohepatitis (NASH): The Role Phosphorylation of Proteins Involved in Apoptosis and Collagen Deposition, American Association for the Study of Liver Diseases. Boston, November 12, 2016 |
| 394 | Pegah Golabi, Munkhzul Otgonsuren, Aimal Arsalla, Madeline Erario, Manirath Srishord, Zobair M Younossi. Long Term Mortality of Patients with Non-alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. Boston, November 12, 2016 |
| 395 | Zobair M Younossi, Maria Stepanova, Kwang-Hyub Han, Wan-Long Chuang, Henry Lik-Yuen Chan, Young-Suk Lim, Rong-Nan Chien, Sang Hoon Ahn, Sook-Hyang Jeong, Ting-Tsung Chang, Seung-Woon Paik, Cheng-Yuan Peng, Chi-Jen Chu, Youn-Jae Lee, Ching-Lung Lai, Jia-Horng Kao, Sharon Hunt. Comparison of Health-Related Quality of Life (HRQL) in Asian Patients with Chronic Hepatitis C Treated with Interferon (IFN)-free Ribavirin (RBV)-Containing Regimens vs Interferon-free and Ribavirin-free Regimens, American Association for the Study of Liver Diseases. Boston, November 12, 2016 |
| 396 | Elzafir Elsheikh Abdelrahman, Azza Karrar, Sean C. Felix, Hussain Allawi, Mehmet Sayiner, Thomas Jeffers, Zahra Younoszai, Munkhzul Otgonsuren, Andrei Racila, Brian P. Lam, Jason Poff, Bryan Raybuck, Lynn Gerber, Zobair M Younossi. Serum Nitrotyrosine is Independently Associated with the Presence of Coronary Artery Disease in Patients with Nonalcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. Boston, November 12, 2016 |
| 397 | Zobair M Younossi, Deidre Blissett, Rob Blissett, Linda Henry, Youssef Younossi, Rachel Beckerman, Sharon Hunt. In The Era of Highly Effective Direct Acting Anti-Viral Agents, Screening The Entire United States Population for Hepatitis C is Cost Effective, American Association for the Study of Liver Diseases. Boston, November 12, 2016 |
| 398 | Aijaz Ahmed, Sammy Saab, Stuart C. Gordon, Douglas T. Dieterich, Robert John Wong, Kimberly Brown, Marcelo Kugelmas, Zobair M Younossi. A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir/Velpatasvir for Patients with Chronic Hepatitis C Virus Genotypes 1 to 6 and Decompensated Cirrhosis in the US, American Association for the Study of Liver Diseases. Boston, November 12, 2016 |
| 399 | Zobair M Younossi, Stuart C. Gordon, Douglas T. Dieterich, Robert John Wong, Kimberly Brown, Marcelo Kugelmas, Sammy Saab, Aijaz Ahmed. A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir/Velpatasvir for Patients with Chronic Hepatitis C Virus Genotype 1 Infection in the US, American Association for the Study of Liver Diseases. Boston, November 12, 2016 |
| 400 | Zobair M Younossi, Munkhzul Otgonsuren, Leyla de Avila, Cameron T. Locklear, Amanda Morgan, Issah Younossi, Chapy Venkatesan, Alita Mishra, Andrei Racila, Linda Henry. Health Care Utilization and Mortality Associated with Primary Biliary Cholangitis (PBC), American Association for the Study of Liver Diseases. Boston, November 11, 2016 |
| 401 | Zobair M Younossi, Maria Stepanova, William Balistreri, Kathleen B. Schwarz, Karen Murray, Philip Rosenthal, Sanjay Bansal, Sharon Hunt. High Efficacy and Significant Improvement of Quality of Life (QoL) in Adolescent Patients with Hepatitis C Genotype 1 (GT1) Treated with Sofosbuvir (SOF) and Ledipasvir (LDV), American Association for the Study of Liver Diseases. Boston, November 11, 2016 |
| 402 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Sharon Hunt, Christophe Bureau, Neil Inhaber, Rajiv Jalan. Patients with Refractory Ascites Treated with alfapump® System (AP) have Better Health-related Quality of Life (HRQL) as Compared to those Treated with Large Volume Paracentesis (LVP): Results of a Multicenter Randomized Controlled Study, American Association for the Study of Liver Diseases. Boston, November 11, 2016 |
| 403 | Rohini Mehta, Zahra Younoszai, Thomas Jeffers, Munkhzul Otgonsuren, Zachary Goodman, Zobair M Younossi. Association of Circulating Receptors for Advanced Glycation Endproducts (RAGE) and RAGE Gene Polymorphism G82S (rs207600) polymorphism in Non-alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. Boston, November 11, 2016 |
| 404 | Azza Karrar, Dinan Abdelatif, Tibyan Mohamed, Mohamad Houry, Fanny Monge, Lakshmi Alaparthi, Munkhzul Otgonsuren, Zahra Younoszai, Sharon Hunt, Zachary Goodman, Zobair M Younossi. Intrahepatic B cells (IHB) as an Independent Predictor of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease (NAFLD) as Quantified by Computer-Assisted Morphometry (CAM), American Association for the Study of Liver Diseases. Boston, November 11, 2016 |
| 405 | Azza Karrar, Sara Kim, Dinan Abdelatif, Tibyan Mohamed, Mohamad Houry, Fanny Monge, Lakshmi Alaparthi, Andrei Racila, Munkhzul Otgonsuren, Zachary Goodman, Zobair M Younossi. Liver Type Arginase (Arginase-1) is Independently Associated with Focal Necrosis in Patients with Non Alcoholic Steatohepatitis (NASH), American Association for the Study of Liver Diseases. Boston, November 11, 2016 |
| 406 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Mercedes Walters, Fatema Nader, Sharon Hunt. Improvement of Health-related Quality of Life(HRQL) Scores in Japanese Cirrhotic Patients with Chronic Hepatitis C(CH-C) who are Treated with Sofosbuvir(SOF)-Containing Regimens , Asian Pacific Digestive Week. Kobe, November 2, 2016 |
| 407 | Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, Fatema Nader, Andrei Racila, Sharon Hunt. The Extra Hepatic Manifestation of Hepatitis C Virus in the Asian Countries- A Systematic Review of the Epidemiologic Burden, Asian Pacific Digestive Week. Kobe, November 02, 2016 |
| 408 | Zobair M Younossi, Maria Stepanova, Kwang-Hyub Han, Young-Suk Lim, Youn-Jae Lee, Wan-Long Chuang, Jia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, Cheng-Yuan Peng. Asian Patients with Hepatitis C (HCV) Genotype 1 Treated with Ledipasvir and Sofosbuvir (LDV/SOF) Experience Very High Efficacy and Improvement of Health-related Quality of Life (HRQL), Asian Pacific Digestive Week. Kobe, November 02, 2016 |
| 409 | Zobair M Younossi, Maria Stepanova, Kwang-Hyub Han, Sook-Hyang Jeong, Seung-Woon Paik, Ting-Tsung Chang, Chi-Jen Chu, Henry Lik-Yuen Chan, Ching-Lung Lai, Sharon Hunt. A Mild and Reversible Health Related Quality of Life (HRQL) Impairments is observed in Asian Patients with Hepatitis C Virus (HCV) Infection Who Are Treated with Ribavirin-Containing Regimens, Asian Pacific Digestive Week. Kobe, November 02, 2016 |
| 410 | Sarah Elfeky, Pegah Golabi, Munkhzul Otgonsuren, Svetolik Djurkovic, Zobair M Younossi. Factors Associated with Discharge to Short Term Care, Long Term Care and Death among Patients with a Hospital Diagnosis of Sepsis, Chest. |
| 411 | Edgar Rodriguez, Katherine Doyle, Kameron Tavakolian, Rohini Mehta, Leo Druker, Aybike Birerdinc, Zachary Goodman, Zobair M Younossi. Protein Levels in The Visceral Adipose Tissue (VAT) of Morbidly Obese Subjects with Non-alcoholic Fatty Liver Disease (NALFD) Suggests Pro-inflammatory and Pro-fibrotic Signaling., American College Gastroenterology. Las Vegas, October 14, 2016 |
| 412 | Elzafir Elsheikh Abdelrahman, Munkhzul Otgonsuren, Elena Younossi, Bryan Raybuck, Zobair M Younossi. HIGH CONCENTRATIONS OF SIMVASTATIN ARE ASSOCIATED WITH LOW LEVELS OF ENDOCAN AND INCREASED CORONARY ARTERY ENDOTHELIAL CELL DEATH IN VITRO, International Academy of Cardiology. |
| 413 | Zobair M Younossi, Maria Stepanova, Sharon Hunt. Development of A Validated Disease-Specific Health-Related Quality (HRQL) Instrument for Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH): CLDQ-NAFLD (ADA), American Diabetes Association. New Orleans, La, June 10, 2016 |
| 414 | Jillian Kallman Price, Patrick Austin, Carey Escheik, Lynn Gerber, Zobair M Younossi. Resting VO2 Significantly Lower in Non-alcoholic Fatty Liver Disease Than General Population Estimate, American College of Sports Medicine. Boston, MA. May 31, 2016 |
| 415 | Mehmet Sayiner, Maria Stepanova, Huong T. Pham, Bashir Noor, Mercedes Walters, Zobair M Younossi. Health-Related Quality of Life and Health Utilities in Patients with Non-alcoholic Fatty Liver Disease, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 416 | Elzafir Elsheikh Abdelrahman, Sean C. Felix, Leo Mclaughlin, Hussain Allawi, Thomas Jeffers, Susan Chen, Zahra Younoszai, Munkhzul Otgonsuren, Brian P. Lam, Jason Poff, Bryan Raybuck, Zobair M Younossi. Low Levels of Circulating Angiopoietin-like 4 Protein are Associated with the Presence of Coronary Artery Disease in Patients with Nonalcoholic Fatty Liver Disease, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 417 | Aaron B. Koenig, Maria Stepanova, Sammy Saab, Aijaz Ahmed, Robert John Wong, Trevor Gogoll, Zobair M Younossi. Long-Term Outcomes of Lung Transplantation in Patients with Hepatitis C Infection: The Data from the U.S. Transplant Registry, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 418 | Azza Karrar, Alex Saffran, Mehmet Sayiner, Tasneem Shaikh, Thomas Jeffers, Sean C. Felix, Tibyan Mohamed, Munkhzul Otgonsuren, Sharon Hunt, Dinan Abdelatif, Zachary Goodman, Zobair M Younossi. The Mucosal Addressin Cell Adhesion Molecule-1 (sMADCAM-1) and MAp44 Activation Are Associated with Different Clinical and Pathologic Features of Non Alcoholic Steatohepatitis (NASH), Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 419 | Azza Karrar, Alex Saffran, Pegah Golabi, Tibyan Mohamed, An Nguyen, Leo Mclaughlin, Zahra Younoszai, Sharon Hunt, Munkhzul Otgonsuren, Dinan Abdelatif, Zachary Goodman, Zobair M Younossi. Liver-Type Fatty Acid Binding Protein (L- FABP) is Strongly Associated with Non-Alcoholic Steatohepatitis (NASH), Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 420 | Michael-Angelo Orciga, Zahra Younoszai, Kuan Yao, Maria Keaton, Ancha Baranova, Aybike Birerdinc, Zobair M Younossi. The Role of Insulin-like Growth Factor 1 (IGF1) in Polycystic Ovarian Syndrome in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 421 | Rohini Mehta, Aybike Birerdinc, Katherine Doyle, Maria Keaton, Indie Srishord, Leo Mclaughlin, Thomas Jeffers, Sean C. Felix, Zachary Goodman, Zobair M Younossi. Receptors for Advanced Glycation Endproducts and Markers of Systemic Inflammation In Non-Alcoholic Fatty Liver Disease (NAFLD), Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 422 | Zobair M Younossi, Linda Henry, Maria Stepanova, Youssef Younossi, Sharon Hunt, Rachel Beckerman. Non-alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes (DM): A Costly Combination, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 423 | Azza Karrar, Dinan Abdelatif, Irfan Ali, Tasneem Shaikh, Sofie Fazel, Tibyan Mohamed, Sami J. Morse, Fanny Monge, Munkhzul Otgonsuren, Zacharia Nayer, Lakshmi Alaparthi, Zachary Goodman, Zobair M Younossi. Collagen Deposition in White Adipose Tissue (WAT) Correlates with Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease (NAFLD) as Quantified by Computer-Assisted Morphometry (CAM), Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 424 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Mark S. Sulkowski, Graham R. Foster, Alessandra Mangia, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Fatema Nader, Sharon Hunt. Patient-Reported Outcomes in Chronic Hepatitis C Patients with Cirrhosis Treated with Ribavirin-Containing Regimens: Sofosbuvir/Velpatasvir and Ribavirin or Sofosbuvir and Ribavirin, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 425 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Graham R. Foster, Nancy Reau, Alessandra Mangia, Keyur Patel, Norbert Brau, Stuart Roberts, Nezam H. Afdhal, Fatema Nader, Sharon Hunt. Ribavirin-Free Regimen with Velpatasvir and Sofosbuvir is Associated with High Efficiency and Improvement of Patient-Reported Outcomes in Patients with Genotypes 2 and 3 Chronic Hepatitis C: Results From ASTRAL-2 and 3 Clinical Trials, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 426 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Fatema Nader, Sharon Hunt. FATIGUE IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH LEDIPASVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN , International Society of Pharmacoeconomics and Outcomes Research. Washington, DC, May 21, 2016 |
| 427 | Spencer Frost, James M. Estep, Kellie Perry, Sean C. Felix, Leo Mclaughlin, Brian P. Lam, Maria Stepanova, Pegah Golabi, Lynn Gerber, Zobair M Younossi. Interferon lambda 4 (IFN-?4) genotype is associated with fatigue in patients with chronic hepatitis C (CH-C) receiving direct-acting antiviral (DAA) treatment, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 428 | Zobair M Younossi, Stuart C. Gordon, Aijaz Ahmed, Douglas T. Dieterich, Sammy Saab, Rachel Beckerman. Reduction in Clinical and Economic Burden by Treating All Medicaid Patients with Chronic Hepatitis C (CHC): A Decision-Analytic Model (DDW), Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 429 | Mehmet Sayiner, Munkhzul Otgonsuren, Rebecca Cable, Issah Younossi, Mariam Afendy, Zobair M Younossi. Contributors of Inpatient and Outpatient Resource Utilization for Medicare Beneficiaries with Non-Alcoholic Fatty Liver Disease and the Relation with Cirrhosis Status in 2010, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 430 | Sofie Fazel, Pegah Golabi, Munkhzul Otgonsuren, Cameron T. Locklear, Nina Badoe, Chapy Venkatesan, Alita Mishra, Zobair M Younossi. Mortality Assessment of Patients with Hepatocellular Carcinoma According to Types of Underlying Liver Disease and Treatment Modalities, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 431 | Ali Weinstein, Carey Escheik, Phan Giang, Bibiana Oe, Zareen Arsalla, Aradhika Darshana Shrestha, Lynn Gerber, Zobair M Younossi. Disconnect between Anti-Depressant Medication Prescription and Depressive Symptomatology in Chronic Hepatitis C Patients During Treatment, Digestive Disease Week. San Diego, May 21, 2016 |
| 432 | Pegah Golabi, Cameron T. Locklear, Patrick Austin, Sophie K. Afdhal, Lynn Gerber, Zobair M Younossi. Evidence for Effectiveness of Exercise in Fat Mobilization from the Liver in People with Non-Alcoholic Fatty Liver: Systematic Review of Literature, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 433 | James M. Estep, Rohini Mehta, Spencer Frost, Mehmet Sayiner, Thomas Jeffers, Zahra Younoszai, Isabella Lao, Zachary Goodman, Zobair M Younossi. Minor Alleles for PNPLA3 and TM6SF2 Inadequate for Diagnosis of Non-Alcoholic Steatohepatitis in a Morbidly Obese Population, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 434 | Pegah Golabi, Mehmet Sayiner, James M. Estep, Spencer Frost, Brian P. Lam, Sean C. Felix, A. Rose Srishord, Lynn Gerber, Zobair M Younossi. Association of Fatigue with Serum Tumor Necrosis Factor-? (TNF-?) and Chemokine (C-C motif) Ligand 2 (CCL2) in Patients with Chronic Hepatitis C Virus (HCV) Infection, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 435 | Aybike Birerdinc, Max Marzouk, Anthony Loria, Lei Wang, Leyla de Avila, Ancha Baranova, Zobair M Younossi. A Meta-Analysis of the Global Prevalence of Hepatitis B in light of increasing HBV vaccination: Is there Any Change?, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 436 | Leo Mclaughlin, Sean C. Felix, Zahra Younoszai, Thomas Jeffers, Ossman Cossio, Ameeta Kumar, Hussain Allawi, Maria Stepanova, Jason Poff, Bryan Raybuck, Sharon Hunt, Zobair M Younossi. Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease in Patients Undergoing Coronary Angiography, Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 437 | Aybike Birerdinc, Lei Wang, Leyla de Avila, Pegah Golabi, Mehmet Sayiner, Manirath Srishord, Ian Shenk, Zobair M Younossi. Global Burden of Metabolic Conditions Associated with Non-alcoholic Fatty Liver Disease (NAFLD), Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 438 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Ira M. Jacobson, Kosh Agarwal, Christophe Hezode, Sharon Hunt. The Use of Sofosbuvir and Velpatasvir is Associated with High Efficacy and Improvement in Patient-Reported Outcomes in Patients with Genotype 1, 2, 4, 5 and 6 Chronic Hepatitis C: Results from the ASTRAL-1 Clinical Trials - (DDW), Digestive Disease Week. San Diego, May 21, 2016 |
| 439 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Fatema Nader, Sharon Hunt. HEALTH UTILITY ASSESSMENT IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS TREATED WITH INTERFERON-FREE REGIMENS , International Society of Pharmacoeconomics and Outcomes Research. Washington, DC, May 21, 2016 |
| 440 | Leyla de Avila, Maria Stepanova, Mariam Afendy, Issah Younossi, Huong T. Pham, Rebecca Cable, Amanda Morgan, Lynn Gerber, Zobair M Younossi. Chronic Liver Disease (CLD) is Associated with Significant Health Care Expenditure in the United States (U.S.), Digestive Disease Week. San Diego, CA, May 21, 2016 |
| 441 | Zobair M Younossi, Stuart C. Gordon, Aijaz Ahmed, Douglas T. Dieterich, Sammy Saab, Rachel Beckerman. Reduction in Clinical and Economic Burden by Treating All Medicaid Patients with Chronic Hepatitis C (CHC): A Decision-Analytic Model (AMCP), Academy of Managed Care Pharmacy. |
| 442 | Zobair M Younossi, Maria Stepanova, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Robert S. Brown, Sharon Hunt. EFFICACY AND PATIENT-REPORTED OUTCOMES IN DECOMPENSATED CIRRHOTIC WITH CHRONIC HEPATITIS C TREATED WITH SOFOSBUVIR AND VELPATASVIR WITH OR WITHOUT RIBAVIRIN: RESULTS FROM ASTRAL-4 CLINICAL TRIAL (abstract), European Association for the Study of the Liver. Barcelona, Spain, April 2016 |
| 443 | Maria Stepanova, Mehmet Sayiner, Leyla de Avila, Zahra Younoszai, Andrei Racila, Zobair M Younossi. LONG-TERM OUTCOMES IN LIVER TRANSPLANT RECIPIENTS TRANSPLANTED FROM HCV-POSITIVE DONORS, European Association for the Study of the Liver. Barcelona, Spain, April 2016 |
| 444 | Maria Stepanova, Leyla de Avila, Thomas Jeffers, Robert John Wong, Aijaz Ahmed, Zobair M Younossi. LONG-TERM OUTCOMES OF HEART TRANSPLANT RECIPIENTS WITH HEPATITIS C INFECTION, European Association for the Study of the Liver. Barcelona, Spain, April 2016 |
| 445 | Pegah Golabi, Elzafir Elsheikh Abdelrahman, Azza Karrar, James M. Estep, Issah Younossi, Maria Stepanova, Lynn Gerber, Zobair M Younossi. THE LEVELS OF MONOAMINE NEUROTRANSMITTERS IN HCV PATIENTS TREATED WITH LEDIPASVIR (LDV)/SOFOSBUVIR (SOF), European Association for the Study of the Liver. Barcelona, Spain, April 2016 |
| 446 | James M. Estep, Rohini Mehta, Gary Bratthauer, Zacharia Nayer, Lakshmi Alaparthi, Fanny Monge, Irfan Ali, Dinan Abdelatif, Zahra Younoszai, Zachary Goodman, Zobair M Younossi. COMPUTER ASSISTED MORPHOMETRIC ANALYSIS OF HEPATIC SONIC HEDGEHOG EXPRESSION (SHH) CORRELATES WITH CIRCULATING MARKERS OF CELL DEATH AND KEY HISTOLOGIC FEATURES OF NONALCOHOLIC STEATOHEPATITIS (NASH), European Association for the Study of the Liver. Barcelona, Spain, April 2016 |
| 447 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Maria Stepanova, Jeiran Kianoush, Kimberly Reeder, Thomas Jeffers, Zahra Younoszai, Zachary Goodman, Emanuel F. Petricoin. PHOSPHOPROTEOMIC ANALYSIS OF INTRACELLULAR SIGNALING IN THE HUMAN HEPATIC TISSUE OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND FIBROSIS, European Association for the Study of the Liver. Barcelona, Spain, April 2016 |
| 448 | Zobair M Younossi, Linda Henry, Maria Stepanova, Youssef Younossi, Andrei Racila, Sharon Hunt, Rachel Beckerman. THE ECONOMIC AND CLINICAL BURDEN OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES, European Association for the Study of the Liver. Barcelona, Spain, April 2016 |
| 449 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Mark S. Sulkowski, Graham R. Foster, Alessandra Mangia, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Sharon Hunt. IMPRESSIVE GAINS IN PATIENT-REPORTED OUTCOMES ARE OBSERVED IN CHRONIC HEPATITIS C PATIENTS WITH OR WITHOUT CIRRHOSIS WHO ARE TREATED WITH SOFOSBUVIR AND VELPATASVIR: RESULTS FROM ASTRAL-1, -2, -3 AND -4, European Association for the Study of the Liver. Barcelona, Spain, April 2016 |
| 450 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Sharon Hunt. Quality of Life of Japanese Patients with Chronic Hepatitis C Treated with Ledipasvir and Sofosbuvir (poster), Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016 |
| 451 | Zobair M Younossi, Haesuk Park, Douglas T. Dieterich, Sammy Saab, Aijaz Ahmed, Stuart C. Gordon. The Value of Cure for Chronic Hepatitis C (CH?C) to the Society, Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016 |
| 452 | Zobair M Younossi, Henry Lik-Yuen Chan, Yock Young Dan, Mei Hsuan Lee, Young-Suk Lim, Ming-Lung Yu, Marta Silva, Jorge Felix. High therapeutic efficiency of LDV/SOF in Asian patients with CHC Genotype 1 infection, Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016 |
| 453 | Zobair M Younossi, Maria Stepanova, Henry Lik-Yuen Chan, Mei Hsuan Lee, Ming-Lung Yu, Yock Young Dan, Moon Seok Choi, Linda Henry. Work Productivity Impairment in Asian Patients with Hepatitis C Treated with Different Regimens, Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016 |
| 454 | Zobair M Younossi, Maria Stepanova, Masashi Mizokami, Masao Omata, Sharon Hunt. Higher Quality of Life Gains in Japanese Hepatitis C Patients treated with Ledipasvir/Sofosbuvir , Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016 |
| 455 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. HCV Patients Treated with IFN?Free Regimens Experience Improvement of Patient-Reported Outcomes, Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016 |
| 456 | Zobair M Younossi, Henry Lik-Yuen Chan, Yock Young Dan, Mei Hsuan Lee, Young-Suk Lim, Eliza Kruger, Seng Tan. Impact of Ledipasvir/Sofosbuvir on the Work Productivity of Chronic Hepatitis C patients in Asia, Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016 |
| 457 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Predictors of Adherence to Treatment of Chronic Hepatitis C (CHC), Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016 |
| 458 | Zobair M Younossi, Maria Stepanova, Henry Lik-Yuen Chan, Mei Hsuan Lee, Ming-Lung Yu, Yock Young Dan, Moon Seok Choi, Linda Henry. Patient Reported Outcomes (PROs) in Asian Patients with Chronic Hepatitis C (CH-C) Treated with Ledipasvir (LDV) and Sofosbuvir (SOF), Asian Pacific Digestive Week. Medicine (Baltimore). 2016 Mar;95(9):e2702. doi: 10.1097/MD.0000000000002702 |
| 459 | Maria Stepanova, Kathryn Brodie, Aybike Birerdinc, Bashir Noor, Nina Badoe, Zobair M Younossi. In Female Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Presence of Type 2 Diabetes (DM) and Chronic Kidney Disease (CKD) are Independently Associated with the Risk of Mortality, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 460 | Munkhzul Otgonsuren, Rebecca Cable, Sean C. Felix, Patrick Austin, Yun Fang, Zobair M Younossi. Non-alcoholic Fatty Liver Disease (NAFLD) Is Associated with Impairment of Health Related Quality of Life (HRQoL): Data from US Population, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 461 | Aaron B. Koenig, Dinan Abdelatif, Yousef Fazel, Mark Wymer, Linda Henry, Zobair M Younossi. A Meta-analytic Assessment of Worldwide Prevalence of Non Alcoholic Fatty Liver Disease (NAFLD) and Associated Co-morbidities, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 462 | Azza Karrar, Mohamad Houry, Irfan Ali, Dinan Abdelatif, Pegah Golabi, Mehmet Sayiner, Zahra Younoszai, Lakshmi Alaparthi, James Cooper, Munkhzul Otgonsuren, Zachary Goodman, Zobair M Younossi. MHC Class I Related Gene A (MICA) Alleles are Independently Associated with Advanced Pathogenic Features of Non Alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 463 | Mehmet Sayiner, Mark Wymer, Pegah Golabi, Joel Ford, Indie Srishord, Zobair M Younossi. Hepatitis C (HCV) Infection in Baby Boomers Are Independently Associated with Mortality and Resource Utilization, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 464 | Zobair M Younossi, Non-Inova or Outside Inova . An Evidence-Based Algorithm to Optimize Patient Selection among Class III Obese Liver Transplant Waitlist Registrants, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 465 | Andy Liu, Ryan Perumpail, Jayasekera Channa R. , Swetha Tummala, Sammy Saab, Zobair M Younossi, Robert John Wong, Aijaz Ahmed. HCV Infection in Aging Baby Boomers is an Independent Predictor of Poor Outcome in Liver Transplant Recipients: An Analysis of the UNOS Database, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 466 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Superiority and Durability of Improvements in Work Productivity (WP) and Patient Reported Outcomes (PROs) with Interferon (IFN)-Free and Ribavirin (RBV)-Free Regimens for Chronic Hepatitis C (CH-C), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 467 | Zobair M Younossi, Haesuk Park, Douglas T. Dieterich, Sammy Saab, Aijaz Ahmed, Stuart C. Gordon. The Value of Cure Associated with Treating Treatment-naïve (TN) Chronic Hepatitis C (CH-C) Genotype 1 (GT1): Are the New All Oral Regimens a Good Value to Society?, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 468 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Susanna Naggie, Linda Henry, Sharon Hunt. Sofosbuvir (SOF) and Ledipasvir (LDV) Improves Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) , American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 469 | Zobair M Younossi, Haesuk Park, Douglas T. Dieterich, Sammy Saab, Aijaz Ahmed, Stuart C. Gordon. Quality-Adjusted Cost of Care for Treatment Naive (TN) Patients with Genotype 1 (GT1) Chronic Hepatitis C (CH-C): An Assessment of Innovation Cost of Drug Regimens versus the Value of Health Gains to the Society, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 470 | Zobair M Younossi, Maria Stepanova, Linda Henry, Issah Younossi, Ali Weinstein, Fatema Nader, Sharon Hunt. Reduced Work Productivity (WP), Absenteeism and Presenteeism of Patients Infected with Hepatitis C Virus (HCV) are Independently Predicted by Physical Component of Patient-Reported Outcomes (PROs), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 471 | Aaron B. Koenig, Rohini Mehta, Gary Bratthauer, Fanny Monge, Zachary Goodman, Zobair M Younossi. Nuclear localization of autophagy marker LC3 is associated with fibrosis in nonalcoholic fatty liver disease (NAFLD), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 472 | Elzafir Elsheikh Abdelrahman, Mehmet Sayiner, Zahra Younoszai, Fanny Monge, Lakshmi Alaparthi, Munkhzul Otgonsuren, Brian P. Lam, Hussain Allawi, Dinan Abdelatif, Zachary Goodman, Zobair M Younossi. Soluble Intercellular Adhesion Molecule-1 is Independently Associated with Increased Collagen Deposition in Patients with Nonalcoholic Steatohepatitis (NASH), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 473 | Rohini Mehta, James M. Estep, Gary Bratthauer, Fanny Monge, Thomas Jeffers, Zachary Goodman, Zobair M Younossi. Hepatic Estrogen Receptor Negatively Correlates with Fibrosis Only in Male Patients with Non-Alcoholic Steatohepatitis (NASH), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 474 | Pegah Golabi, Mehmet Sayiner, James M. Estep, Elzafir Elsheikh Abdelrahman, Brian P. Lam, Huong T. Pham, Maria Stepanova, Zobair M Younossi. Treatment of Hepatitis C Virus with Direct Acting Antivirals (DAA) and Ribavirin (RBV) is Associated with Changes in Serum Apolipoprotein and TNF-alpha Levels, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 475 | Zobair M Younossi, Maria Stepanova, James M. Estep, Azza Karrar, Bibiana Oe, Elzafir Elsheikh Abdelrahman, Siddharth Hariharan, Kazi Ahmed, Patricia Tran, Fatema Nader, Linda Henry, Ali Weinstein, Lynn Gerber. TNF-alpha is the Most Consistent Predictor of Impairment of Mental Health-Related Patient-Reported Outcomes (PROs) in Patients with Chronic Hepatitis C (CH-C) Treated with Ledipasvir (LDV) and Sofosbuvir (SOF) with or without Ribavirin (RBV), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 476 | Azza Karrar, Dinan Abdelatif, Irfan Ali, Yousef Fazel, Pegah Golabi, Mohamad Houry, Zahra Younoszai, Fanny Monge, Munkhzul Otgonsuren, Zachary Goodman, Lakshmi Alaparthi, Zobair M Younossi. Macrophages (CD68+ Cells) and CD8+ T Cytotoxic Cells are Independently Associated with Advanced Fibrosis in Patients with Non Alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 477 | Zobair M Younossi, Maria Stepanova, Sarah Elfeky, A. Rose Srishord, Carey Escheik, Leo Mclaughlin, Mariam Afendy, Robert John Wong, Aijaz Ahmed, Sharon Hunt. The Prevalence and Mortality of Chronic Liver Disease (CLD) in the Baby Boomer Cohort (BB) in the United States, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 478 | Zobair M Younossi, Munkhzul Otgonsuren, Cameron T. Locklear, Chapy Venkatesan, Alita Mishra, Madeline Erario, Manirath Srishord, Andrei Racila, Aimal Arsalla, Shirley Kalwaney. In Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Metabolic Conditions are Independently Associated with Mortality, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 479 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Interferon (IFN), Ribavirin (RBV), Duration of Treatment and Baseline Patient-Reported Outcomes (PROs) Predict Adherence to the New Regimens for Treatment of Chronic Hepatitis C (CH-C), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015 |
| 480 | Issah Younossi, Ali Weinstein, Maria Stepanova, Sharon Hunt, Zobair M Younossi. Mental and Emotional Impairment in Patients with Hepatitis C is related to Lower Work Productivity, American College Gastroenterology. Honolulu,HI, October 16, 2015 |
| 481 | Linda Henry, Haesuk Park, Ayoade Adeyemi, Maria Stepanova, Zobair M Younossi. Depression and Chronic Hepatitis C (CH-C): A Common and Costly Association, American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 482 | Zobair M Younossi, Louis L. LaLuna, John J. Santoro, Flavia Mendes, Victor Araya, Natarajan Ravendhran, Lisa Pedicone, Idania Lio, Fatema Nader, Sharon Hunt, Andrei Racila, Maria Stepanova. Implementation of Baby Boomer Hepatitis C (HCV) Screening and Linking to Care in Gastroenterology (GE) Practices: A Multi-Center Pilot Study, American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 483 | Azza Karrar, Irfan Ali, Dinan Abdelatif, Mehmet Sayiner, Mohamad Houry, Kaitlyn Chhe, Zahra Younoszai, Munkhzul Otgonsuren, Fanny Monge, Lakshmi Alaparthi, Zachary Goodman, Zobair M Younossi. CD4+T Helper Cells in The Liver are Independently Associated with Inflammation in Patients with Non Alcoholic Fatty Liver Disease (NAFLD), American College Gastroenterology. Honolulu, HI, Octobe 16, 2015 |
| 484 | Haesuk Park, Ayoade Adeyemi, Maria Stepanova, Linda Henry, Zobair M Younossi. Hepatitis C Virus (HCV) Related Arthritis and Arthralgia: The Epidemiologic and Economic Burden in the United States, American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 485 | Azza Karrar, Dinan Abdelatif, Irfan Ali, Mohamad Houry, Siddharth Hariharan, Khatera Salem, Sara Kim, Sreya Addanki, Zahra Younoszai, Munkhzul Otgonsuren, Zachary Goodman, Zobair M Younossi. Serum Amyloid A (SAA) Is Strongly Associated with Hyperlipidemia in Patients with Non Alcoholic Fatty Liver Disease (NAFLD) , American College Gastroenterology. Honolulu, HI, 2015 |
| 486 | Elzafir Elsheikh Abdelrahman, Mehmet Sayiner, Zahra Younoszai, Fanny Monge, Lakshmi Alaparthi, Munkhzul Otgonsuren, Brian P. Lam, Sharon Hunt, Zachary Goodman, Zobair M Younossi. Von Willebrand Factor is Associated with Increased Collagen Deposition in Patients with Nonalcoholic Steatohepatitis (NASH) , American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 487 | Aaron B. Koenig, Rohini Mehta, Fanny Monge, Zachary Goodman, Zobair M Younossi. PNPLA3 (I148M) variant is not associated with LC3 mediated autophagy in Non-alcoholic Fatty Liver Disease (NAFLD), American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 488 | Ameeta Kumar, Siddhartha Sikdar, Sharon Hunt, Hussain Allawi, Zobair M Younossi. Use of Ultrasound Echotexture Analysis to Determine the Presence of Nonalcoholic Fatty Liver Disease, American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 489 | Emma Powers, Patrick Austin, Carey Escheik, James M. Estep, Kazi Ahmed, Jillian Kallman Price, Ali Weinstein, Lynn Gerber, Zobair M Younossi. Serum Serotonin is Associated with Self-Reported Physical Function in Chronic Liver Disease, American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 490 | Patrick Austin, Kerry Dhakal, Lynn Gerber, Patricia Tran, Stephen C. Clement, Zobair M Younossi. Research Measurements of Insulin Resistance in Liver Disease: A Scoping Review, American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 491 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Adherence to Interferon (IFN) and Ribavirin (RBV)-Free Regimens for Treatment of Chronic Hepatitis C (CH-C): Are There Any Associations with Clinical and Patient-Reported Outcomes (PROs)? , American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 492 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. The Impact of Interferon (IFN)-Free Regimens for Treatment of Hepatitis C Viral (HCV) Infection on Health Related Quality of Life (HRQL), Fatigue and Work Productivity, American College Gastroenterology. Honolulu, HI, October 16, 2015 |
| 493 | Ossman Cossio, Ameeta Kumar, Lynn Gerber, Siddhartha Sikdar, Hussain Allawi, Zobair M Younossi. Validation of Hepato-Renal Index for Detection of Hepatic Fat by Ultrasound, Biomedical Engineering Society. Tampa Convention Center, October 7, 2015 |
| 494 | Jillian Kallman Price, Carey Escheik, Patrick Austin, Ali Weinstein, Patrice Winter, Lynn Gerber, Zobair M Younossi. Diastolic Hypertension, Prehypertension Associated with Significantly Lower Performance and Activity in Chronic Liver Disease (CLD), American College of Sports Medicine. San Diego, CA, May 2015 |
| 495 | Lynn Gerber, James M. Estep, Elzafir Elsheikh Abdelrahman, Maria Stepanova, Carey Escheik, Zobair M Younossi. Improvement of Central and Peripheral Fatigue and Associated Biomarkers After Sustained Virologic Response (SVR) with Ledipasvir (LDV)/Sofosbuvir (SOF) in Patients with Chronic Hepatitis C Virus (CH-C), Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 496 | Haesuk Park, Ayoade Adeyemi, Linda Henry, Maria Stepanova, Zobair M Younossi. ASSOCIATION OF HEPATITIS C VIRUS INFECTION WITH RISK OF CHRONIC KIDNEY DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS , International Society of Pharmacoeconomics and Outcomes Research. Philadelphia, PA, May 16, 2015 |
| 497 | Zobair M Younossi, Bruce R. Bacon, Douglas T. Dieterich, Steven L. Flamm, Kris V. Kowdley, Eric Lawitz, Scott Milligan, Naoky Tsai. Evaluation of access to care in patients prescribed sofosbuvir-containing regimens: Data from the TRIO network., Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 498 | Winnie Suen, Munkhzul Otgonsuren, Aaron B. Koenig, Bashir Noor, Yun Fang, Zobair M Younossi. Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients with Chronic Hepatitis C (CHC) in the United States, Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 499 | Zobair M Younossi, Nathaniel Smith, Maria Stepanova, Ashley S. Brown, Maria Buti, Stefano Fagiuoli, Stefan Mauss, William Rosenberg, Ankur Srivastava, Yushan Jiang, Rachel Beckerman. The Impact of Sustained Viral Eradication on the Work Productivity of Patients with Chronic Hepatitis C (CHC) from the Five Western European Countries and the United States, Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 500 | Zobair M Younossi, Haesuk Park, Ayoade Adeyemi, Maria Stepanova, Linda Henry. A Meta-analytic Estimation of the Burden of Extra Hepatic Manifestations of Hepatitis C, Digestive Disease Week. Washington D.C., May 16, 2015 |
| 501 | Elzafir Elsheikh Abdelrahman, Zahra Younoszai, Munkhzul Otgonsuren, Maria Keaton, Leo Mclaughlin, Fanny Monge, Lakshmi Alaparthi, Zachary Goodman, Zobair M Younossi. Serum Apolipoprotein B is Associated with Increased Collagen Deposition in Patients with Nonalcoholic Steatohepatitis (NASH), Digestive Disease Week. Washington, D.C., May 16,2015 |
| 502 | Azza Karrar, Siddharth Hariharan, Kaitlyn Chhe, Kalyanee Khoeun, Sharon Hunt, Fanny Monge, Zachary Goodman, Munkhzul Otgonsuren, Zobair M Younossi. 3DS1 Killer- Cell Immunoglobulin- Like Receptors (KIR) Activating Gene is an Independent Predictor of Fibrosis in Patients with Non Alcoholic Steatohepatitis (NASH), Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 503 | Zobair M Younossi, Maria Stepanova, Stephen C. Clement, Sean C. Felix, Irfan Ali, Shirley Kalwaney, Aybike Birerdinc, Tasneem Shaikh, Keanu Lee, Manirath Srishord. Low Rates of Vaccination against Hepatitis B in Patients with Chronic Liver Disease and Type 2 Diabetes, Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 504 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Brian P. Lam, Mariam Afendy, Rebecca Cable, Sharon Hunt. Improvement of Patient-Reported Outcomes in Older Patients with Chronic Hepatitis C (CH-C) Treated with Interferon- and Ribavirin-Free Sofosbuvir (SOF)-Containing Regimens, Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 505 | Stephen C. Clement, Maria Stepanova, Olivier Libert, Sammy Saab, Aijaz Ahmed, Zobair M Younossi. Presence of Diabetes and Chronic Liver Disease is Associated with an Increased Risk for Overall Mortality: A Population Study from the United States, Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 506 | Ali Weinstein, Carey Escheik, Bibiana Oe, Patrice Winter, Indie Srishord, Timonthy Oe, Von Botteicher, Phan Giang, Panagiota Kitsantas, Lynn Gerber, Zobair M Younossi. Identifying Predictors of Adherence in Chronic Hepatitis C (CH-C): Statistical Approach to Multi-Level Medical Record Data, Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 507 | Rohini Mehta, Aaron B. Koenig, Zahra Younoszai, Zobair M Younossi. Effects of Farnesoid X receptor (FXR) agonist on expression of genes that regulate fatty acid metabolism in hepatocyte model of non-alcoholic fatty liver disease (NAFLD), Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 508 | Zobair M Younossi, Haesuk Park, Ayoade Adeyemi, Maria Stepanova, Divya Goel, Bashir Noor. Patient Reported Outcomes (PROs) in Chronic Hepatitis C (CH-C): A Meta Analysis of Health Related Quality of Life (HRQL) and Fatigue Data, Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 509 | Elzafir Elsheikh Abdelrahman, Hussain Allawi, Yousef Fazel, Thomas Jeffers, Zahra Younoszai, Munkhzul Otgonsuren, Maria C. Albano, Ingrid Schneider, Michael Campbell, Brian Marsiglia, David Chapman, Bryan Raybuck, Zobair M Younossi. CD45-CD34+ Circulating Progenitor Cells Levels are Associated with the Presence of Coronary Artery Disease (CAD) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) (abstract), Digestive Disease Week. Washington, D.C., May16, 2015 |
| 510 | Jeiran Kianoush, Rohini Mehta, Munkhzul Otgonsuren, Aaron B. Koenig, Zachary Goodman, Ancha Baranova, Zobair M Younossi. Mitochondrial DNA Polymorphisms and Protection against Fibrosis in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Digestive Disease Week. Washington, D.C., May 16, 2015 |
| 511 | Ryan Perumpail, Andy Liu, Randy Liang, David Chao, Sammy Saab, Zobair M Younossi, Olivier Libert, Aijaz Ahmed, Waldo Concepciom, Carlos Esquivel, Clark Bonham. Hepatitis C Virus Infection is Associated with Lower Survival Following Living Donor Liver Transplantation in the U.S., European Association for the Study of the Liver. Vienna, Austria, April 2015 |
| 512 | Zobair M Younossi, Maria Stepanova, Stanislas Pol, Jean-Pierre Bronowicki, Maria Patrizia Carrieri, Marc Bourliere. The Impact of Ledipasvir (LDV)/Sofosbuvir (SOF) Combination on Health-Related Quality of Life (HRQL) and Patient-Reported Outcomes (PROS) in Cirrhotic Patients with Chronic Hepatitis C (CH-C): The SIRIUS Study , European Association for the Study of the Liver. Vienna, Austria, April 2015 |
| 513 | Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario, Sharon Hunt. Increasing Association of Non-alcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma in the United States: Data from Surveillance, Epidemiology and End Results (SEER)-Medicare Registries (2004-2009), European Association for the Study of the Liver. Vienna, Austria, April 2015 |
| 514 | Zobair M Younossi, Maria Stepanova, Linda Henry, Haesuk Park, Andrei Racila, Zahra Younoszai, Sharon Hunt. Direct Medical Costs Associated with the Extrahepatic Manifestations of Hepatitis C Infection in the United States, European Association for the Study of the Liver. Vienna, Austria, April 2015 |
| 515 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader. The Quality of Life Journey for Patients with Chronic Hepatitis C: From Interferon and Ribavirin to Interferon-Free and Ribavirin-Free Regimens, European Association for the Study of the Liver. Vienna, Austria, April 2015 |
| 516 | Zobair M Younossi, Elzafir Elsheikh Abdelrahman, Maria Stepanova, Lynn Gerber, Fatema Nader, Diana Brainard, John McHutchison. Ledipasvir (LDV)/Sofosbuvir (SOF) Treatment of Hepatitis C Virus (HCV) is Associated with Reduction of Serum Apolipoprotein Levels, European Association for the Study of the Liver. Vienna, Austria, April 2015 |
| 517 | Elzafir Elsheikh Abdelrahman, Zahra Younoszai, Munkhzul Otgonsuren, Thomas Jeffers, Hussain Allawi, Brian Marsiglia, David Chapman, Sharon Hunt, Brian P. Lam, Zobair M Younossi. Evaluation of Circulating Progenitor Cells Levels and Functional Capacity in Patients with Nonalcoholic Fatty Liver Disease (NAFLD), European Association for the Study of the Liver. Vienna, Austria, April 2015 |
| 518 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Linda Henry, Sharon Hunt. INTERFERON- AND RIBAVIRIN-FREE REGIMEN WITH LEDIPASVIR AND SOFOSBUVIR IMPROVES FATIGUE AND VITALITY DURING TREATMENT AND AFTER ACHIEVING SUSTAINED VIROLOGIC RESPONSE, Asian Pacific Association for the Study of Liver. Istanbul, Turkey, March 2015 |
| 519 | Maria Buti, Maria Stepanova, Zobair M Younossi. Impact of Sofosbuvir/Ledipasvir treatment on the economic burden associated to productivity loss due to chronic hepatitis C in Spain, ASOCIACIÓN ESPAÑOLA DEL ESTUDIO DEL HÍGADO. Madrid. February 01, 2015 |
| 520 | Stuart C. Gordon, Aijaz Ahmed, Sammy Saab, Zobair M Younossi. Evaluation Of The Long?Term Health Outcomes Of Ledipasivir?Sofosbuvir (LDV/SOF) And Sofosbuvir?Based Regimens For Patients With Chronic Hepatitis C And Liver Cirrhosis Across Genotypes 1 To 4, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 521 | Maria Keaton, Katherine Doyle, Lei Wang, Zahra Younoszai, Rohini Mehta, Zachary Goodman, Aybike Birerdinc, Ancha Baranova, Zobair M Younossi. Visceral Adipose Levels of mRNA Encoding GATA3 and FOXP3 Transcription Factors and CSF1 Marker of Macrophage Infiltration Negatively Correlate with Histologically Assessed Inflammatory Scores in Liver Biopsies , American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 522 | Elzafir Elsheikh Abdelrahman, Zahra Younoszai, Munkhzul Otgonsuren, Fanny Monge, Lakshmi Alaparthi, Brian P. Lam, Sharon Hunt, Zachary Goodman, Zobair M Younossi. Circulating Cholesteryl Ester Transfer Protein is Associated with Percentage of Collagen Deposition in Patients with Nonalcoholic Fatty Liver Disease, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 523 | Zobair M Younossi, Yushan Jiang, Nathaniel Smith, Maria Stepanova, Rachel Beckerman. Sofosbuvir-Containing Regimens for Chronic Hepatitis C (CHC) Infection: Insights from a Work Productivity Economic Model, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 524 | Zobair M Younossi, Sammy Saab, Aijaz Ahmed, Stuart C. Gordon. A Decision- Analytic Markov Model To Evaluate The Health Outcomes of Ledipasvir/Sofosbuvir (LDV/SOF) for Patients with Chronic Hepatitis C (HCV) Genotype 1 (GT1) Infection, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 525 | Stuart C. Gordon, Aijaz Ahmed, Sammy Saab, Zobair M Younossi. Evaluation of the Long-Term Health Outcomes of Ledipasivir/Sofosbuvir (LDV/SOF) and Sofosbuvir-based Regimens for Patients With Chronic Hepatitis C (CHC) And Liver Cirrhosis Across Genotypes 1 to 4, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 526 | DC Alsop, Zobair M Younossi, Maria Stepanova, Nezam H. Afdhal. Cerebral MR spectroscopy and patient-reported mental health outcomes in hepatitis C genotype 1 naïve patients treated with ledipasvir and sofosbuvir, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 527 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Gregory Trimble, Alita Mishra, Shirley Kalwaney, Zahra Younoszai, Fatema Nader, Linda Henry. Hepatitis C Virus Infection is an Independent Predictor of Post-Liver Transplant Diabetes: Data from the U.S. Scientific Registry of Transplant Recipients, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 528 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Kris V. Kowdley, Stefan Zeuzem, Sharon Hunt. Treatment with Interferon (IFN) and Ribavirin (RBV)-Free Regimens with Ledipasvir (LDV) and Sofosbuvir (SOF) Improves Patient-Reported Outcomes (PRO) for Patients with Genotype 1 Chronic Hepatitis C (CH-C): Results from the ION-1,2 and 3 Clinical Trials, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 529 | Zobair M Younossi, Maria Stepanova, Francesco Negro, James M. Estep, Paul Clark, Sharon Hunt, Lisa Kratz, Qinghua Song, Matthew Paulson, Luisa Stamm, Diana Brainard, Mani Subramanian, John McHutchison, Keyur Patel. Serum Lipid and Sterol Analysis in Hepatitis C (HCV) Genotype 2 and 3 Infections Treated with Sofosbuvir (SOF) and Ribavirin (RBV) Regimens, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 530 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Kameron Tavakolian, Brian P. Lam, Manirath Srishord, Chapy Venkatesan, James Cooper, Homan Wai, Linda Henry. Outcomes of Liver Transplantation in Patients with Hepatitis C and Hepatocellular Carcinoma (HCC): The U.S. Transplant Registry Data, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 531 | Zobair M Younossi, Li Zheng, Jessica Heintz, James Cooper, Andrei Racila, Madeline Erario, Linda Henry, Alita Mishra, Sharon Hunt, Gregory Trimble. Hospice Care Utilization Improves Outcome of Medicare Patients Diagnosed with Hepatocellular Carcinoma, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 532 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Manirath Srishord, Spencer Frost, Huong T. Pham, Andrei Racila, Mariam Afendy, Thomas Jeffers. Interferon (INF)-Free Regimens for Chronic Hepatitis C (CHC): Barriers to Treatment Candidacy and Insurance Coverage, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 533 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Kelly Hoyle, Rebecca Cable, Alita Mishra, Stephen C. Clement, Sharon Hunt. Patients with Non-Alcoholic Steatohepatitis are at High Risk of Developing Post-Transplant Diabetes, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 534 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Kris V. Kowdley, Stefan Zeuzem, Sharon Hunt. Sustained Virologic Response with Ledipasvir (LDV) and Sofosbuvir (SOF) Regimens Leads to Substantial Improvement in Patient-Reported Outcomes (PROs) Among Chronic Hepatitis C (CHC) Patients with Early Hepatic Fibrosis as Well as Those with Advanced Hepatic Fibrosis, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 535 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Susanna Naggie, Sharon Hunt. Patient-Reported Outcomes (PROs) in HIV-HCV Co-infected Patients Treated with Sofosbuvir (SOF)-containing Regimens , American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 536 | Zobair M Younossi, E Mendel Singer, Linda Henry, Sharon Hunt, Thomas Jeffers, Spencer Frost, Brian P. Lam. The Use of All Oral Regimens for Treatment of Chronic Hepatitis C (HCV) Coupled with HCV Birth Cohort Screening Is Highly Cost Effective: The Health and Economic Impact on the U.S. Population, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 537 | Elzafir Elsheikh Abdelrahman, Zahra Younoszai, Munkhzul Otgonsuren, Maria C. Albano, Ingrid Schneider, Hussain Allawi, Brian P. Lam, Yousef Fazel, Michael Campbell, Thomas Jeffers, Spencer Frost, Bryan Raybuck, Zobair M Younossi. Autoimmunity to Human Heat Shock Protein-70 is Associated with the Presence of Coronary Artery Disease in Patients with Nonalcoholic Fatty Liver Disease, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 538 | Rohini Mehta, Katherine Doyle, Thomas Jeffers, Drew Venuto, Aybike Birerdinc, Zobair M Younossi. Expression of Cell Death-Inducing DFF45-Like Effector (CIDE) Family of Proteins in Patients with Obesity Associated Non-Alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 539 | Ali Weinstein, Heibatollah Baghi, Carey Escheik, Lynn Gerber, Zobair M Younossi. Two Types of Fatigue in Subjects with Chronic Liver Disease Can Be Distinguished Through Correlations with Physical Activity and Mental Symptoms, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 540 | James M. Estep, Kellie Perry, Kameron Tavakolian, Zahra Younoszai, Maria Stepanova, Ali Noorzad, Richard Binder, Zobair M Younossi. Interferon Lambda-4 (IFNL4) TT allele is associated with lower expression of genes associated with early inflammation after initiation of treatment, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 541 | Azza Karrar, Li Zheng, Ali Moosvi, Siddharth Hariharan, Yun Fang, Maria Stepanova, Zachary Goodman, Zobair M Younossi. HLA Class II Alleles Are Strongly Associated with Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Fibrosis, American Association for the Study of Liver Diseases. Boston, MA, November 2014 |
| 542 | Zobair M Younossi, Azza Karrar, Rohini Mehta, Siddharth Hariharan, Keanu Lee, Maria Stepanova, Zachary Goodman. HLA-A11 Gene Loci Is Strongly Predictive of Susceptibility to Severe Hepatic Steatosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD), American College Gastroenterology. Philadelphia, PA, October 2014 |
| 543 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Kris V. Kowdley, Stefan Zeuzem, Linda Henry, Sharon Hunt. Health Related Quality of Life (HRQL) and Health Utilities (HU) of Patients with Chronic Hepatitis C (CH-C) Treated with an Interferon (IFN)-Free Regimen Containing Ledipasvir (LDV) and Sofosbuvir(SOF), American College Gastroenterology. Philadelphia, PA, October 2014 |
| 544 | Aybike Birerdinc, Maria Keaton, Katherine Doyle, Zahra Younoszai, Lei Wang, Zachary Goodman, Ancha Baranova, Zobair M Younossi. IL-8 is an Important Contributor to Both the Progression of Systematic Inflammation and Increasing Severity of Non-Alcoholic Fatty Liver Disease (NAFLD), American College Gastroenterology. Philadelphia, PA, October 2014 |
| 545 | Azza Karrar, Ali Moosvi, Maria Stepanova, Siddharth Hariharan, Li Zheng, Zachary Goodman, Zobair M Younossi. HLA Class II Alleles Are Associated to Histological Inflammatory Features of Steatohepatitis (NASH), American College Gastroenterology. Philadelphia, PA, October 2014 |
| 546 | Kameron Tavakolian, James M. Estep, Ancha Baranova, Zachary Goodman, Zobair M Younossi. Adiponectin Ligand and Receptor Expression in Omental Adipose Tissue of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD), American College Gastroenterology. Philadelphia, PA, October 2014 |
| 547 | Azza Karrar, Siddharth Hariharan, Khatera Salem Malik, Li Zheng, Munkhzul Otgonsuren, Sharon Hunt, Zachary Goodman, Zobair M Younossi. The Role of Mannan Binding Lectin Pathway in Non Alcoholic Fatty Liver Disease (NAFLD), American College Gastroenterology. Philadelphia, PA, October 2014 |
| 548 | Linda Henry, Kathleen Whitly, Kerry Dhakal, Libby Samuel, Lois Culler, Melinda Byrns, Sharon Hunt, Zobair M Younossi. A Systematic Review Assessing the Impact of Chronic Hepatitis C (CH-C) on Health Related Quality of Life (HRQL) and Patient Reported Outcomes (PROs), American College Gastroenterology. Philadelphia, PA, October 2014 |
| 549 | Zobair M Younossi, Stuart C. Gordon, Sammy Saab, Aijaz Ahmed, Haesuk Park, Mark S. Sulkowski. Health and economic outcomes of Sofosbuvir therapy as predicted by a markov model in the hcv/hiv co-infected population, International Society of Pharmacoeconomics and Outcomes Research. Beijing, China, September 6, 2014 |
| 550 | Kosh Agarwal, Edward J. Gane, Xavier Forns, Michael Manns, Sammy Saab, Massimo Colombo, Zobair M Younossi, Norah Terrault. The cost-effectiveness of Sovaldi treatment pre-transplant to prevent HCV recurrence post-transplant, International Liver Transplantation Society. London, UK, June 2014 |
| 551 | Zobair M Younossi, Ali Weinstein, Maria Stepanova, Sharon Hunt, Carey Escheik, Fatema Nader, Manirath Srishord, Lynn Gerber. Factor Analysis Identifies Types of Fatigue in Patients with Hepatitis C and Their Relationships to Health Related Quality of Life (HRQL), Work Productivity and Activity Impairment , Digestive Disease Week. Chicago, IL, May 2014 |
| 552 | Maria Stepanova, Sharon Hunt, Sammy Saab, Spencer Frost, Thomas Jeffers, Zobair M Younossi. Outcomes of Liver Transplantation in the United States: What Has Changed Over the Last 25 Years?, Digestive Disease Week. Chicago, IL, May 2014 |
| 553 | Munkhzul Otgonsuren, Linda Henry, Sharon Hunt, Chapy Venkatesan, Alita Mishra, Andrei Racila, Zobair M Younossi. Resource utilization of Medicare patients with Advanced Liver Disease and Ascites, Digestive Disease Week. Chicago, IL, May 2014 |
| 554 | Maria Keaton, Katherine Doyle, Lei Wang, Rohini Mehta, Zahra Younoszai, Aybike Birerdinc, Hazem Elariny, Ancha Baranova, Zobair M Younossi. The Potential Factors involved in the Differentiation of BAT from WAT in Morbidly Obese Patients with Non-alcoholic Fatty Liver Disease (NAFLD) , Digestive Disease Week. Chicago, IL, May 2014 |
| 555 | Katherine Doyle, Maria Keaton, Lei Wang, Rohini Mehta, Massih Abawi, Zahra Younoszai, Thomas Jeffers, Hazem Elariny, Amir Moazzez, Aybike Birerdinc, Ancha Baranova, Zobair M Younossi. Role of Vitamin D in the inflammatory response of morbidly obese patients with Non-alcoholic Fatty Liver Disease (NAFLD), Digestive Disease Week. Chicago, IL, May 2014 |
| 556 | Elzafir Elsheikh Abdelrahman, Munkhzul Otgonsuren, Elena Younossi, Brian P. Lam, Rebecca Cable, Thomas Jeffers, Spencer Frost, Zobair M Younossi. Angiogenic growth factors in patients with nonalcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease , Digestive Disease Week. Chicago, IL, May 2014 |
| 557 | Elzafir Elsheikh Abdelrahman, Zahra Younoszai, Munkhzul Otgonsuren, Elena Younossi, Thomas Jeffers, Spencer Frost, Bryan Raybuck, Zobair M Younossi. Factors associated with Statins use in patients with nonalcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD), Digestive Disease Week. Chicago, IL, May 2014 |
| 558 | Azza Karrar, Sneha Lingam, Elena Younossi, Sharon Hunt, Zahra Younoszai, Maria Stepanova, Zachary Goodman, Zobair M Younossi. Human H-ficolin Is Independently Associated with Non Alcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH), Digestive Disease Week. Chicago, Illinois, May 2014 |
| 559 | Azza Karrar, Sneha Lingam, Elena Younossi, Sharon Hunt, Zahra Younoszai, Maria Stepanova, Zachary Goodman, Zobair M Younossi. Pentraxins are independently associated with non-alcoholic Steatohepatitis (NASH), Digestive Disease Week. Chicago, IL, May 2014 |
| 560 | Brian P. Lam, James M. Estep, Fanny Monge, Lakshmi Alaparthi, Zachary Goodman, Yun Fang, Maria Stepanova, Zobair M Younossi. Inflammatory Cytokines Are Associated with Hepatic Steatosis and Fibrosis Measured by Computer-Assisted Morphometry (CAM) in Patients with Non-Alcoholic Fatty Liver disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), Digestive Disease Week. Chicago, IL, May 2014 |
| 561 | James M. Estep, Ashley Greer, Rohini Mehta, Elzafir Elsheikh Abdelrahman, Thomas Jeffers, Zachary Goodman, Hazem Elariny, Amir Moazzez, Zobair M Younossi. Histologic NASH Is Associated Lack of Improvement of Metabolic Conditions Post Bariatric Surgery, Digestive Disease Week. Chicago, IL, May 2014 |
| 562 | Lisa M. Nyberg, Kevin M. Chiang, Z. Li, Anders H. Nyberg, Zobair M Younossi, T. Craig Cheetham. Comorbid conditions associated with decision-making regarding treating or not treating chronic hepatitis C in a large U.S. health maintenance organization, Digestive Disease Week. Chicago, IL, May 2014 |
| 563 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Sharon Hunt. Ledipasvir (LDV) and Sofosbuvir (SOF) Combination Improves Patient-Reported Outcomes (PRO) During Treatment of Chronic Hepatitis C (CH-C): The Result from ION-1 Clinical Trial, European Association for the Study of the Liver. London, UK, April 2014 |
| 564 | Ira M. Jacobson, Mary Kay Washington, Alexander Thompson, Nid Afdhal, Raul Aguilar Schall, Phillip Dinh, Jeff Bornstein, John Flaherty, Mani Subramanian, John McHutchison, Zobair M Younossi, Patrick Marcellin, Keyur Patel. Presence of steatosis and HBeAg-positive status and independently associated with peristently elevated serum alt levels in chronic HBV patients during antiviral therapy, European Association for the Study of the Liver. London, UK, April 2014 |
| 565 | Emmi Suomela, Mervi Oikonen, Johanna Virtanen, Riita Parkkola, Eero Jokinen, Tomi Laitnen, Nina Hutri-Kahonen, Mika Kahonen, Terho Lehtimaki, Leena Taittonen, Paivi Tossavainen, Britt-Marie Loo, Zobair M Younossi, Jorma S. A. Viikari, Markus Juonala, Olli T. Raitakari. Prevalence and determinants of fatty liver in normal weight and overweight young adults: The cardiovascular risk in young Finns study, European Association for the Study of the Liver. London, UK, April 2014 |
| 566 | Zobair M Younossi, Maria Stepanova, Stefan Zeuzem, Hendrik W. Reesink, Ola Weiland, Fatema Nader, Sharon Hunt. Health-related Quality of Life (HRQL) and Patient-reported Outcomes (pros) assessment in chronic hepatitis C (Ch-C) treated with Sofosbuvir (SOF) and Ribavirin (RBV): the valence study, European Association for the Study of the Liver. London, UK, April 2014 |
| 567 | Elzafir Elsheikh Abdelrahman, Zahra Younoszai, Munkhzul Otgonsuren, Elena Younossi, Brian P. Lam, Thomas Jeffers, Spencer Frost, Bryan Raybuck, Zobair M Younossi. Increased serum level of heat shock protein 27 associated with low risk of Coronary Artery Disease (CAD) in patients with Nonalcoholic Fatty Liver Disease (NAFLD), European Association for the Study of the Liver. London, UK, April 2014 |
| 568 | Zobair M Younossi, Maria Stepanova, Fatema Nader, David R. Nelson, Eric Lawitz, Ira M. Jacobson, Edward J. Gane, Sharon Hunt. Independent predictors of patient-reported outcomes (PROs) and quality of life (QOL) in chronic hepatitis c patients receiving interferon (IFN)-free versus IFN-containing regimens with sofosbuvir (SOF), European Association for the Study of the Liver. London, UK, April 2014 |
| 569 | Zobair M Younossi, Maria Stepanova, Fatema Nader, David R. Nelson, Eric Lawitz, Ira M. Jacobson, Edward J. Gane, Sharon Hunt. Patient-reported Outcomes (PROs) in Chronic Hepatitis C Patients with Cirrhosis Treated with Sofosbuvir (SOF) Containing Regimens, European Association for the Study of the Liver. London, UK, April 2014 |
| 570 | Zobair M Younossi, Maria Stepanova, Lynn Gerber, Fatema Nader, Spencer Frost, Sharon Hunt. Improvement of Central Fatigue is Associated with Sustained Virologic Response (SVR) Following Sofosbuvir (SOF) Containing Regimens, European Association for the Study of the Liver. London, UK, April 2014 |
| 571 | Maria Stepanova, Sammy Saab, Sharon Hunt, Thomas Jeffers, Shirley Kalwaney, Zobair M Younossi. Donor´s and recipient´s diabetes are independently associated with mortality in liver transplant recipients, European Association for the Study of the Liver. London, UK, April 2014 |
| 572 | Zobair M Younossi, Maria Stepanova, Sandrine Cure, Francois Bourhis, Fatema Nader, Sharon Hunt. Estimating health status using EQ5D for chronic hepatitis C (CH-C) patients treated with sofosbuvir (SOF) containing regimens, European Association for the Study of the Liver. London, UK, April 2014 |
| 573 | Chapy Venkatesan, Nancy Maaty, Shirley Kalwaney, Alita Mishra, Jillian Kallman Price, Yun Fang. Standardizing the Discharge Process With an Electronic Medical Record-Based Checklist - A Resident-Led Quality Improvement Initiative , Society of General Internal Medicine. San Diego, CA, April 23-26, 2014 |